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Nanoparticles, even though small in dimension, have a huge impact on the 
economy. Nanotechnology is a multidisciplinary approach that is perceived to be 
building up the future of coming era. Thus, it is absolutely necessary to understand the 
health impact of the nanomaterials to facilitate a safe and sustainable progression of 
the nanotechnology. Nanotoxicology is one of the latest branches of nanotechnology 
that investigate the biological properties of nanoparticles. Previous studies in 
nanotoxicology demonstrated adverse health effects of many commercialised 
nanomaterials. Based on the early reports, a robust research was initiated to 
understand the toxicity of nanomaterials currently in demand. 
In the studies described in this thesis, we have investigated the toxicity 
associated with silver and platinum nanoparticles both in vitro and in vivo. The 
nanoparticles were screened using zebrafish embryos and human cell lines, to identify 
potential toxicity of the nanoparticles, which were further investigated to elucidate the 
mechanism of toxicity. In vivo models were monitored for developmental defects such 
as pericardial and yolk sac edema, bent notochord, malformation of eyes, 
accumulation of blood etc. The distribution of the toxic nanoparticles inside the 
embryos were further studied by using transmission electron microscopy of embryo 
sections, which showed presence of nanoparticles in various developing organs such 
as brain, heart etc. Nanoparticle deposition was seen in the nucleus of the embryonic 
cells as well. Cell lines (human lung fibroblasts and human glioblastoma cells) were 
treated with various nanoparticles to identify the degree of toxicity through viability 
assay. The mechanism of nanoparticles uptake and bio distribution was studied in 
detail. Metabolic activity in nanoparticles treated cells were measured using ATP 
content of cells and mitochondrial activity which indicateded metabolic dysfunction. 
  xi
Generation of reactive oxygen species was measured using fluorescence staining and 
subsequent flow cytometry analysis which established increased production of 
hydrogen peroxide and superoxide. Oxidative stress is a common cause of DNA 
damage in chemical toxicity. Therefore, DNA damage in cells was studied using 
single cell gel electrophoresis and other genotoxic effects of nanoparticles were 
looked at by studying chromosomal aberrations (fluorescence insitu hybridizations) 
and micronucleus formation. The nanoparticle treated cells showed increased DNA 
damage, micronuclei formation and chromosomal aberrations. The fate of the cells 
was further studied through cell cycle analysis and cell viability-death assay by flow 
cytometry, which further showed a G2/M arrest and minimal cell death at higher 
concentration of nanoparticles. Recovery of treated cells was monitored and the ability to 
form colonies was investigated. Colony formation assay showed absence of colony 
formation only in silver nanoparticles treated cells, which was more pronounced in cancer 
cells. The genes and proteins differentially expressed following nanoparticle treatment were 
identified through pathway specific array, RT-PCR and western blotting. The interactions 
of silver nanoparticles with cytosolic proteins were studied through isothermal titration 
calorimetry which evidenced strong interaction with proteins. Platinum nanoparticles 
exhibited a lesser degree of toxicity compared to silver nanoparticles. In vivo models expose 
to silver nanoparticles exhibited up regulation of genes involved in DNA damage and 
oxidative stress. 
In summary, this study has identified significant toxicity associated with the 
commercially available nanomaterials. Thus it is ideal that large scale production and 
commercialisation of such nanoparticles must be minimised until proper guidelines are 
developed. Also, nano-wate disposal must be taken care of to avoid environmental 
pollution. 
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1. 1. Nanotechnology: An overview 
The term ‘nano’ derived from the Greek word meaning ‘dwarf’. It represents 
one billionth of a unit. Nanometre stands for 10-9 of a metre and nano litre denotes 10-9 
of a litre. The term nanotechnology was conceived by Dr. Norio Taniguchi in 1974 
(Taniguchi, 1974). However, the glory of nanotechnology dates back to Fourth 
century A.D, to the era of Roman Empire Lycurgus and the famous Lycurgus cup. The 
Lycurgus cup was carved with exceptional workmanship to depict the triumph of King 
Dionysus over Lycurgus.  The cup is made up of colloidal silver and gold, which gives 
a dichroic appearance to the glass; opaque green colour in reflected light due to 
colloidal silver (300 ppm) and ruby red in transmitted light due to the presence of 
colloidal gold (40 ppm) (Freestone et al., 2007). The revival of modern nanotechnology 
began in 1959, following the inspiring speech (“There is plenty of room at the bottom”) 
by the American Physicist Dr. Richard Feynman (Feyman R.P, 1960).   
The golden era of nanotechnology that designs, synthesise and characterise 
nanoparticles through a “bottom up approach” materialised following the pioneering 
work by Dr. Eric Drexler (Drexler, 1986). The exceptionally sensitive technology that 
manipulates materials at atomic level to create nano-sized objects, took a humongous 
leap in the 1980’s following the invention of fullerenes (1985), carbon nanotubes 
(CNTs, 1991) and advanced microscopic technique like scanning tunnelling 
microscopy (1981). 
The interest created by nanotechnology has initiated rapid economic growth 
and industrial developments. In the near future, nanotechnology may emerge as an 




important scientific discipline which designs and develop nanomaterials with unique 
physio-chemical properties. A large number of US based federal regulatory bodies 
were launched following the sudden increase in active nano research and 
commercialisation. National Nanotechnology Initiative launched in 2000, is one such 
kind which has centres in different countries. Nanotechnology regulatory bodies have 
resulted in a well organised network for co-ordinating the inventions, sharing and 
classifying the information based on its relevance. This has led to a more appropriate 
classification of nanoparticles specifically as fine particles (200 nm to 10 µM) and 
ultra-fine particles (<100 nm).  
In the recent years, the increased interest in nanotechnology has initiated many 
industries to commercialise of nanomaterials at a rapid rate of 3-4 new products every 
week compared to other leading technologies (Analysis, 2009). Based on the statistics 
published in 2006 by Nanotechnology consumer products inventory, around 600 nano 
based products are currently marketed by approximately 322 companies (Nel et al., 
2006). The most recent statistics published in 2009 revealed an increase in the number 
of commercialised nano products to 1015, with 605 products in health and fitness, 152 in 
household products, 98 in food and beverages, 57 in sporting goods and 19 products in 
baby/child products (Analysis, 2009). The analysis revealed silver nanoparticles as the 
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Figure 1.1: Updated nano products inventory from 24 countries. The 
graphs show increase in the commercialisation of nanoparticles every 
year in different areas (Analysis, 2009). 
 




Human engineered nanoparticles with surfaces designed and functionalised to 
perform specific functions are created in large scale these days. It is estimated that the 
production of nanoparticles for commercial use will increase from 2300 tons produced 
today to 58000 tons by 2020 (Xia et al., 2009). Based on the current sales figures, the 
market is expected to exceed one trillion US dollars by 2015 (Xia et al., 2009). Nano 
based commercial products are expected to revolutionize areas such as therapeutic 
medicine and information technology. Engineered nanomaterials are currently used in 
textiles, sporting equipments, medical applications and cosmetics (Bawarski et al., 
2008; Sgobba and Guldi, 2009; Staggers et al., 2008). The wide array of applications 
has paved the way for the emergence of multiple branches of nanotechnology, 
depending on the applications for which they are designed. Nanobiotechnology, 
nanoelectronics, nanomagentics, nanophotonics, nanomechanics, nanolithography, 
nanomedicine and nanotoxicology are among a few.  
1. 2. Classification of nanomaterials 
Nanoparticles can be produced by either  
i) ‘Top down’ approach, where bulk materials are broken down to nano size   
    by milling or etching. 
ii) ‘Bottom up’approach that makes nano sized objects by combining atomic   
      scale materials (Hallock et al., 2008).  
Even though many different classifications exist, nanomaterials are mainly 
classified based on their composition and shape. Based on composition nanoparticles 
are classified as:  
 




(a) Organic nanoparticles (eg. Polymeric nanoparticles) 
(b) Inorganic nanoparticles such as metal nanoparticles (eg. gold, silver)  
(c) Organic–inorganic hybrids (eg. nanocomposites)  
(d) Carbonaceous nanostructures (eg. Buckyballs)  
(e) Liposomes that can be filled with specific materials and  
(f) Biological nanoparticles such as proteins.  
Based on their shape, nanomaterials are classified as nanotubes, nanoparticles, 
nanoprisms, nanocubes, nanosheets and nanorods. Different morphological variants of 
nanomaterials are represented in Figure 1.2. 





Figure 1.2: Morphological variants of nanomaterials. (A) is nanowires (B) nanorods 








1.3. Synthesis and properties of metal nanoparticles  
 The metal ions are reduced by employing reducing agents to yield 
corresponding metal atoms that aggregate to form a metal clump. In nanoparticle 
synthesis, the growth of the metal clump is inhibited at some stage by employing a 
capping agent (surface functionalisation) that prevents further addition of atoms to the 
clump thus maintaining the size and shape. A typical reaction can be represented as 
given in equation 1.1, 
Mn+ + ne-  Mo          1.1 
Where M is the metal ion employed and n is the number. 
The electron is not supplied as electron per se, but as a reducing agent, which gets 
oxidized in the process as given below (equation 1.2).  
Reductionm- – ne-  Oxidation (m-n)-        1.2  
During this process, the reducing species (reductant) of finite charge gets oxidized 
losing certain charge. The possibility of the net reaction is in equation 1.3.  
Mn+ + Reductionm-   Mo + Oxidationm-n-       1.3  
Equation 1.3 depends on the thermodynamics of the process, which in turn is 
represented by the electrochemical potentials of the corresponding half cell reactions. 
These are called the standard reduction potentials. If the reduction potentials 
corresponding to the reactions 1.1 and 1.2 are added (with their signs), and if we get a 
net positive value, the process is thermodynamically feasible. This corresponds to a 
net negative free energy change as, ΔG = -nFE, where ΔG is the free energy change of 
the reaction 1.3, n is the number of electrons involved, F is a constant called Faraday 
and E is the electrochemical potential of reaction 1.3. In conclusion, the process is 




thermodynamically feasible if ΔG is negative.  A typical appearance of nanoparticle is 
represented in Figure 1.3 (Hallock et al., 2008). 
          
 
Figure 1.3: High resolution electron micrograph of a quantum dot (QD) showing 
arrangement of atoms (Hallock et al., 2008). 
 
The properties of nanoparticles depend on various factors such as size, shape, 
purity, crystallinity, electronic properties, type of surface functionalisation, solubility 
and stability (Nel et al., 2006). They exhibit entirely different properties from their 
bulk materials and thus their applications are very different from that of their bulk. 
The typical characters depend on their A pictorial representation of factors affecting 
the properties of  nanoparticle is depicted in Figure 1.4 (Stern and McNeil, 2008). 





Figure 1.4: Schematic representation of a nanoparticle, showing factors affecting its 
properties (Stern and McNeil, 2008). 
 
1.3.1. Size of the nanoparticle 
 Presence of a large number of atoms on the surface increases its catalytic 
properties. It is known that ultrafine particles are more reactive than fine particles, 
which may be due to the higher penetration efficiencies privileged by their smaller 
size. However, the uptake kinetics challenges this concept by adding evidences to an 
increase in the uptake of 40-50 nm size particles when compared with 20 nm particles 
(Chithrani and Chan, 2007). 
1.3.2. Quantum confinement 
 Another unique feature of nanoparticle is its surface to volume ratio. As this 
ratio is high for nanoparticles, a large number of atoms are exposed to the surface than 
interior, giving many size dependent phenomena. The finite size of the particle 




confines the spatial distribution of electrons, leading to the quantized energy levels 
due to size effect. This quantum confinement has applications in semiconductors, 
optoelectronics, and non-linear optics. The spherical-like shape of nanoparticles 
produces surface charges (positive or negative) resulting in lattice relaxation 
(expansion or contraction) and change in lattice constant. The electron beam energy 
bandgap is sensitive to lattice constant. The lattice relaxation introduced by 
nanoparticle size could affect its electronic properties. 
1.3.3. Surface plasmon resonance 
 The nanoparticle core exists in a plasma state due to the negatively charged 
conducting electron and the positively charged lattice. When challenged with 
electromagnetic waves, they oscillate beyond neutral charged state and back to their 
normal state. This collective excitation of Plasmon is termed as surface plasmon 
resonance (SPR). The oscillations of surface plasmons in the nanoparticles give strong 
colours to the nanoparticle solutions, which act as identification markers for the 
nanoparticles. For example silver nanoparticles have greenish brown colour while 
gold nanoparticles exhibit magenta colour. This remarkable optical property forms the 
basis of the dichroic nature of the Lycurgus cup. The SPR of silver nanoparticles that 
are embedded in the glass give the green colour in reflected light while gold 
nanoparticles give ruby red colour in transmitted light (Figure 1.5).  





Figure 1.5: Dichroic appearance of Lycurgus cup due to the SPR of gold and silver 
nanoparticles (Freestone et al., 2007); greenish colour of the cup in reflected light 
(left) due to the silver nanoparticles and ruby red appearance in transmitted light 
(right) contributed by gold nanoparticles. 
 
1.3.4. Morphology of the nanoparticle 
 Even though differently shaped (anisotropic) nanomaterials have different 
applications, spherical nanoparticles are among the most studied nanoparticles. A few 
examples of anisotropic metallic nanoparticles include gold nanorods, CNTs and 
silver nanorods. However the difficulty in attaining the desired shape and 
reproducibility of the procedure limits the application. 
1.3.5. Surface functionalisation 
 Surface functionalisation gives stability to the nanoparticles. Besides, it can 
control the uptake (Villanueva et al., 2009)  and modulates the biocompatibility or 
cytotoxicity (Yildiz et al., 2009) of the nanoparticles, either by direct interaction with 
receptors or by preventing aggregation of nanoparticles. Choice of surface 
functionalising agents also determines the shape of the nanoparticles, when combined 
with specific synthesis procedures. The strength of attachment of surface 
functionalisation determines the reactivity of nanoparticles by facilitating ligand 




exchange in the presence of multiple ligands (eg. cytosolic proteins) (Cedervall et al., 
2007). These properties make surface functionalisation a crucial factor in 
nanotechnology. Thus care must be taken while chosing a suitable surface 
functionalisation for the nanoparticles. Choice of capping agent must complement the 
application for which they are employed for. For example, in drug delivery it is ideal 
to choose a ligand that facilitate easy receptor mediated uptake. Also, chosing 
biomolecules as capping agent will contribute to the biocompatibility of the 
nanoparticles. 
1. 4. Nanotechnology: An outlook at current trends 
The term “nano” has been passionately adopted by the world and many 
unrelated products such as “i-pod nano” and “nano-cars”, have captured the market. 
Nanoparticles are being commercialised in a fast pace. Metal oxide nanoparticles such 
as TiO2 are being used in sunscreen lotions to provide protection against harmful UV-
rays. Gold nanoparticles and nanorods are used for the diagnosis and treatment of 
pathological conditions such as cancer (Boisselier and Astruc, 2009). Silver 
nanoparticles, owing to their broad spectrum of antimicrobial action, are widely used 
in antiseptics, wound dressings, components in food containers, detergents, cosmetics 
and in many other consumer products (Rai et al., 2009; Edwards-Jones, 2009). 
Polymeric nanoparticles are used as nanocarriers which can transport therapeutic 
agents directly to the target site with high efficiency (Mandal and Kundu, 2009). 
Many other nanomaterials such as CNTs have applications in electronics due to their 
excellent conductivity (Kang et al., 2007). Although many branches of science have 
benefited by nanotechnology, medicine is one of the areas where extensive research is 
undergoing for developing better therapeutic strategy. Approximately 160 nanodrugs 




are currently in market with many more in clinical trials (Peer et al., 2007). 
Nanotechnology has also attracted the defence force, where ongoing research develops 
nanomaterials-based rocket fuels, wear and tear resistant coating on warships and so 
on. (Loney, 2004). NASA is actively developing nanoparticle-based systems in their 
space shuttles for better performance (Hunley, 1999). 
1. 5. Nanotechnology: Future prospects 
Nanotechnology is expected to capture the commercial as well as research field 
in the 21st century. It is expected to advance in four phases (Nel et al., 2006). At 
present, the first phase of nanotechnology aims to develop passive nanostructures for 
specific applications, such as, nanoparticles for the use in sunscreens and other 
commercial products. The success and advancement of the first phase lays open many 
promising opportunities. The second phase of nanotechnology is expected to rely on 
active nanomaterials that can perform multiple tasks (eg. biodevices). The third phase 
will comprise of nano-systems with a large number of interacting components acting 
together in a robotic manner. The fourth phase will open up more complex systems 
that can function like living systems in a coordinated hierarchical way to provide 
better understanding of the processes under study.  
1. 6. Nanoparticles in the limelight 
The importance of nanoparticles in this century is undisputable. Even though, 
nanomaterials are manufactured for specific applications, a few nanoparticles which 
comprise of particles such as magnetite, gold, silver, platinum and CNTs are largely 
used in multidisciplinary areas.  CNTs are released to the air during natural gas and 
wood burning (Murr, 2009). CNTs have many applications due to their remarkable 
mechanical and electrical properties and are thus highly researched materials. The 




superior mechanical properties of the CNTs have been made use in improving the 
quality and performance of sporting equipments and gears.  
1.6.1. Gold nanoparticles 
The therapeutic application of gold colloids started in BC 2500 (Bhattacharya 
and Mukherjee, 2008). In Asia, different forms of gold colloids had been in use since 
ancient times. Swarnabhasma and Makaradhwaja are the common forms used as 
medicines that revitalise the body (Mahdihassan, 1971; Mahdihassan, 1981; 
Mahdihassan, 1985). It had also been used in 16th century for treating nerve conditions 
and epilepsy (Daniel and Astruc, 2004). In the 19th century, gold was introduced as a 
medication for the treatment of syphilis (Daniel and Astruc, 2004) . Due to their 
bacteriostatic properties, gold has categorised itself under therapeutic agents for 
treating tuberculosis in 1920s (Daniel and Astruc, 2004). Biological applications of 
gold nanoparticles started in 1971 as labels in immunostaining (Faulk and Taylor, 
1971). Today gold nanoparticles are being developed as tumour imaging and targeting 
agents (Shi et al., 2009). The anti-angiogenic property of gold nanoparticles adds on to 
their significance (Bhattacharya and Mukherjee, 2008).  
1.6.2. Silver nanoparticles 
Silver salts have been in use for thousands of years in jewellery, utensils, 
dental alloy, photography materials and decorations for oriental pastries. Colloidal 
silver is well known for its anti-microbial potential. In 1000 BC, ancient Greeks used 
silver vessels for cooking and as storage to prevent bacterial overgrowth (Wadhera 
and Fung, 2005; Silver et al., 2006). In 8th century silver was introduced as medicine 
for the treatment of blood-related disorders and heart palpitations (Wadhera and Fung, 
2005). Seventeenth and eighteenth centuries were rewarded by the implementation of 




silver compounds for treating ulcers (Klasen, 2000b). In the 19th century, the common 
anti-septics used in surgery was replaced by the silver salts (Klasen, 2000b). However 
the trend disappeared after World War II, after which silver sulphadiazine was used 
for treating only burn infections (Klasen, 2000a). After the emergence of 
nanotechnology, nano-sized silver invaded the market with more and more wound and 
burn dressings being commercialised. According to the latest studies, silver 
nanoparticles-based products are one of the fastest growing product categories in the 
current market (Chen and Schluesener, 2008). 
Some of the commercialised silver nanoparticles containing wound dressings are 
listed in Table 1.1. The exceptionally powerful antimicrobial activity of silver 
nanoparticles was investigated in many studies and is proposed to damage bacterial 
cell wall, bind with proteins or DNA and inactivate the enzyme phosphomannose 
isomerase (Rai et al., 2009). 
Silver nanoparticles exhibit antiviral properties, abolishing the replication of 
hepatitis B virus (Lu et al., 2008). Interestingly, they have shown to reduce the 
infectivity of HIV viruses as well through blocking the gp120 subunits in the viral 
envelope (Elechiguerra et al., 2005). Silver nanoparticles have many applications in 
medicine such as wound and burn dressings, contraceptives, linings for surgical 
instruments and bone prostheses and catheters (Chen and Schluesener, 2008). Non 
therapeutic silver nano products include nano silver room spray, air fresheners, 
electrical appliances, wall paint, detergents and clothes, especially socks to control 
odour and bacterial growth.  
 
 




Table 1.1: Commercially available nanoparticle based wound dressings. 




impregnated fibres that 
continuously release Ag+ ions 
upon hydration 
Convatec, Skillman, NJ, 
USA 
 
Actisorb silver 220 
Actisorb pads adsorb bacteria 
to the charcoal and are killed 
by nanoparticles 
Johnson & Johnson, New 
Brunswick, NJ, USA. 
 
Acticoat-7 
Mesh coated with silver 
nanoparticles provide large 
amount of silver to the wound 
site 
Smith and Newphew, UK 
Silverlon 
Polymeric fabric containing  
Silver nanoparticles. 




Wound dressings containing  
silver nanoparticles. 
Kinetic Concepts, Inc, San 
Antonio, USA 
 
1.6.3. Platinum nanoparticles 
Platinum complexes are known for their anti-tumour activity. Cis-platin was 
discovered in 1960s by Rosenberg (Rosenberg et al., 1967), which prompted the 
research on platinum based therapeutic agents. 
Platinum nanoparticles are still in the early phase of development. One of the 
growing areas where potential applications are being explored is nanomedicine, for 
designing a better nano-platinum drug with improved therapeutic index. Preliminary 
reports have shown that platinum nanoparticles complexed with other metals had 




remarkable anti-cancer properties (Gao et al., 2007). Scientists are exploring the ways 
to exploit the innate potential of platinum nanoparticles and develop a highly specific 
targeted nano-platinum drug. Platinum nanoparticles complexed with CNTs, find 
other applications in medicine as DNA biosensors, owing to their superior catalytic 
properties (Wang et al., 2006b). 
1.7. Nanotechnology: A two-sided sword? 
The novel features of the nanoparticles are impressive and attractive in a 
nanotechnologist’s perspective. However the use of nanoparticles for daily 
applications has to be justified with the safety of exposure to the nanomaterials. The 
safety concerns among consumers and environmental protesters are unquestionably 
sensible. Some preliminary studies suggest that nanoparticles could affect cellular 
functions at molecular levels (Fujita et al., 2009). Some nanoparticles are capable of 
penetrating all physiological barriers to reach vital organs. In addition, evidences 
suggest significant toxicity associated with many of the nanomaterials currently in use 
(Brunet et al., 2009; Hu et al., 2009; Pan et al., 2009; Barrena et al., 2009). Amidst of 
the outcries from consumers, researchers and environmental activists, a new branch of 
nanotechnology, nanotoxicology took birth. Nanotoxicology investigates the toxicity 
of nanomaterials in biological systems, as a function of their individual properties 
such as size, surface functionalisation and charge. 
1.8. Lessons from history 
Nanotoxicology is in its infancy. It has to rely heavily on the history of use of 
nanomaterials before distinguishing “nanos” as tiny harmless structures or potentially 
dangerous agents. In early 20th century (Tetley, 2007), reports on asbestos 
demonstrated carcinogenic effects, however was taken lightly due to their exciting 




applications. This approach resulted in devastating effects with occupational hazards 
leading to mesothelioma. Care should be taken that the history of asbestose will not be 
repeated in the 21st century with nanotechnology. Earlier studies have shown the 
association of particulate air pollution with respiratory conditions such as asthma, lung 
cancer and cardiovascular conditions like myocardial infarction (Dockery, 2009). 
Evidences suggest adverse health conditions following exposure to metal salts (Kim et al., 
2009). Thus more research must be done to provide a complete understanding of 
biological properties of nanoparticles including uptake, distribution, intracellular 
trajectory, interactions with sub cellular system and biomolecules. The current pool of 
data available in the literature offers much valuable information gathered from the 
bioactivity studies of nanoparticles such as TiO2 nanoparticles, one of the earliest 
commercialised nanomaterials. The data obtained from such studies shed light to the 
mechanisms of nanoparticle toxicity. However, it should also be taken into 
consideration that the properties of nanomaterials vary within the same elemental type 
based on size, shape and surface functionalisation of nanomaterials. 
1.9. Portals of entry of nanomaterials and the factors contributing to the uptake 
Exposure to nanoparticles occurs in various ways, the common routes of entry 
being inhalation, ingestion, absorption or through therapeutic applications. A detailed 


















Figure 1.6: Potential routes of exposure, translocation and deposition of 
nanomaterials (Oberdorster et al., 2005). 
 
1.9.1. Inhalation 
Inhalation is widely accepted as a major unintentional route of exposure to 
nanomaterials. The severity of exposure varies depending on the size, chemical nature 
and reactivity of the nanoparticles (Nel et al., 2006). Nanoparticles with large size 
(100-2000 nm) are unlikely to reach the lung and are efficiently expelled by 
mucociliary escalator system and macrophages (Kumar, 2006). Experimental evidence 
points at a 4 fold increase in deposition of nano sized particles (less than 100nm) 
compared to micron sized particles (Kanapilly and Diel, 1980). Moreover, the size 
distribution of the nanoparticles affects the target regions of deposition in the 
respiratory tract where smaller particles penetrate deeper (Oberdorster et al., 2005). 
Those particles which get deposited in the lung alveoli have a higher chance of 
inhibiting normal respiratory functions; They can penetrate the alveoli and get 




absorbed to the lung or could be cleared by macrophages, a process that is affected by 
the size and shape of nanomaterials (Zhao and Nalwa, 2007). CNTs are reported to 
cause impaired phagocytosis, where the phagocytes are not able to phagocytose 
micron long tubes which in turn suffocate phagocytes, releasing inflammatory 
cytokines and impairing their functions (Monteiro-Riviere et al., 2005). On the other 
hand smaller sized particles (less than 70 nm) are less efficiently phagocytosed, as 
macrophages cannot recognise ultra small particles below a phagocytic cut off point of 
500 nm (Rupper and Cardelli, 2001). In some cases nanoparticles can impair the 
phagocytic capacity of alveolar macrophages leading to apoptosis (Zhao and Nalwa, 
2007). Occupational exposure of human beings to nanomaterials generated pleural 
granuloma formation characterised by shortness of breath and pulmonary fibrosis 
(Song et al., 2009).  
Nanoparticles of size 1.3 to 400 nm have a higher chance of crossing the lung- 
epithelial barrier and enter the blood or lymphatic systems thus travelling to different 
organs. Particle laden macrophages can transport them to various organs (Furuyama et 
al., 2009). Inhalation experiments of gold (Semmler-Behnke et al., 2008) and silver 
nanoparticles (Kim et al., 2008) in animal models resulted in systemic distribution of 
these nanoparticles and subsequent deposition in various organs. Inhalation of silver 
nanoparticles did not change the nasal mucosal architecture significantly (Hyun et al., 
2008). Nonethless, inhalation of commercially available products such as “magic nano 
spray” resulted in serious lung injury, haemorrhage and subsequent death in rat 
models (Pauluhn et al., 2008). Solubility of the nanoparticles can control the extent of 
injury by giving stability and dispersity to the nanoparticles. Agglomerated 
nanoparticles are unlikely to reach the alveoli.  




1.9.2. Absorption through skin 
Skin is the most effective barrier against nanoparticles and other chemicals. 
The strongly keratinised stratum corneum (10 m) expels foreign bodies effectively. 
However, the sweat glands and hair follicles could make this barrier more vulnerable 
and thus facilitate entry of nano size particles. TiO2 is a component in sunscreen 
lotions. Micron and submicron sized TiO2 was shown to cross the skin and reach hair 
follicles and dermis (Lademann et al., 1999). Study conducted in human volunteers 
further confirmed the skin penetration of nanosized TiO2 (10-50 nm) (Tan et al., 
1996). This process was affected by the shape of nanoparticles where lanceolate 
shaped TiO2 lost its potential to penetrate skin and remained on the surface (Schulz et al., 
2002). Particle coating also affect skin damage caused by TiO2 (Carlotti et al., 2009).  
It is suggested that absorption of 5-20 nm size TiO2 can occur through the skin, 
leading to interaction with the immune system (Kreilgaard, 2002). This absorption 
process was found to be effective for particles less than 1 micron in size. Skin absorption 
of nanomaterials was proposed to be due to the interaction with lipid systems of the skin 
and subsequent phagocytosis by Langerhans cells (Hoet et al., 2004). TiO2 nanoparticles 
are also associated with exacerbation of atopic dermatitis and progression of other skin 
conditions by histamine release (Yanagisawa et al., 2009). Contradictory to these reports, 
other studies have found that exposure of human skin to nano-ZnO and TiO2 showed no 
skin penetration of these nanomaterials. Both nanoparticles remained on the skin surface, 
folds or on hair follicles (Zvyagin et al., 2008). However, a few other reports have shown 
that nanoparticles can enter antigen presenting cells (Langerhans cells) of the skin by 
crossing the skin barrier (Mahe et al., 2009). These studies suggest that there must be 
some unknown parameters playing vital roles in the skin absorption of nanomaterials 




which are yet to be identified. The uptake of metallic nanoparticle through the skin has 
always been considered more obscure than other routes of entry. Multiple parameters 
such as dose, vehicle, valence, age and origin of the skin are involved in the process.  
Apart from metal oxide nanoparticles, other metals such as silver nanoparticles 
in synthetic sweat when exposed to intact and damaged  human skin exhibited low 
skin penetration (Filon et al., 2007; Larese et al., 2009), suggesting their safe 
application on intact skin. The damaged skin used in the experiment showed 
significant absorption of silver nanoparticles when compared to intact skin. Silver 
nanoparticles are usually applied as wound dressing on damaged skin which facilitates 
their rapid penetrations. Larese et al. (Larese et al., 2004) have studied the effect of 
Cobalt nanoparticles in human volunteers and established their skin penetration 
potentials. Skin irritations have been reported for metal oxide nanoparticles in in vivo 
systems (Zhu et al., 2008). Exposure of carboxylated QDs to UV irradiated and non 
irradiated murine skin showed a faster penetration rate in UV irradiated skin 
(Mortensen et al., 2008). Also, similar work on damaged rat skin showed increased 
penetration of QDs (Zhang and Monteiro-Riviere, 2008). These reports emphasise that 
nanoparticles could penetrate faster in a damaged skin under normal conditions. 
Concisely, nanoparticles are capable of crossing intact and damaged skin, a property 
which is controlled by unknown parameters of the material. Damaged skin facilitates 
accelerated uptake rates. 
1.9.3.  Ingestion 
Nanoparticles which are employed as food additives and drugs are likely to get 
absorbed into the body through gastro-intestinal tract (GI) tract, which is one of the. 
potential routes for the transport of particles (Florence and Hussain, 2001; Hussain et al., 




2001). From the GI tract, they enter lymphatic tissues (Hussain et al., 2001) containing 
phagocytic cells. Multiple parameters such as size, surface charge, attachment to 
ligand or type of ligand could control their targeting and absorption in GI tract 
(Hillyer and Albrecht, 2001; Jani et al., 1990; Florence et al., 1995). Ingested 
nanomaterials are likely to get expelled if they are unstable in the extreme conditions 
of the GI tract. Change in pH may trigger agglomeration of nanomaterials inside the 
intestinal tract. If agglomerates are small enough, they will get expelled through 
faeces with little absorption. Bigger agglomerates can result in obstruction of GI tract 
and death. This was experimentally proven in mice fed with zinc nanoparticles. 
Following exposure to these nanoparticles, mice developed severe diarrhoea, vomiting 
and anorexia followed by death. Autopsy revealed clumps of particles blocking the 
intestine (Wang et al., 2006a). Ingestion of polystyrene nanoparticles by rats resulted 
in absorption of the nanoparticles through GI (Jani et al., 1990) tract, whereas 
fullerenes got cleared within 48 hrs (Yamago et al., 1995). On the other hand, gold 
nanoparticles (15 nm) showed higher penetration rates in rat intestinal models 
(Sonavane et al., 2008). These reports suggest that nanoparticles could penetrate the 
GI tract to translocate to organs. 
1.9.4. Translocation 
From the site of entry, nanoparticles can enter the circulatory system 
(Furuyama et al., 2009; Mills et al., 2009; Zhu et al., 2009). Intra-tracheal instillation 
of 30 nm gold nanoparticles translocated to platelets within 30 min. (Berry et al., 
1977) Nano-carbon particles showed a rapid diffusion (5 min) from lung to blood in 
hamster models (Nemmar et al., 2001) and in  humans (Nemmar et al., 2002). Many 
animal experiments have shown rapid translocation of nanoparticles from the site of 




entry to target organs such as brain, spleen, liver, kidney and  muscles through blood 
(Oberdorster et al., 2004; Muhlfeld et al., 2008; Peters et al., 2006). However, there 
exists many contradictory reports where 60 nm labelled nanoparticles were cleared 
from human body within 2 hrs (Brown et al., 2002). Inhalation experiment in rats showed 
rapid translocation of particles to various organs within 24 hrs (Oberdorster et al., 2002).  
Once in the blood stream, stable nanoparticles can get distributed to various 
organs such as liver, spleen, bone and kidney where they impart specific side effects. 
Recent evidences suggest that the nanoparticles can cross blood brain barrier and 
could thus target brain as well (Sarin et al., 2008). MnSO2 and single walled carbon 
nanotubes (SWCNTs) are known to reach the central nervous system through the 
olfactory bulb or axonal ends (Oberdorster et al., 2004). Nanoparticles entering the 
blood could be phagocytosed based on the size as described before (Section 1.9.1). 
Phagocytes could thus suffer injuries due to the nanoparticles exposure. It is well 
known that particles of size less than 200 nm will be filtered off by the spleen while 
larger particles gets deposited in the liver (Monteiro-Riviere and Tran, 2007). Many 
research groups have studied the effects of nanoparticles on cardio vascular systems. 
Exposure of nanoparticles in experimental animals resulted in myocardial infarction 
(Nemmar et al., 2007). Most recent reports have shown anti-platelet properties of 
silver nanoparticles (Shrivastava et al., 2009). Exposure of mice to 23.5 nm copper 
particles damaged liver, spleen and kidneys (Chen et al., 2006). Exposure to ZnO 
nanoparticles resulted in necrosis of liver tissues (Wang et al., 2006a). The effects of 
long term deposition of metal nanoparticles in various organs are still unknown. They 
may lead to organ dysfunction at later stages, which again is dependant on the dose 
and nature of nanoparticles. 




1.10. Excretion of nanoparticles  
Even though literature suggests many routes for excretion of nanoparticles, 
only a few are proven experimentally. Nanoparticles are proposed to be expelled 
through kidneys, faeces, sweat, breast milk and saliva (Oberdorster et al., 2005). 
However, experimental evidence supports excretion only through urine (Burns et al., 
2009) and faeces (Kreuter et al., 1983). Expulsion of nanoparticles through kidney is 
dependant on various parameters such as size of the particles and adsorption of 
biomolecules onto the particles. Glomerular capillaries have a pore size of 70 nm, 
which allows smaller particles to get filtered off. Adsorption of proteins on to 
nanoparticles greatly increases the size of the particles thus inhibiting filtration 
through urine. Moreover kidneys were one of the target organs for nanoparticle 
toxicity (Chen et al., 2006). Mice exposed to nano-Cu resulted in glomerulitis, 
degeneration, necrobiosis, edema and discoloration of kidneys. Nano ZnO particles 
resulted in glomerulitis (Chen et al., 2006). Nanoparticles are also known to alter 
metabolic functions in the kidney leading to nephrotoxicity (Lei et al., 2008). These 
evidences suggest that nanoparticles are able to damage the excretory systems leading 
to nanoparticle retention and organ failure. 
1.11. Biodistribution at cellular level 
Intra cellular targets of nanoparticles are largely unknown. The target organs of 
nanoparticles are well documented in the literature. However, the direct interaction of 
nanoparticles with cells, uptake and subsequent distribution in intracellular 
compartments are less explored. Uptake kinetics of gold nanoparticles were reported 
to be via receptor mediated clathrin dependant endocytosis (Chithrani and Chan, 2007; 
Chithrani et al., 2006). The above report also emphasised the faster wrapping of 




plasma membranes for the uptake of nanoparticles of 50 nm size compared to smaller 
nanoparticles and large size nanoparticles. Uptake of smaller nanoparticles required 
clustering of many small nanoparticles. For particles larger than 50 nm, the wrapping 
time was longer as the receptor diffusion kinetics was much slower (Chithrani and 
Chan, 2007; Chithrani et al., 2006). A shape dependant study proved that 
nanoparticles are taken up faster than nanorods (Chithrani and Chan, 2007; Chithrani 
et al., 2006). However, study on the exocytosis kinetics showed an inverse relation, 
where 14 nm gold nanoparticles were expelled much faster than 74 nm gold 
nanoparticles (Chithrani and Chan, 2007; Chithrani et al., 2006). Existing 
experimental data suggest endocytosis as a major route for uptake of many 
nanoparticles (gold, CNTs and silica) (Jin et al., 2009; Oh et al., 2009; Xing et al., 
2005).  Clathrin knockdown rabbit conjunctiva cells endocytosed chitosan 
nanoparticles efficiently suggesting involvement of other pathways in nanoparticle 
uptake (Huang et al., 2002). Rejman et al (Rejman et al., 2004) studied fluorescent 
latex particle uptake which suggested that smaller particles (<200 nm) are internalised 
by caveoli mediated endocytosis whereas, particles larger than 500 nm are internalised 
by caveoli mediated endocytosis. It is likely that, mechanisms other than phagocytosis 
exist, for the uptake of nanoparticles, as most of the non-phagocytic cells were efficiently 
taking the nanoparticles. Macropinositosis is also documented as one of the mechanisms 
for the uptake of nanoparticles. Macropinosomes are larger structures (1 µm) compared to 
clathrin pits (150 nm), but the selection between the two processes remain rather 
obscure. Due to the limited number of reports on the uptake of nanoparticles, it cannot 
be concluded that common mechanisms are applicable for all nanoparticles. 




Following uptake, gold nanoparticles have been observed to interact with 
endosomal proteins, escape from endosomes and cluster in cytosol or perinuclear 
regions while some of them enter nucleus (Thomas and Klibanov, 2003). To enter the 
nucleus, particles must be incorporated into nuclear envelope or pass through nuclear 
pores directly or through cargo complexes (Antonin and Mattaj, 2005). Similar 
interactions may be possible for other nanoparticles. 
As discussed previously, TiO2, CNTs, gold, platinum and silver nanoparticles 
are the ones currently in heavy demand. Their applications span across diverse 
scientific domains.  TiO2, CNTs and gold nanoparticles had been investigated for their 
bioactivity. The databases are flooded with reports on their uptake and mechanisms of 
toxicity. Metal oxides and gold nanoparticles invite much attention due to their heavy 
demand while newly emerged nanoparticles like silver and platinum are beginning to 
capture interest. There is a lack of information on their properties and biological 
activity. Hence this thesis will focus on silver and platinum nanoparticles due to the 
scarcity of toxicological information available about them. 
1.12. Literature in nanotoxicity 
1.12.1. Cytotoxicity 
Silver salts are known to cause irreversible pigmentation of skin (argyria) upon 
long term exposure (Cho et al., 2008). Reports on toxicity of silver nanoparticles 
indicated significant cytotoxicity in cell lines, indicated as the depletion of 
intracellular glutathione (Hussain et al., 2005). A Similar study in the mammalian 
germ line stem cells showed significant damage to the cells as shown by apoptosis 
(Braydich-Stolle et al., 2005). However, the toxicologists were more sceptical about 
the physical and chemical nature of the nanoparticles employed. As addressed 




previously, the nanoparticle bioactivity is influenced by various parameters such as 
purity and stability of the particles. Agglomeration of the nanoparticles will yield 
particles of size in the micron range, skewing data interpretation. The commercially 
available nanoparticles are not often characterised well and are less dispersible. These 
obstacles called for an urgent need for proper characterisation of the nanoparticles to 
enable proper data correlation. This study stems from the existing dilemma and 
questions related to silver nanotoxicology. Apart from the basic cytotoxicity end point, 
no information pertaining to the nanoparticle uptake, distribution, sub cellular targets, 
toxic end points and effect on gene expression are available. This huge knowledge gap 
inspired our research on silver nanotoxicity. 
In the case of silver nanoparticles, inhalation and skin absorption are primary 
routes of exposure from where the nanoparticles are translocated to different parts of 
the body. Silver nano sprays are able to overload lungs with high concentrations of the 
nanoparticles. Innate immunity plays an active role in expelling nanoparticles, except 
when nanoparticles interfere with these mechanisms.  Extrusion efficiency depends on 
the surface coating of nanoparticles. In the alveoli, particles are usually cleared by 
alveolar macrophages. Studies have shown that silver nanoparticles are retained by 
alveolar macrophages for 7 days (Takenaka et al., 2001). Aggregates of silver 
nanoparticles induced oxidative stress and inflammation in macrophages and lung 
epithelial cells (Soto et al., 2007). However, no detailed studies were conducted in this 
area. Inhalation studies on animals showed that silver nanoparticles were not able to 
cause significant toxicity to the nasal mucosa (Hyun et al., 2008). Similar studies 
showed rapid clearance of nanoparticles from the lungs and subsequent deposition in 
various organs including brain, liver, spleen and kidney (Takenaka et al., 2001). Silver 




nanoparticles are reported to bring about significant toxicity to C. elegans in terms of 
reduced reproducing capacity and oxidative stress (Roh et al., 2009). Exposure of 
silver nanoparticles resulted in upregulation of many oxidative stress response genes 
in the mouse brain (Rahman et al., 2009). But studies have not progressed to a stage 
beyond that of oxidative stress. Most recent reports on silver nanoparticles suggest 
involvement of necrosis as well (Foldbjerg et al., 2009). Reports suggest active JNK 
pathway mediated apoptotic activity which is concentration dependant (Hsin et al., 
2008). Even though inflammatory activity is well documented (Carlson et al., 2008), 
equal number of reports showing anti-inflammatory properties are also available in the 
field (Wong et al., 2009). Recent findings suggest the influence of capping agent in 
reducing the silver nanotoxicity (Chung et al., 2008). According to a recent report, 
silver nanoparticles when the surface is functionalised with polysaccharide retains 
their antimicrobial activity and are non-toxic (Travan et al., 2009). Existence of 
contradictory reports proposed existence of additional elements in nanotoxicity. 
Ongoing nanotoxicology studies are expected to answer many of such questions. 
Vlachou et al (Vlachou et al., 2007) suggest absorption of silver nanoparticles 
from burn dressings to circulation, marked by increased silver concentration in the 
blood. Many studies showed biocompatibility of wound dressings (Forner-Cordero et 
al., 2007) while others showed cytotoxicity (Poon and Burd, 2004). 
Recent reports have shown that Fe@Pt yolk shell nanoparticles were able to 
kill HeLa cells by releasing Pt2+ ions from the core (Gao et al., 2007). However, the 
effect of Fe3+ ions in the system remains doubtful. Research reports have established 
weak and selective mutagenic potential of platinum nanoparticles in bacteria 
(Maenosono et al., 2007).  Antioxidant activity of platinum nanoparticles and ability 




to suppress transformation in cells were established much earlier (Nishikawa et al., 
2005).  Hamasaki et al (Hamasaki et al., 2008), investigated antioxidant activity of 
platinum nanoparticles in different cell lines which further confirmed the radical 
scavenging activity of platinum nanoparticles. Exposure of umbilical vein endothelial 
cells and alveolar cells to platinum nanoparticles of different shapes resulted in 
accumulation of platinum nanoparticles in cells without causing cytotoxicity (Elder et 
al., 2007). However, existing reports are not sufficient to establish biocompatibility or 
toxicity of platinum nanoparticles. The mechanism of action of platinum nanoparticles 
still remains as a challenge as well. In order to get the full spectrum of therapeutic 
potentials of platinum nanoparticles, their uptake mechanisms, biodistribution, bio 
activity and mechanism of action must be well studied. 
1.12.2. Uptake of nanoparticles  
In order to understand the behaviour of nanoparticles in biosystems, their uptake 
mechanism must be known. To date no study has been conducted on the mechanism 
of internalisation of silver nanoparticles. No reports are available on the investigations 
of uptake kinetics of silver or platinum nanoparticles.  
1.12.3. Genotoxicity 
Genotoxicity in cells treated with nanoparticles can occur as a direct 
interaction of nanoparticles with DNA or due to the corresponding ions. ROS is 
another potential factor that could induce DNA damage response. Protein expression 
analysis have further evidenced the DNA damage response in silver nanoparticle 
treated cells by the upregulation of damage response proteins such as RAD50 and 
BRCA1 (Ahamed et al., 2008). However no detailed studies were done in this area to 




explore the type of DNA damage or chromosomal aberrations. Platinum nanoparticles 
are not yet explored for genotoxicity. 
1.12.4. Protein expression 
Over the past few years, a few studies investigated the changes in protein/gene 
expression in various cells exposed to silver nanoparticles. All these studies were 
focused on oxidative stress pathway following the initial reports of oxidative stress 
mediated toxicity in silver nanoparticles exposed cells (Ahamed et al., 2008; Foldbjerg 
et al., 2009; Hsin et al., 2008; Griffitt et al., 2009). The study is in premature stage and 
the nanotoxicology and nanomedicine fields require this information for elucidating 
the mechanism of action of nanoparticles. This could shed light to developing 
nanoparticles that can target specific pathways. A summary of the important 





           
         Table 1.2: Summary of literature in silver and platinum nanotoxicology 




Rat liver cells Unknown Cytotoxicity, ROS (Hussain et al., 2005) 
15 nm Mouse germ line stem cells Unknown  Cell death (Braydich-Stolle et al., 
2005) 
11-15 nm Zebrafish Citrate Real time transport across 
 chorion 
(Lee et al., 2007) 
60 nm Rat Unknown Lung function changes, 
 lesions and infiltration of 
phagocytes 
(Sung et al., 2008) 
15 nm, 30 nm, 50 
nm (aggregates) 
Alveolar macrophages Hydrocarbon Distribution, ROS, 
 inflammation 
(Carlson et al., 2008) 















15 nm Mouse embryonic fibroblast Polysaccharide Apoptosis 
Upregulation of p53,H2AX 
 and Rad51 
(Ahamed et al., 2008) 
60 nm Rat Unknown Accumulation in organs (Kim et al., 2008) 
1.5 nm Lymphocytes Unknown Anti-inflammation (Shin et al., 2007) 
70 nm Monocytes PVP Apoptosis, necrosis, ROS (Foldbjerg et al., 2009) 
26 nm Adult zebrafish Unknown Gill injury (Griffitt et al., 2009)  
7-20 nm Primary fibroblasts and liver 
cells 
Unknown Cell death, intracellular 
 distribution 
(Arora et al., 2009) 
  Pt-np   
10 nm Hela cells Oleic acid Pt-Fe yolk shell 
 nanoparticles kills cancer  
cells by releasing Pt2+ ions 
(Gao et al., 2007) 
35nm -flowers 
22 nm-sphere 
20 nm-multi pode 
11 nm-sphere 
Human epithelium and  
endothelium 
Unknown No cytotoxicity (Elder et al., 2007) 
     





 The applications of nanoparticles in healthcare and other industries are 
undeniable. It is impractical to withdraw nano products, but commercialisation and 
safe use of non-hazardous nanomaterials are mandatory. To achieve this goal, the 
health effects of nanomaterials must be known. Thus toxicity studies are inevitable. 
Reports on nanotoxicity have shown significant levels of toxicity associated with 
various nanoparticles. Due to the lack of safety information and regulations available 
to materials chemists, workers who synthesise nanomaterials are constantly exposed to 
these nanomaterials without knowing the adverse health effects.  
 The toxicologists are not aware of the tedious engineering, characterization 
and purification procedures in nanoparticle synthesis which force them to rely on 
commercially available nanomaterials. In most of the cases commercially available 
nanomaterials exhibit agglomeration. The reproducibility of different batches of 
commercially available nano powders and their purity remains unclear. Considering 
the existing problems, we have synthesised, characterised and purified nanomaterials 
used in this toxicity studies to achieve reproducibility and accurate results. Research 
reports on the adverse effects of silver and platinum nanoparticles have focused 
mainly on cytotoxicity of these particles. Moreover, cytotoxicity reports are 
controversial.  Here, we have undertaken investigations to determine the genotoxicity 
and molecular toxicity of silver and platinum nanoparticles which are crucial in 








Hence we propose to address the issue in the following way; 
1. Synthesis, purification and characterization of candidate nanoparticles. 
2. Investigation of in vivo and in vitro toxicological information, in terms of 
cytotoxicity & genotoxicity. 
3. Cellular & molecular toxicity profiling which includes uptake, exocytosis, 
gene and protein expression changes in silver and platinum nanoparticles. 
 The data gathered from the toxicity studies will be employed to construct a 
model that could explain the mechanism of uptake and action of nanoparticles in cells. 
In vitro systems will be compared with in vivo models to study the similarity and 
differences in response if any.  
This thesis will be divided accordingly into 3 sections. In the first section 
(chapter 3), details on the toxicity of silver nanoparticles in in vitro systems will be 
discussed. Second section (chapter 4) is dedicated for platinum nanoparticles and third 























2. Materials and Methods 
2.1. Synthesis of nanoparticles 
 The nanoparticle synthesis was carried out using the standard procedure 
through reduction of silver nitrate. All experiments were done in a clean atmosphere 
to eliminate the chances of contamination that may interfere with the toxicity profile 
of the nanoparticle.  
2.1.1. Synthesis of polyvinyl alcohol (PVA) capped silver nanoparticles (Ag-np-1)  
 Silver nanoparticles capped with PVA (Sigma-Aldrich, USA ) were 
synthesised by reducing AgNO3 solution (1 mM) with 0.005 gm of NaBH4 (Alfa-
Aesar, MA, USA), followed by the addition of 5 mL of PVA solution (2%), under 
constant stirring at room temperature. A colour change of the solution to brown colour 
indicated silver nanoparticle formation.  Stirring was continued for 2 hrs and the 
solution was left overnight before purification to get rid of the excess of reducing 
agent. For purification, the nanoparticle solution was centrifuged at 20,000 rpm for 1 hr 
and resuspended in ultrapure water. The washing was done twice and the final pellet 
was lyophilised. 
2.1.2. Synthesis of silver nanoparticles capped with Bovine serum albumin (BSA) 
(Ag-np-2) 
 Silver nanoparticles capped with BSA were synthesised by reducing the 1 mM 
AgNO3 solution with sodium borohydride (0.025 gm) and subsequent stabilisation 
with BSA (0.1gm), under constant stirring. The particles were processed similar to 
Ag-np-1. 
 




2.1.3. Preparation of starch capped silver nanoparticles (Ag-np-3) 
Starch coated silver nanoparticles were synthesised by the reduction of silver 
nitrate with sodium borohydride followed by stabilisation with starch. Starch capped 
nanoparticles showed lesser degree of agglomeration even at high concentrations 
compared to the silver nanoparticles capped with PVA and BSA. Furthermore, the 
choice of capping agent is important since the properties of nanoparticles can be 
significantly altered through surface modification. The distribution of nanoparticles in 
the body is strongly influenced by its surface characteristics. The hydrophilic nature of 
starch as compared to organic polymers could enhance the water dispersion and hence 
stability in cell culture medium. Moreover, using starch as the capping agent 
eliminated the need of other organic solvents, or capping agents, which are toxic to the 
cells. Soluble starch from potatoes (0.28 gm) was dissolved in 10 ml of boiling 
ultrapure water and filtered using 0.2 m syringe filter (sartorius, Goettingen, 
Germany). Silver nanoparticles were synthesised by reducing silver nitrate solution (1 
mM), using sodium borohydride (0.03 gm) followed by the addition of the filtered 
starch solution, under constant stirring at 70ºC. The colour of the solution changed to 
dark brown with time, indicating nanoparticle formation and stirring was continued 
for an additional 2 hrs. The nanoparticle suspension was centrifuged at 18,000 rpm for 
1 hr to pellet nanoparticles. The pellets were further washed in ultrapure water to 
remove traces of unbound starch.  
The dry pellet obtained after the lyophilisation of the centrifuged nanoparticles 
was dissolved in ultrapure water using sonication. The size of the nanoparticles was 
determined by Transmission electron microscopy (TEM, JEOL JSM 2010f, JEOL, 
Tokyo, Japan) analysis, dynamic light scattering (DLS, Malvern Zetasizer 




Nanosystems with DTS 5.00 software) and absorption spectrum (Shimadzu 1601-PC 
UV-visible spectrophotometer, Shimadzu Corporation, Tokyo, Japan) using pure 
nanoparticle suspensions reconstituted from the lyophilised powder. A size 
distribution histogram was extracted using Gatan digital micrograph software (Gatan 
Inc.CA, USA). The zeta potentials of the nanoparticles were measured using Zetasizer 
nano systems. 
2.1.4. Synthesis of PVA capped gold nanoparticles (Au-np)  
 Gold nanoparticles capped with PVA was synthesised by reducing 1.5 mM 
gold chloride (Sigma-Aldrich, MO, USA) with 0.006 μg/mL of NaBH4, followed by 
addition of 15 mL of 10 mg/mL polyvinyl, under constant stirring. The colour of the 
solution changed to majenda with time. The solution was further stirred for 2 hrs.  
2.1.5. Synthesis of PVA capped platinum nanoparticles (Pt-np) 
 The nanoparticles were synthesised via the reduction of 1 mM 
hexachloroplatinic acid hexahydrate (Sigma-Aldrich, USA) using sodium borohydride 
(0.02 gm) and immediate stabilisation with PVA (120 mg) under constant stirring. The 
solution was stirred overnight and centrifuged at 20,000 rpm for 1 hr at 18°C. The 
supernatant solution was removed and pellet resuspended in ultrapure water by 
sonication. This process was repeated twice to get pure nanoparticles. The final pellet 
was resuspended in 5 mL of ultrapure water and lyophilised. Dry weight of the 
nanoparticle powder was noted before dispersing in sterile distilled water (5 mg/mL) 
by ultra sonication (Sonics vibra cell VC130, Amplitude 45 for 5 min, Sonics and 
Materials Inc. USA). 
 




2.2. Cell culture and nanoparticle treatment 
  Normal human lung fibroblasts (IMR-90) (Coriell Cell Repositories, USA) 
were cultured in minimum essential medium (MEM, Sigma-Aldrich, USA) 
supplemented with 15 % foetal bovine serum (Hyclone, USA), 2 % essential amino 
acids and 1% each of non-essential amino acid, vitamins and penicillin-streptomycin 
(GIBCO, Invitrogen, USA). The cells (passage 15 ± 4) were maintained at 37C in 
presence of 5 % CO2 at log phase. Human glioblastoma cells (U251 cells) (from Dr. 
Masao Suzuki, National Institute of Radiological Sciences, Chiba, Japan) were 
maintained in Dulbecco’s modified eagles medium (DMEM) supplemented with 10 % 
foetal bovine serum (FBS, GIBCO) and 1 % penicillin-streptomycin. IMR-90 cells 
served as a representative for normal primary cells as well as a cell type of lung origin, 
which is a common route of nanoparticles exposure. Silver nanoparticles are known to 
localise in brain, thus glioblastoma cells provide a suitable model for studying 
interactions of nanoparticles in brain cells. Also, use of a cancer cell type and normal 
cell type allows comparison of responses between normal and cancer cells. 
2.3. Preparation of stock solution and treatment 
 Stock solutions of nanoparticles (5 mg/mL) were prepared in sterile distilled 
water and diluted to the required concentrations using the cell culture medium. 
Appropriate concentrations of stock solution were added to the cultures to obtain 
respective concentration of nanoparticles and incubated. Following nanoparticles 
treatment, the plates were observed under a light microscope (Olympus CK 40) to 
detect morphological changes and photographed using Olympus C7070WZ camera. 
 




 2.4. Uptake of nanoparticles 
 The nanoparticle uptake by the cells was quantitated using inductively coupled 
plasma-optical emission spectroscopy (ICP-OES, Perkin Elmer Optima 5300 DV). 
Cells were seeded at a density of 1.5 × 105 cells in T-75 flask and treated with 
nanoparticles to achieve a final concentration of 100, 200 and 400 g/mL for Ag-np-3 
and 40, 80 and 160 µg/mL for Pt-np. Higher concentrations were employed to show 
the stability of the nanoparticles in cell culture medium. To study the uptake 
mechanism of nanoparticles, U251 cells were incubated with nanoparticles under three 
different conditions. The initial step was to calculate the rate of uptake of 
nanoparticles when the cells were incubated for 2 hrs at normal culture conditions 
(37°C).  Endocytosis was considered as a possible mechanism of uptake based on our 
electron micrographs which showed endosomes with nanoparticles. Hence cells were 
treated with 0, 100, 200 and 400 g/mL of Ag-np-3 at 4°C for 2 hrs to inhibit 
endocytosis. Low temperature treatments inhibit endocytosis in cells (Chithrani and 
Chan, 2007).  The transmission electron micrographs (TEM) did not show the 
presence of coated endosomes. This raised a suspicion that nanoparticles could be 
taken up by a method apart from clathrin coated pits. Hence, cells were pre-treated 
with K+ depleted medium for 30 min prior to nanoparticle treatment for 2 hrs. This 
treatment blocked formation of clathrin but facilitated formation of uncoated pits 
(caveoli) (Chithrani and Chan, 2007).  Involvement of other uptake pathways such as 
macropinocytosis and caveoli dependant endocytosis were investigated by selective 
inhibition of the pathways in presence of specific inhibitors wortmannin (New and 
Parker, 2009) and nystatin (Suksanpaisan et al., 2009), respectively. Analyses for 
macropinocytosis and caveoli mediated processes were carried out as per previous 




reports (New and Parker, 2009; Suksanpaisan et al., 2009). Following incubation 
period, medium was removed and flasks were washed 5 times with 1 × phosphate 
buffered saline (PBS, 1st Base, Singapore). Cells were harvested using trypsin - EDTA 
(ethylene diamine tetra acetic acid, GIBCO, Invitrogen, USA), washed 3-4 times in 
PBS and resuspended in 10 mL PBS. The cell number in all tubes was adjusted to 2 
million and one millilitre of the lysate was analysed after homogenisation. 
Concentration of silver estimated from cells treated under normal conditions for 2 hrs 
were compared with results from low temperature incubation (endocytosis blocking), 
K+ depleted treatment (clathrin inhibition), wortmannin (macropinocytosis inhibition) 
and Nystatin (caveoli inhibition).   
Rate of exocytosis was studied by treating U251 cells using similar 
concentrations of Ag-np-3 as described above. Following 3 hrs of incubation, 
nanoparticles were completely washed away with buffer and further incubated for 2, 
6, 24 and 48 hrs in fresh medium. At the end of individual incubation period, medium 
and cells were collected separately, homogenised and assayed.  
2.5. Microscopy 
2.5.1. Light microscopy 
 Cells were plated at a density of 1 × 104 per well of 96-well plates and treated 
with different concentration of nanoparticles. After 48 hrs incubation, cells were 
photographed to study the morphology under the light microscope (Olympus CK 40) 
using Olympus C7070WZ camera. 
 
 




2.5.2. Transmission electron microscopy of nanoparticles treated cells  
 Ultrathin sections of the cells were analysed using TEM, to reveal the 
distribution of nanoparticles. Briefly the cells (1.5 × 106 cells) were treated with 
nanoparticles (Ag-np-3: 100 g/mL; Pt-np: 160 g/mL) for 48 hrs. At the end of the 
incubation period, culture flasks were washed many times with phosphate buffered 
saline to get rid of excess unbound nanoparticles. Cells were trypsinised and washed 
4-5 times in phosphate buffer and fixed in 2.5% glutaraldehyde for 2 hrs. Fixed cells 
were washed 3 times with phosphate buffer. Post fixation staining was done using 1% 
osmium tetroxide for 1 hr at room temperature. Cells were washed well and 
dehydrated in alcohol ( 40, 50, 70, 80, 90, 95 and 100% ethanol) and treated twice 
with propylene oxide for 30 mins each, followed by treatment with propylene oxide,  
spurr’s low viscosity resin (1:1), for 18 hrs. Cells were further treated with pure resin 
for 24 hrs and embedded in BEEM capsules containing pure resin. Resin blocks were 
hardened at 70°C for 2 days. Ultrathin sections (70 nm) were cut using Reichert Jung 
Ultracut. The sections were stained with 1% lead citrate and 0.5% uranyl acetate and 
analysed under JEOL JEM 2010F. The presence of nanoparticles was confirmed by 
the electron dispersive X-ray analysis  
2.5.3. Scanning transmission electron microscopy (STEM)  
 Scanning transmission electron microscopy (STEM) and the elemental 
mapping of cell sections were done to elucidate the distribution pattern of 
nanoparticles. The sections prepared for the TEM analysis was employed for STEM 
study. The instrument performed elemental mapping by labeling silver as red dots in 
the image captured. The analysis was done using JEOL JSM 6701F at an accelerating 
voltage of 25KV. 




2.5.4. Qualitative analysis of cell morphology by SEM 
  Cells grown on sterile cover slip were treated with Ag-np-3 (400 g/mL) for 
48 hrs and fixed in 2.5% glutaraldehyde for 30 mins. The cover slips were washed 5 
times in Sorensen buffer and post fixed in 1% osmium tetroxide for 1 hr. Dehydration 
of the cells was done in ethanol series (50%, 70%, 90% and 100%). Critical point 
drying and platinum coatings were done as per standard SEM procedures. The slides 
were analysed using JEOL JSM 6701F with an accelerating voltage of 5 KV. 
2.5.5. Live imaging of nanoparticles using cytoviva ultrahigh resolution 
illumination systems 
 Cells were grown on cover slips and treated with Pt-np for 2 hrs. Following the 
incubation period, cover slips were washed and kept on slide and observed under 
Samples were then observed under a Nikon Eclipse 200 I microscope with a Cytoviva 
light source for dark field imaging.  
2.6. Cell viability assay 
2.6.1. Measurement of ATP content 
 The viability of Ag-np-3 treated cells were measured using Cell-Titer glow 
luminescent cell viability assay (Promega, Madison, WI, USA) following 
manufacturer’s instructions. This assay is a homogenous method for determining the 
number of viable, metabolically active cells in a culture based on quantification of the 
ATP concentration. The procedure involves addition of an equal volume of reagent to 
the medium in test wells, which in a single step generates a luminescent signal 
proportional to the concentration of ATP present in cells. The reagent contains 
detergents to break the cell membrane causing ATP release in the medium, and 




ATPase inhibitors to stabilise the released ATP. The assay is based on the conversion 
of beetle luciferin to oxyluciferin by a recombinant luciferase in the presence of ATP. 
The observed luminescence is proportional to the quantity of ATP in cells. The 
experiments were performed in white opaque walled 96 well plates (Corning, Costar, 
NY, USA). Additional controls were included in the test, to rule out auto 
luminescence and quenching by nanoparticles. For the ATP assay, 1 × 104 cells per 
well were plated and treated with different concentrations of nanoparticles (25, 50, 
100, 200 and 400 g/mL for Ag-np-3; 0, 20, 40, 80 and 160 g/mL for Pt-np) for 24, 
48 and 72 hrs. The dependence of toxicity on purity of nanoparticles was studied using 
the supernatants from the last centrifugation step. The supernatant (50 mL), obtained 
after removing the nanoparticle pellet, was concentrated by lyophilisation and 
reconstituted in 1 mL sterile water. Different volumes of the stock solution (0, 5, 10, 
15, 20 and 25 µL) were dispensed in to 100 µL of medium in 96 well plates and 
incubated for 48 hrs. 
 2.6.2. Mitochondrial function-cell titer blue cell viability assay 
 Cell titre blue cell viability assay (Promega, Madison, WI, USA) is a 
fluorimetric measurement of the metabolically active cells in a culture. The 
mitochondrial and microsomal enzymes reduce resazurin in the reagent to resorufin, 
which are highly fluorescent. Cells were seeded at a density of 1 × 104 cells per well, 
in black opaque walled 96 well plates (Corning, Costar, NY, USA) and treated with 
Ag-np-3 as described for ATP assay. A time dependant study was conducted 
employing different incubation period (24, 48 and 72 hrs) after nanoparticle addition. 
The experiments were carried out as per supplier’s instructions. 
 




2.7. Cell cycle analysis 
 Cell cycle analysis was carried out by staining the DNA with propidium iodide 
(PI) followed by flow cytometric measurement of the fluorescence. Approximately               
4 × 105 U251 cells and 8 × 105 IMR-90 cells were placed in 100 mm tissue culture 
dishes (Falcon, USA). Following the nanoparticle treatments for 48 hrs 
(concentrations employed were similar as in viability studies), the medium was 
removed and stored. Cells were washed in 1 × phosphate buffered saline (PBS, 1st 
Base, Singapore) trypsinised, harvested in the stored medium and centrifuged. The 
pellet was washed in PBS, fixed in ice-cold ethanol (70%) and stored at -20C. Before 
flow cytometric analysis, cells were washed in PBS and stained with propidium iodide 
(PI) in RNAse (40 g/ml PI and 100 g/ml RNAse A) and incubated at 37C for 30 
min, followed by incubation at 4C until analysis. Flow cytometry analysis was 
performed using Epics Altra (Beckman and Coulter) at an excitation wavelength of 
488 nm and emission wavelength of 610 nm. Data collected for 2 × 104 cells were 
analysed using WinMDI 2.8 software.  
2.8. Cell death 
2.8.1. Annexin -V staining for apoptosis and necrosis 
 Annexin - V staining was performed to differentiate apoptosis from necrotic 
cell death induced by Ag-np-3. Annexin-V has a high affinity for phosphotidyl serine, 
which is translocated from the inner to the outer leaflet of the plasma membrane at an 
early stage of apoptosis. Its conjugation with the fluorescent probe, FITC facilitates 
measurement by flow cytometric analysis. Use of propidium iodide (PI) staining helps 
distinguish between apoptosis and necrosis due to difference in permeability of PI 




through the cell membranes of live and damaged cells. Cell number, concentrations 
and culture conditions were similar to cell cycle analysis. Treated cells were harvested 
and washed twice in PBS. The staining was carried out as per manufacturer’s 
instruction (Annexin-V- FITC apoptosis detection kit, Sigma-Aldrich, St. Louis, MO, 
USA). Data analyses were done using WinMDI software. 
2.8.2.  DNA fragmentation analysis 
 The cells were treated with Ag-np-3 for 48 hrs. Medium was removed and 
plates were washed in PBS. The cells were scraped and centrifuged in PBS for 5 min 
at 1,200 rpm. The pellet was resuspended in lysis solution (Triton X-100 Lysis Buffer:  
40 ml of 0.5 M EDTA 5 ml of 1 M TrisCl buffer pH 8.0 5 ml of 100% Triton X-100 
50 ml of water), followed by incubation on ice for 20 min. The tubes were centrifuged 
at 13,000 rpm for 30 min and supernatant was collected in a mixture of phenol: 
chloroform (1:1) and centrifuged. The aqueous layer containing the DNA was 
removed and precipitated with cold ethanol overnight. The pellets were dried and 
resuspended in TE buffer (Tris Cl and EDTA). The DNA was quantified and 8 g of 
the samples were loaded in 1.5% agarose gel (with 0.3 g ethidium bromide) and 
separated using electrophoresis. The bands were visualised under UV illumination. 
Apoptotic DNA will appear as many low molecular weight fragments which gives a 
laddering.  
2.9. Detection of reactive oxygen species (ROS) production 
 The generation of hydrogen peroxide and superoxide radical was monitored by 
employing 2’,7’- dichlorodihydrofluorescein diacetate (DCF-DA, Invitrogen, USA ) 
staining  and dihydroethidium (DHE, Sigma-Aldrich, USA) staining, respectively. 




DCF-DA is nonfluorescent unless oxidised by the intracellular ROS. Dihydroethidium 
is blue fluorescent in the reduced form, which upon oxidation by superoxide radical 
emits red fluorescence. Dose and time dependant measurements of the generation of 
reactive oxygen species were done by incubating one million cells with nanoparticles 
(25 g, 50 g, 100 g and 200 g of Ag-np-3; 40, 80 and 160 g/mL of Pt-np) for        
2 hrs and 5 hrs, followed by staining with 2 M DHE and 10M DCF-DA for 15 min 
at 37 C. Hydrogen peroxide treated cells (0.09% H2O2) were used as positive control 
for DCF-DA analysis, whereas, diethyldithio-carbamic acid (DDC) at a concentration 
of 100 M (2 hrs at 37C) was used as positive control for DHE staining. DDC is a 
strong inhibitor of superoxide dismutase activity in cells. Cells were then washed 
twice in serum free medium and analysed using Epics Altra flow cytometer (Beckman 
& Coulter) at an excitation wavelength of 488 nm and emission wavelength of 530 
and 610 nm for DCF-DA and HE, respectively. The concentrations were chosen based 
on the viability data. For each sample, 1 × 104 cells were collected (Epics Altra, 
Beckman Coulter) and data were analysed using WinMDI 2.8 software. 
2.10. Evaluation of genotoxicity 
2.10.1. Cytokinesis-blocked micronucleus assay (CBMN) 
 Cytokinesis-blocked micronucleus assay (CBMN) measures the chromosomal 
breakage occurred due to exposure to toxic agents (Fenech, 2006). Cell density was 
similar to cell cycle analysis. The cells were treated with different concentrations of 
Ag-np-3 (25, 50, 100, 200 and 400 g/mL of Ag-np-3; 0, 20, 40, 80 and 160 g/mL of 
Pt-np) for 48 hrs followed by further incubation for 22 hrs with cytochalasin B 
(Sigma-Aldrich, USA, 5 g/mL). The analysis was performed according to a reported 




procedure (Fenech, 2006). Cells were harvested and treated with ice cold KCl and 
centrifuged immediately. The pellet was fixed in Carnoy’s fixative (3 methanol: 1 
acetic acid), and a few drops of formaldehyde were added to preserve the cytoplasm. 
The cells were aged for at least 4 days at 4C, streaked on clean glass slides and dried. 
The slides were then stained with acridine orange (30 g/mL), which differentially 
stains the nucleus and cytoplasm (Hande et al., 1996). One thousand binucleated cells 
were scored and the number of micronuclei was recorded. The IMR-90 cells had 
approximately seven hundred binucleated cells. 
2.10.2. Alkaline single-cell gel electrophoresis (Comet assay) 
 Alkaline single-cell gel electrophoresis (Comet assay) detects DNA damage 
through electrophoresis and subsequent staining in SYBR green dye. Treated cells 
were harvested and washed twice in PBS before resuspending in Hank’s balance salt 
solution (HBSS, Sigma-Aldrich, St. Louis, MO, USA) with 10% dimethyl sulphoxide 
(DMSO, AppliChem GmbH, Ottoweg, Darmstadt, Germany) and EDTA (1st Base, 
Singapore). The cells were embedded in 0.8% low melting agarose (Pronadisa, Spain) 
on comet slides (Trevigen, Gaithersburg, MD, USA) and lysed in pre-chilled lysis 
solution (2.5 M NaCl, 0.1 M EDTA, 10 mM Tris base, pH-10) with 1% Triton X 
(Trevigen, Gaithersburg, MD, USA) for 1 hr at 4C. Cells were then subjected to 
denaturation in alkaline buffer (0.3 M NaCl, 1mM EDTA) for 40 min in the dark at 
room temperature. Electrophoresis was performed at 25 V and 300 mA for 20 min. 
The slides were immersed in neutralisation buffer (0.5M Tris-HCl, pH 7.5) for 15 min 
followed by dehydration in 70% ethanol. The slides were air-dried and stained with 
SYBR green dye. The tail moments of the nuclei were measured as a function of DNA 




damage. Analysis was done using comet imager v1.2 software (Metasystems GmbH, 
Altlussheim, Germany) and fifty comets were analysed per concentration.  
2.10.3. Chromosomal analysis by fluorescence in situ hybridisation (FISH) 
Cells were plated in T-75 flasks at a density of 8 ×105 and incubated with              
0, 25, 50 and 100 g/mL of Ag-np-3 for 48 hrs. Treated cells were allowed to grow in 
fresh medium for 24 hrs. Cells were then arrested at metaphase with 10 μL/mL 
karyomax colcemid solution (Gibco) before being subjected to hypotonic swelling in 
warm 0.075M KCl and fixation with Carnoy’s fixative (3:1 Methanol: Acetic Acid 
solution). FISH was performed on metaphase spreads using telomere and centromere 
specific peptide nucleic acid (PNA) probes (Applied Biosystems) labelled with Cy-3 
and FITC respectively.  Fifty spreads were captured per sample, using Zeiss Axioplan-
2 imaging (Carl Zeiss, Germany). The data were analysed using the in-situ imaging 
software (Metasystems, Germany). Chromosomal analysis was done to detect 
abnormalities like chromosome breaks, fusions and abnormal segregation. 
2.11. Colony formation studies 
  To study the ability of cells to recover from nanoparticle induced stress, 
colony formation assays was employed. Cells (1 × 104) were plated in 100 mm tissue 
culture dish and treated with Pt-np (0, 20, 40, 80 and 160 µg/mL) and 100, 200 and 
400 µg/mL of Ag-np-3. Following 48 hrs of incubation, the medium containing 
nanoparticles was replaced with fresh medium and incubated for 4 days. The ability to 
form colony and the number of colony formed were recorded after staining with 0.2% 
crystal violet stain for each concentration. 
 




2.12. Analyses for protein/ gene expression  
2.12.1. Western blotting 
 Cells were treated with Ag-np-3 (50, 100 and 400 g/mL) or  Pt-np (160 
µg/ml) for 48 hrs and proteins were isolated by lysing the cells in radioimmuno 
precipitation assay buffer (RIPA) for 20 min on ice, followed by centrifugation at 
13,000 rpm for 1 hr at 4°C. Proteins were quantitated by Bradford method (Biorad 
laboratories, Hercules, CA, USA). Proteins (100 µg) were separated using 10% 
polyacrylamide gel (Biorad laboratories, Hercules, CA, USA) and blotted on to 
nitrocellulose membrane (Amersham biosciences, Piscataway, NJ, USA). Membranes 
were blocked in 5% non-fat milk for 1 hr and incubated with primary antibody (mouse 
monoclonal) overnight. Primary antibodies for p53, p21, PCNA, PARP,                
Caspase 3 (Santa Cruz Biotechnologies, USA), phosphorylated p53 (phospho p53, cell 
signalling technologies Inc, Danvers, MA, USA) and β actin were employed for the 
experiments. Following incubation, membranes were washed and incubated with 
secondary antibody (goat anti-mouse antibody, Santa Cruz biotechnologies, CA, 
USA) for 1 hr and chemiluminescent substrate (ECL, Pierce biotechnology, Rockford, 
IL, USA) was used to generate luminescent signals which was detected using X-ray 
films (Pierce biotechnology, Rockford, IL, USA). 
2.12.2. Gene expression profile using real time-reverse transcriptase- polymerase 
chain reaction (RT-PCR) 
  Light cycler 480 RNA amplification kit SYBR green 1 (Roche, Switzerland) 
was used for RT-PCR analyses as per manufacturer’s instructions. Cells were treated 
with 200 g/mL of Ag-np-3 whereas, embryos were exposed to 25 and 50 g/mL of 




nanoparticles and total RNA from cells were isolated using RNA isolation kit (Qiagen, 
Germany). Nanoparticle treated embryos were washed in egg water and frozen in 
liquid nitrogen. The embryos were resuspended in 500 µL of trizol reagent and 
homogenised. Aqueous layer containing RNA was isolated by centrifugation, after 
supplementing equal volume of trizole and 200 µl of chloroform. RNA was 
precipitated in propanol, washed in ethanol and air dried. Before the experiment, RNA 
was resuspended in RNAse free water. The concentration and integrity of RNA was 
measured using nanodrop spectrophotometer prior to the experiment. Primers were 
designed using cybrgene primer design utility. The primer sequences and cycling 
conditions are included in Table 2.1. 
2.12.3. Messenger RNA isolation and array hybridisation 
Cells were seeded at a density of 2 × 106 cells/ T75 flasks and treated with 400 
µg/mL of Ag-np-3 for 48 hrs. Cells were harvested in cold 1 × phosphate buffered 
saline (PBS, 1st Base, Singapore) and mRNA was isolated using Qiagen RNeasy mini 
kit (Qiagen, Hilden, Germany), following manufacturer’s instruction. The 
concentration and integrity of mRNA was tested using Nanodrop spectrophotometer 
(Thermo Fischer Scientific, USA). The RNA from untreated and nanoparticle treated 
cells were used for hybridisation. The arrays (Oligo GEArray; SuperArray Bioscience 
Corporation, MD, USA) employed were human cell cycle oligo GEArray (OHS-020), 
human DNA damage signalling pathway oligo GEArray (OHS-029), human signal 
transduction pathway finder oligo GEArray (OHS-014) and human extracellular 
matrix and adhesion molecules oligo GEArray (OHS-013). Probing was done as per 
manufacturer’s instructions. Briefly, complementary RNA (cRNA) was synthesised 
using TrueLabeling-AMP Linear RNA Amplification Kit (SuperArray Bioscience 




Corporation, Frederick, MD) as per manufacturer’s instructions and biotinylated using 
Biotin-16-uridine-5'-triphosphate (Roche, Germany) . The biotinylated cRNA (3 mg) 
was used for overnight hybridisation at 60°C. The membrane was treated with alkaline 
phosphatase conjugated to streptavidin. Treated membranes were exposed to 
chemiluminescence reagent and image was captured on X- ray films. Image analysis 
was performed using GEArray expression analysis suite (SuperArray Bioscience 
Corporation, MD, USA). Normalisation was carried out using Rps27a, Gapdh, B2m, 
Hsp90ab1 and Beta actin. 
2.13. Immunofluorescence staining for H2AX 
 Phosphorylation of H2AX occurs following a double strand DNA break, 
where ATM/ATR is activated. The phosphorylated protein binds to the DNA, at the 
damage site, aiding the repair process, which can be used as a biomarker for detecting 
ds DNA damage. The cells were plated on cover slips (0.4 million cells/well) in 6-well 
plates and treated with the nanoparticles (25, 50 and 100 µg/mL of Ag-np-3; 80 and 
160 µg/mL of Pt-np) for 2 hrs. Cells exposed to10 µM H2O2 were used as positive 
controls. Following incubations, the cover slips were washed in PBS twice and fixed 
in 4% formaldehyde for 15 min. After washing away excess formaldehyde, the cells 
were permeabilised in 0.2% triton X solution (7 min), blocked in 5% BSA (1 hr) and 
incubated in primary Anti-phospho histone H2AX mouse monoclonal antibody (Ser 
139, JBW 103, Upstate biotechnology Inc., USA) for 1 hr. The cover slips were 
washed thrice in PBS to remove excess of primary antibody and stained with 
secondary antibody (anti-mouse antibody conjugated to FITC, eBiosciences, USA) for 
1 hr. After washing away the excess of secondary antibodies, the cover slips were 




mounted in DAPI-vectashield. The images were captured under the DAPI-FITC filter 
of Zeiss Axioplan microscope. 
2.14. Isothermal titration calorimetry (ITC) 
ITC experiments were carried out using a VP-ITC titration calorimetric system 
(Microcal Inc., MA, USA) operated at 25°C.  Each microcalorimetric titration 
experiment consisted of 60 successive injections of a constant volume (5 μL/injection) 
of cytosolic protein (300 μg) in water to the reaction cell containing (150 μg in 1.8 mL) 
Ag-np-3. The binding of starch to protein solutions in the absence of silver 
nanoparticles and binding of starch capped silver nanoparticles with genomic DNA 
was determined, using the same number of injections and concentration of 
proteins/DNA as in the titration experiments.  Data analysis was carried out with 
Origin 7.0 software supplied with the instrument. 
2.15. Cytokine detection assay 
The effect of Ag-np-3 on the levels of cytokines and chemokines of human 
lung fibroblasts were determined by collecting the supernatants from both the 
untreated and silver nanoparticles treated cultures were collected and stored in -80°C 
until used. The cytokines were quantified using Bio-PlexTM Cytokine assay (Bio-Rad 
Laboratories, CA, USA). Premixed multiplex beads of the Bio-Plex human cytokine 
panel, which included 17 cytokines of choice (IL-1β, IL-2, IL-4, IL-6, IL-7, IL-8, IL-16, 
IL-17, TNF, IFNγ, MCP-1 (CCL2), MIP-1 (CCL3), MIP-1β, RANTES, ICAM-1, 
GM-CSF, GRO) were used and the assay was performed by strictly adhering to the 
manufacturer’s instructions. The data were analysed using the Bio-Plex Manager 4.0 
software (Bio-Rad Laboratories, CA, USA).  




2.16. Intracellular calcium measurement 
   The Ca2+ measurements were done using Fluo-2NW calcium assay kit, 
(Invitrogen, USA). The assay was designed to measure Ca2+ transients occurring in 
target cells. The assay was performed as per the supplier’s instructions. Ag-np-3 were 
added to the wells and incubated for different time intervals starting from 0s, 4 hrs, 24 
hrs and 48 hrs. Kinetic study was performed by prior loading of the cells with Ca2+ 
sensors at 37C for 30 min followed by incubation at room temperature for 30 min. 
Different concentrations of Ag-np-3 (25, 50, 100, 200 and 400 g/mL) were added to 
the wells containing the dye and readings were taken immediately. End point 
measurements (4, 24 and 48 hrs) were taken after treatment with Ag-np-3s and 
subsequent loading with the dye. Fluorescence measurements were taken using 
TECAN Genios plus and BioTek Flx 800 spectrofluorometer. 
2.17. Statistical analysis 
 Statistical analyses of the values for all experiments are expressed as               
mean  standard deviation of three independent experiments. The data were analysed 
using Student’s t-test (Microsoft Excel, Microscoft corporation, USA) where statistical 
significance was calculated using untreated (control) and nanoparticle treated samples 
and those with P value <0.05 are considered as significant. 
2.18. Collection and exposure of the embryos to nanoparticles 
 Zebrafish embryos were collected and staged according to standard procedure 
(Westerfield, 2000) For toxicity studies, 10 healthy embryos were transferred to the 
wells of a 24 well plate along with 1 mL of embryo water. Different concentrations of 
nanoparticles were added to the wells and incubated for 72 hrs. For all nanoparticles, 6 




different concentrations (10, 25, 50, 75, and 100 g/mL) were used to study their 
impact on embryos. Similarly, toxicity of capping agent polyvinyl alcohol (PVA) at 
different concentrations (10, 25, 50, 75, and 100 g/mL) and ionic forms of the 
corresponding metals (Ag+, Pt2+ and Au3+ at 0, 10, 20 40, 80 and 100 nM) was also 
evaluated. Tests were done in duplicates and repeated thrice (60 embryos per 
concentration). Mortality of the embryos was noted after 24 hrs, 48 hrs and 72 hrs. 
The dead embryos that appeared opaque and white in colour were transferred to 6 well 
plates along with 4 mL of the medium. This step was essential as the silver treated 
eggs appeared white opaque with live embryos still inside. The movements inside the 
chorion indicated the presence of live embryos. The mortality rate is expressed as the 
total number of dead embryos after 72 hpf. Hatching rate was expressed as the number 
of embryos that hatched by 72 hrs post fertilisation (hpf) compared to the control. Heart 
rate was recorded using a stopwatch at different time intervals (24, 48 and 72 hpf), by 
direct microscopic observation. At the end of incubation period, the embryos were 
anesthetised in 0.01% phenoxy ethanol and photographed using Zeiss Axiovert 200M 
equipped with Axiocam HRc.  
2.19. TEM analysis of the embryos 
Embryos were incubated with 25 g/mL of Ag-np-3 for 48 hrs, dechorinated, 
fixed in 4% para formaldehyde, dehydrated and embedded in spurr’s low viscosity 
resin. Ultrathin sections of resin embedded (spur low viscosity resin) embryos were 
taken using Reichert Jung Ultracut and negatively stained. TEM analysis was done 
using JEOL JSM 3010F and JEOL JSM 2010F. Presence of nanoparticles inside the 
embryo was confirmed using EDS. 
 




2.20. Acridine orange staining 
 To investigate the role of apoptosis in silver nanoparticles toxicity, acridine 
orange staining of nanoparticle treated embryos was performed by incubating embryos 
with 3 µg/mL of acridine orange at 37°C for 25 min, followed by immediate washing 
in PBS. The embryos were imaged using Zeiss Axiovert 200M equipped with 
Axiocam HRc. 
2.21. 4,6-diamidino-2-phenylindole-dihydrochloride hydrate (DAPI) staining 
 DAPI (Roche, Switzerland) staining of the fluid inside the chorion was 
performed to analyse whether the brown colour flakes found dispersed in the chorion 
were cells or not. A solution (1 g/mL) of DAPI was prepared in methanol. The 
chorion was poked using a fine needle to aspirate the fluid and the embryos were 
transferred back to the embryo water. Slides containing the chorionic fluid were air 
dried and stained with DAPI at 37C for 15 min, washed twice with phosphate 
buffered saline (1 × PBS) and air-dried.  Slides were then analysed under the DAPI 
filter of the microscope. 
2.22. Quantification of metal content in embryos  
 This assay was performed to identify metal accumulation in embryos that 
appeared healthy after nanoparticle exposure. Accumulation of metals in embryos 
could be used as a parameter for understanding chronic effects of nanoparticles. 
Embryos were treated with 25 and 50 g/mL of nanoparticles as described above. At 
72 hpf, larvae which do not exhibit any phenotypic defects were transferred to 1.5 mL 
tubes, washed 5 times in ultrapure water and immersed in liquid nitrogen for 1 min 
followed by digestion in 200 µL nitric acid for 3 days. The digested samples were 




reconstituted to 5 mL with ultrapure water and filtered using syringe filter (0.2 µm, 
Sartorius, Germany) before analysing by ICP-OES to detect metal content. 
2.23. Preparation of single cell suspension from embryos for cell cycle analysis 
 The embryos were exposed 25 and 50 g/mL of Ag-np-3 and incubated till 
they reach 24 hpf. The embryos were dechorinated using 1 mg/mL of pronase, 
homogenised and neutralised with MEM. The cells were separated by centrifugation 
and fixed in ice cold ethanol. The samples were processed for cell cycle analysis as 


















Table 2.1: Primer sequence used in RT-PCR 
Gene Accession number Left primer Right primer 
In vivo 
 p53  NM_131327.1 ATCATCTGAGCCCAAACAGG AAATGACCCCTGTGACAAGC 
ATM AJ605775.1 AAGCCCTTTTGACCATTGTG TCTGACTGTCACTGGCCTTG 
ATR XM_691071.3 TGCAGAGAACTCCCACCTCT ATCGCATTGCTCTCGAAGTT 
RAD51 NM_213206.1 CCAAGAAGCCTATTGGTGGA TGGTATACATGGCCGACAGA 
BRCA1 XM_001920581.1 CGTCTCTCCGAACACACAGA AGACAGAGCTCCCTTCACCA 
RAD50 BC076425.1 AGCTGCTTTCCACCAAAGAA TGTCCAGAGCTTTGATGTCG 
MAPK NM_131721.1 ACAGGAATAAGCGCGAGAAA TTGTGGTTGACGCATTTCAT 
C-jun NM_199987.1 ACGGGGAGTTGAGGAACTTT AAAGTGGCACTGTCATGCTG 
GAPDH NM_001115114.1 GATTGCCGTTCATCCATCTT AACAGCAAAGGGGTCACATC 
Ku70 DQ859046.1 CCTGGTTGCTTTGGTGTTTT ACTGCCCATGGTCTTTTCAG 
Ku80 BM036305.1 ACAAATAGAGGCTGCGCAAT CACTCCTGTGCATTTCTCCA 
MDM2 NM_131364.2 AACTCCCAACACAACCTTCG GGCTGTGATGATGTGGTTTG 
β actin AF057040.1 CTCTTCCAGCCTTCCTTCCT CTTCTGCATACGGTCAGCAA 
Cyclin B1 NM_131513.1 GCCAAAATATCTGGCAGGAA TGCAATCTCTGGTGGGTACA 
Cyclin E X83594.1 GCGTGGGATTTACGCAGTAT ATCGCTCTCATTTTGGGTTG 
Cyclin D1 NM_131025.2 TGACTTGCCTTGACTTGTCG GAAAAAGCAGGGAGCACTTG 
PCNA NM_131404.1 AGCCAGTGCAGCTCATTTTT TGCAGAATGAAAATCCCACA 
SOD1 NM_131294.1 GTTTCCACGTCCATGCTTTT AGCATTGCATCCTCGATTTC 
BCL2 NM_001030253.2 GGAAATGTCCCAACAAATGG AAAACGGGTGGAACACAGAG 
BAX NM_131562.2 AGGGCTTCCAAATGTCTGTG GTTTTGTCCATCCCTGCTGT 
Pax6a NM_131304.1 CTGACGTTTTTGCACGAGAA AAAGGATACTGGCGTTGTGG 




Pax6b NM_131641.1 CAGCAACTCCTCCAGTCACA GGTTGCATAGGCAGGTTGTT 
BMP4 NM_131342.2 CTGCATCACCTCTCGACAAA CGCTTTCTTCTTCCCTTCCT 
Cdc2 NM_212564.2 GTGTTTGGGGAAAATGGATG ATTTGGATTCCTGCATCAGC 
P21 XM_001923789.1 AGAAGAGCAGCGAGCTGAAG CGGAATAAACGGTGTCGTCT 
In vitro 
Met1F BC029453 CCACTGCTTCTTCGCTTCTC AGGAGCAGCAGCTCTTCTTG 
HO-1 X14782.2 GAGACGGCT TCAAGCTGGTGATGG CCACGGGGAAAGTGGTCATGG 
Filamin NM_001456 AAGTGACCGCCAATAACGAC GGCGTCACCCTGTGACTTAT 
18s X69150 GTAACCCGT TGAACCCCATT CCATCCAATCGGTAGTAGCG 
P53 NM_001126116 GGCCCACTTCACCGTACTAA GTGGTTTCAAGGCCAGATGT 
MAPK NM_002745 CCACCCATATCTGGAGCAGT CAGTCCTCTGAGCCCTTGTC 
IL-8 NM_000584 ATGACTTCCAAGCTGGCCGTGGCT TCTCAGCCCTCTTCAAAAACTTCTC 
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 Silver nanoparticles have gained much popularity recently owing to their 
broad-spectrum of antimicrobial activity (Gogoi et al., 2006; Kim et al., 2007; Lok et 
al., 2006). Silver impregnated catheters (Samuel and Guggenbichler, 2004)  and 
wound dressings (Edwards-Jones, 2009) are used in therapeutic applications. In spite 
of the wide usage of silver nanoparticles in wound dressings which can cause easy 
entry into the cells, very few reports on the toxicity of silver nanoparticles are 
available. Moreover, the mechanisms involved in the toxicity of nanoparticles to 
microorganisms can also be active in humans. Although a few research groups have 
investigated the toxicity of silver nanocomposites and nanoparticles in cell lines to 
estimate viability and reactive oxygen species (ROS) generation (Arora et al., 2009; 
Braydich-Stolle et al., 2005; Hussain et al., 2005), little is known about the 
mechanisms of silver nanoparticle toxicity. Recent reports have shown the 
involvement of mitochondria dependant jun-N terminal kinase (JNK) pathway in Ag-
np toxicity (Hsin et al., 2008). In vivo experiments in rats have demonstrated lung 
function changes and inflammation (Sung et al., 2008). However, the primary targets 
of and distribution patterns remain ambiguous. The occupational hazard associated 
with nanoparticle exposure and the molecular mechanisms underlying silver 
nanoparticle toxicity are still unknown. Our study aims to unravel the cellular events 
that occur upon exposure to silver nanoparticles. 
 Here, an effort was initiated to understand various steps in silver nanoparticle 
toxicity by studying the effect of starch coated silver nanoparticles on cell lines. The 
parameters investigated include, 
 




1. Cytotoxicity:  
i) ATP production 
ii) Metabolic activity 
iii) ROS production 
iv) Ca2+ fluctuations 
v)  Apoptosis/necrosis 
2. Uptake, excretion and distribution (Electron microscopy) 
3. Genotoxicity: 
i) DNA single/double strand breaks (Comet assay) 
ii) Chromosomal aberrations (CBMN Assay and chromosomal analysis by 
FISH) 
4. Proliferation:  
i) Cell cycle  
ii) Colony formation 
5. Mechanism of action 
i) Gene expression : RT-PCR, Super array 
ii) Protein expression (Western blot and ELISA)  
Here, we report a detailed study on the potential molecular mechanisms underlying 
silver nanoparticle toxicity using two different human cell types.  
3.2. Results  
 It is expected that the bio-kinetics of nanoparticles, which is measured as rate 
of nanoparticle uptake, intracellular distribution and exocytosis, contribute tremendously 
to their toxicity. The nanoparticle size, surface area and surface functionalisation are 
major factors that influence bio-kinetics and thus toxicity (Nel et al., 2006; Zhao and 




Nalwa, 2007).  The nanoparticles employed in this study were of 6- 20 nm in size (Figure 
3.1A) with an absorption maximum at 400 nm (Figure 3.1B). The calculated size 
distribution histogram confirmed the size distribution of nanoparticles (Figure 3.1C). 
These nanoparticles showed good stability in water. The hydrodynamic size of the 
nanoparticles was detected by dynamic light scattering to monitor the size distribution 
of nanoparticles in the whole liquid sample. The results confirmed the TEM data by 
showing a similar size range (Figure 3.1D), thus supporting the stability of the particles. 
The zeta potential of the nanoparticle was -1.72 mV. 

























Figure 3.1: Characterisation of silver nanoparticles: Typical TEM image (A) and UV-
visible spectrum (B) of Ag-starch nanoparticles reconstituted after lyophilisation. 
Absorbance maximum at 400 nm and narrow peak indicate small size of the particles. 
The size distribution histogram generated using image (A) captured in JEOL JSM 
2010F showed nanoparticles of size between 6-20 nm (C). Hydrodyanamic size of the 
nanoparticles in water (D). Analyses were performed from the stock solution 
reconstituted after lyophilisation.  
 

















3.2.1. Effect on cell morphology 
 The first and most readily noticeable effect following exposure of cells to toxic 
materials is the alteration in cell shape or morphology in a monolayer culture. 
Microscopic observations of treated cells showed distinct morphological changes 
indicating unhealthy cells whereas the control appeared normal (Figure 3.2A). 
Nanoparticle treated cells appeared to be clustered with a few cellular extensions and 
cell spreading patterns were restricted as compared to control cells. Similar results 
were observed by other groups in dermal fibroblasts cells treated with citrate coated 
gold nanoparticles (Pernodet et al., 2006). Dark orange patches were seen on the cell 
surface which could represent the adsorption of nanoparticles (Figure 3.2B). However 
only a few floating cells were observed under the microscope, suggesting the absence 
of widespread cell death due to necrosis.  
Scanning electron microscopy (SEM) analysis of untreated fibroblasts revealed 
their normal morphology and spreading patterns (Figure 3.2C). Adjacent cells were 
connected to each other through short and slender extensions of the parent cells. No 
blebbing was observed in control cells. On the other hand, the Ag-np-3 treated 
fibroblasts appeared more spherical, with minimum filopodia (Figure 3.2D). Similar 
pattern was observed for cancer cells. Untreated cancer cells appeared to have normal 
morphology (Figure 3.2E). The spreading patterns of the Ag-np-3 treated cancer cells 
were affected (Figure 3.2F). A few cells showed cell membrane blebbing and 
decreased ruffle formation.  





Figure 3.2: Microscopic observations of silver nanoparticles treated cells: Optical 
micrographs of U251 cells without any nanoparticle treatment (A) and cells treated 
with Ag-np 3 (200 g/mL) (B). Dark orange patches are visible on the cell surface of 
the treated cells, and remained even after repeated washings. IMR-90 control cells, 
without any nanoparticle treatment preserved their normal morphology (C). The Ag-
np-3 treated fibroblasts appeared more spherical and small with less cellular 
extensions (D). Untreated cancer cells showed normal morphology (E) whereas 








3.2.2. Cell viability 
 Viability assays are vital steps in toxicology that explain the cellular response 
to a toxicant. Also, they provide information on cell death, survival and metabolic 
activities. We have exploited the high sensitivity of a luminescence-based assay and a 
fluorescence-based assay to study the activity of Ag-np-3. ATP assays to assess the 
toxicity of silver nanoparticles (Figure 3.3A) showed a concentration and time 
dependant drop in luminescence intensity in cancer cells and normal cells, signifying 
time and dose dependant toxicity. The ATP content of the cells was not significantly 
affected at 24 hrs of incubation in the presence of nanoparticles. ATP content dropped 
drastically after 48 hrs and the same trend was seen up to 72 hrs. It is noteworthy that 
the adverse effects of nanoparticles were also concentration dependant. In the case of 
nanoparticle agglomeration and subsequent precipitation, uptake rate of nanoparticles 
will drop which could be observed as a decrease in ATP depletion and cytotoxicity. 
When starch alone was used as a control, it showed no significant cytotoxicity in both 
cells (Figure 3.3B). This observation ensures the biocompatibility of starch as a 
capping agent in nanoparticles. Another challenge in nanoparticle toxicity studies was 
the purity of nanoparticles employed for the study. The nanoparticles should be free 
from reactants used in the synthetic steps. To check the presence of any toxic 
materials left over from synthesis, toxicity studies were done using the supernatant 
liquid obtained after centrifugation of nanoparticle solution, which is expected to 
contain excess of reagents, if any. Our results showed no evidence of toxicity for this 
supernatant liquid. The cell viability in all the wells was comparable to that of the 
control (Figure 3.3C). 




 Microscopic observation of treated cells showed no indication of massive cell 
death. Absence of large number of floating cells even after prolonged incubation 
period together with low ATP levels implies a potential for metabolic arrest. Hence 
metabolic activity studies were conducted using cell titre blue assay. The results from 
cell titre blue assays confirmed metabolic arrest through the observed drop in 
mitochondrial activity (Figure 3.3D). The observations from the cell titre blue assay 
led to the same inference as from the ATP assay.  Structural and functional damage to 
the mitochondria could result in metabolic arrest, followed by a decrease in ATP 
yield. A low ATP measure or mitochondrial activity does not always represent cell 
death, but could lead to metabolic inhibition in cells. In order to study the effect of 
starch in Ag-np-3 toxicity, starch alone controls were also tested. However, starch did 
not result in any toxicity which further confirmed that the observed toxicity was due to 
Ag-np-3 alone. In summary, the viability assays were pointing at metabolic arrest rather 
than cell death. Hence, it was necessary to analyse the cell cycle to interpret the viability 
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Figure 3.3: Cytotoxicity studies of silver nanoparticles: The data obtained from 
luminescent assay for Ag-np-3 treated cancer cells (U251) and fibroblasts (IMR-90) 
representing intracellular ATP content (A). The Y-Axis represents the % of reduction 
in ATP content compared to control. X-axis represents the time of incubation for 
different cell types (U251, IMR-90). The different colours of the bars identify the 
concentration of Ag-np-3. (B) Represents data from starch alone controls, which after 
72 hrs of incubation showed no significant cytotoxicity. (C) Viability of cells exposed 
to the supernatant after the final washing step in nanoparticle purification, indicating 
that all the excess toxic reactants have been removed from the nanoparticles. (D) 
CellTitre blue cell viability assay shows a gradual drop in metabolically active cells. 
The Y-axis represents the % of metabolically active cells present in the treated 
sample. X-axis represents the time of incubation for different cell lines (U251, IMR-
90). The different colours of the bars identify the concentration of Ag-np-3. The 
values represents mean ± standard deviation of 3 experiments.* denotes P<0.05 
 
3.2.3. Cellular uptake and exocytosis of nanoparticles 
Attempts to identify the uptake routes of Ag-np-3 led to the conclusion that 
Ag-np-3 were taken up mainly through endocytosis. Clathrin dependent endocytosis 
and macropinocytosis played a major role in Ag-np-3 uptake. Untreated cells showed 
no detectable levels of silver. The cells incubated at low temperature had a reduced 
concentration of silver (less than 1 ppm (1ppm is equivalent to 1 µg/mL)) as compared 
to 37°C incubated cells, which implies that endocytosis is the major pathway for Ag-
np-3 uptake (Figure 3.4A). Nevertheless, inhibition of clathrin pits formation did not 
result in a complete drop in endocytosis which indicates that Ag-np-3 endocytosis can 




occur in the absence of clathrin pits. When cellular uptake through macropinocytosis 
was aborted, a significant drop in Ag-np-3 uptake was observed, suggesting the active 
involvement of the pathway. Inhibition of caveoli pits did not affect Ag-np-3 uptake. 
Exocytosis studies showed a gradual increase in silver concentration in cell culture 
supernatants together with a drop in nanoparticle concentration in cell homogenates. 
The nanoparticle concentration in culture medium showed a time and concentration 
dependant increase (Figure 3.4B). The process of exocytosis was compared with 
endocytosis, by calculating the percentage drop of total endocytosed silver to that of 
exocytosed, with time (Figure 3.4C). The exocytosis profile followed a concentration 
dependant increase over time, where ~66 % of endocytosed nanoparticles where 
exocytosed by 48 hrs compared to an exocytosis of ~ 10% at 2 hrs. A long incubation 
period of 48 hrs was taken to expel 66% of the particles endocytosed in 2 hrs, 
implying a slow exocytosis rate than endocytosis. A significant amount of 
endocytosed nanoparticles (34%) was still retained by the cells.  




            
Figure 3.4: Uptake of silver nanoparticles: (A) Data obtained from endocytosis 
studies using U251 cells. X axis represents different conditions employed viz. K+ 
depletion and temperature. Cells incubated at 37°C showed double the concentration 
of Ag than cells incubated at 4°C and K+ depleted environment suggesting role played 
by other routes like diffusion. The concentration of Ag isolated from clathrin blocked 




cells and endocytosis blocked cells were approximately equal showing a clathrin 
independent process of uptake. (B) Exocytosis data show a concentration and time 
dependant exocytosis as indicated by the increased concentration of Ag in culture 
supernatant and a gradual decrease in cells. X axis represents different time and 
concentrations employed for exocytosis. Y axis represents concentration of silver 
detected by ICP-OES. (C) Comparison of exocytosis and endocytosis rate in U251 
cells. Percentage of endocytosed nanoparticles expelled from cells over a period of 
time is depicted in the graph. 
 
3.2.4. Transmission electron microscopy (TEM) of cell sections to study bio 
distribution 
 In order to study the biodistribution of the Ag-np-3, TEM analyses of the 
cancer and normal cells treated with 100 g/mL of nanoparticles were performed. 
Untreated cancer cells showed no abnormalities (Figure 3.5A), whereas Ag-np-3 
treated cells showed endosomes near the cell membrane with a large number of 
nanoparticles inside (Figure 3.5B). The nanoparticles were found to be distributed 
throughout the cytoplasm, inside lysosomes and nucleus (Figure 3.5C). Clumps of 
nanoparticles found inside endosomes and in the cytoplasm were similar to nano-
aggregates. However, magnified images showed presence of individual nanoparticles 
within the clump (Figure 3.5D).We also observed large endosomes with nanoparticles 
in the cytoplasm of the cells and near the cell and nuclear membrane, which suggested 
that nanoparticles were entering the cells through endocytosis rather than diffusion. 
The cytoplasm of the cells showed multiple endosomes with engulfed nanoparticles 
and such endosomes were also observed near the nuclear membrane (Figure 3.5E). 
The nanoparticles were also observed to be deposited inside other organelles such as 
the mitochondria (Figure 3.5F).  
  Similarly, electron micrographs of fibroblasts revealed uniform intracellular 
distribution of Ag-np-3. Endosomes containing Ag-np-3 were seen near the cell 




membrane (Figure 3.5G), suggesting that nanoparticles enter the cells via 
endocytosis. The cytoplasm of the treated cells showed numerous endosomes with 
engulfed nanoparticles, autophagic vacuoles filled with structures resembling 
mitochondria and electron dense contents of unknown origin. Nanoparticles were 
detected in the nucleus of the treated cells (Figure 3.5H). Numerous exocytic vesicles 
were also observed inside the cells (Figure 3.5I).  
 






Figure 3.5: TEM images of ultra thin sections of cells. Untreated cells showed no 
abnormalities (A) whereas, cells treated with Ag-np-3 showed large endosomes near 
cell membrane with many nanoparticles inside (B). Electron micrographs showing 
lysosomes with nanoparticles inside (thick arrows) and scattered in cytoplasm (open 
arrow). Diamond arrow shows presence of nanoparticle in the nucleus (C). Magnified 
images of nano-groups showed that, the cluster is composed of individual 
nanoparticles rather than clumps (D). Image shows endosomes in cytosol that is 
lodged to nuclear membrane invaginations (E) and presence of nanoparticles in 
mitochondria and on nuclear membrane (F). Electron micrograph of Ag-np-3 treated 
IMR-90 cells: Image shows presence of nanoparticles inside the phagosomes, near the 
cell membrane (G). Cell shows nanoparticles in the cytosol, nucleus and nucleoli. 
Arrow points at nanoparticles (H). Exocytic vesicles were observed at the cell 
periphery containing nanoparticles and cellular debris (I). The EDS of stained ultra 
thin sections of cells treated with Ag-np-3. Spectra represents figure 9E.The source of 
copper in the spectra is the copper grids used to mount the sample. Lead and uranium 
is from the negative staining (J). 
 
 Elemental mapping of cell sections using STEM confirmed the distribution of 
Ag-np-3 within the cell (Figure 3.6A). The embedded Ag-np-3 were located and 
represented as red dots in the figure (Figure 3.6B). Scanning transmission electron 














Figure 3.6: Elemental mapping of cell sections: (A) STEM images of nanoparticle 
treated cell sections. (B): superimposed image of nanoparticle treated cells with 
elemental mapping. Red spots indicate presence of silver. Images of the cell and 
mapping of the same cell were captured using field emission scanning electron 
microscope. The images were merged using Image Merger version 1.0.20. Scale Bar: 
2 m. 
 
3.2.5. Production of ROS in human cells exposed to silver nanoparticles 
  Oxidative stress has specific effects in the cells including oxidative damage to 
protein and DNA. To determine the production of ROS as a decisive factor in silver 
nanoparticle toxicity, DCF-DA and DHE staining methods were performed. In the 
presence of ROS, fluorescence intensity of the cells stained with dyes increased, 
which led to a right shift of the emission maximum. Untreated cells were used as 
standards to calculate the extent of ROS production by measuring the percentage of 
cells with increased fluorescence intensity. The analysis showed significant increase in 
hydrogen peroxide (Figure 3.7A) and superoxide production (Figure 3.7B) in cells 
treated with 25 g/ml and 50 g/ml of Ag-np-3. The percentage of gated cells from 
DCF-DA (Figure 3.7C) staining and HE staining (Figure 3.7D) were used for 
assessing the extent of ROS production. No significant increase was observed beyond 
100 g/mL.  
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Figure 3.7: ROS production in silver nanoparticles treated cells: The histogram 
represents data from DCF-DA staining for detecting hydrogen peroxide production in 
the Ag-np-3 treated fibroblasts. (25 g/mL) (A). Shift was independent of the time of 
incubation starting from 2 hrs to 5 hrs of incubations. DHE staining (B) of the cells 
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fluorescence intensity and Y-axis represents the number of cells collected (10000 
cells). The graph represents the % of gated cells for DCF-DA staining (C) and DHE 
staining (D) as obtained from the statistics generated by WinMDI 2.8 software. For 
DCF-DA staining along with untreated control, H2O2 treated cells were used as 
positive control. DDC was used as positive control for detecting superoxide 
production. * represents p < 0.05. 
 
3.2.6. Genotoxicity of silver nanoparticles 
   Chromosome abnormalities are a direct consequence of DNA damage such as 
double strand breaks and misrepair of strand breaks in DNA, resulting in chromosome 
rearrangement. Micronuclei (MN) are formed in dividing cells from chromosome 
fragments or whole chromosomes that were unable to engage with the mitotic spindle 
during mitosis (Fenech, 2006). To assess such damages at the genomic and 
chromosomal levels, three assays were carried out: The alkaline single cell gel 
electrophoresis (comet) assay for DNA damage analysis, cytokinesis blocked 
micronucleus assay for studying genomic instability and fluorescence in situ 
hybridization for observing damage at the chromosomal level.  
3.2.6.1. DNA damage in silver nanoparticle treated cells 
 When cells containing damaged DNA are subjected to electrophoresis, 
fragmented DNA migrates towards the positive electrode away from the nucleus, 
manifesting as a tail-like structure. The extent of DNA damage can then be assessed 
by measuring the tail moment, which is a function of tail length and fluorescence 
intensity of DNA. Apparently undamaged nuclei therefore have very little or no tails, 
while nuclei with damaged DNA appear as ‘comets’. Extensive and dose dependent 
damage to DNA was observed after treatment of the cells with Ag-np-3. Comet assay 
of Ag-np-3 treated cells showed a concentration dependant increase in tail moment 
(Figure 3.8B) compared to control cells (Figure 3.8A), which gave the extent of 




DNA damage (Figure 3.8C). An increase in DNA damage with increase in 
nanoparticle concentration was observed in cancer cells whereas the fibroblasts 
showed no further increase in DNA damage beyond a nanoparticle concentration of 
100 g/mL. 






























Figure 3.8: Comet analysis of silver nanoparticle treated cells: Untreated (A) and Ag-
np-3 treated (B) cancer cells stained by SYBR green (conc. 400 g/mL). The graph 
(C) represents the tail moments of DNA (m). Fibroblasts exhibited a concentration 
dependant increase in DNA damage up to 100 g, above which, the values remained 
constant, whereas cancer cells showed a steady increase, * represents P < 0.05. 
 
3.2.6.2. Micronuclei in silver nanoparticles treated cells 
 In the cytokinesis blocked micronucleus assay, cells are blocked immediately 
after nuclear division, right before cytokinesis via the use of cytochalasin B, an actin 
polymerization inhibitor. Binucleated cells are then assessed for genomic instability. 




Damaged DNA or chromosomes that fail to attach to mitotic spindles during 
replication are extruded by the nucleus during nuclear division. These fragments 
manifest as micronuclei, which is a marker for genomic instability. The results from this 
assay further corroborated the comet results in Ag-np-3 treated cells (Figure 3.9B) when 
compared to the untreated cells (Figure 3.9A). Extent of genomic instability was much 
higher in cancer cells as compared to fibroblasts and significant numbers of micronuclei 
were formed in cancer cells compared to fibroblasts (Figure 3.9C).  








Figure 3.9: Micronucleus analysis for chromosomal aberrations in silver 
nanoparticles exposed cells: Images of untreated (A) and Ag-np-3 (100 g/mL) 
treated (B) fibroblasts showing binucleated cell. White arrow (B) points to 
micronucleus formed in a binucleated cell. Data from MNA (C) shows chromosomal 
aberrations. The data represents 1000 binucleated cells for U251 and 700 binucleated 








































3.2.6.3. Chromosomal aberrations in silver nanoparticles treated cells 
 Ag-np-3 treated cells were thoroughly analysed for chromosome aberrations. 
However, cells treated with a high concentration of nanoparticles (50 and 100 g/mL) 
did not yield enough metaphases, which suggested that only a few cells were entering 
mitosis. No significant abnormalities were observed in chromosomes of untreated 
fibroblasts (Figure 3.10A). However, fibroblasts treated with the lower dose (25 
g/mL) showed an increased percentage (10%) of aberrations characterised by the 
presence of acentric and centric fragments (Figure 3.10B). Similarly, cancer cells 
treated with the same concentration of Ag-np-3 showed increased chromosomal 
aberrations compared to control cells. Untreated cancer cells (Figure 3.10C) showed 
aberrations in the form of centric fragments (2%) and dicentric chromosomes (16%, 
Figure 3.10D), whereas Ag-np-3 treated cancer cells showed many acentric (12%, 
Figure 3.10E) and centric fragments (6 %, Figure 3.10F) and dicentric chromosomes 
(14%).  The percentage of aberrant cells was 10% and 20% for treated normal and 
cancer cells respectively (Table 3.1). Untreated normal cells showed no aberrant cells 
whereas untreated cancer cells showed 16% aberrant cells. The aberrations observed 
in both the cell types are represented in Figure 3.10G.The number of dicentric 
chromosomes were comparable in control and treated groups. 











Figure 3.10: The chromosomal aberrations in IMR-90 and U251 cells. Chromosomes 
from the untreated cells shows no damage (A), Ag-np-3 treated IMR-90 cells shows 
acentric and centric fragments (B). Arrow indicates acentric fragments Images show 
untreated cancer cells with no aberrations (C), metaphases shows dicentric 
chromosomes in untreated cells (D) and treated cells. White arrows points at dicentric 
chromosomes. Cancer cells treated with Ag-np-3 also show acentric fragments (E) 
and centric fragments (F). Red arrows points at fragments. The graph (G) represents 
the frequency of aberrations observed in treated cells. X-axis represents type of 
aberrations corresponding to the cell lines employed. Y-axis denotes frequency of 




           Table 3.1: Summary of chromosomal aberrations observed in cancer cells and normal cells. 
 










Data represents mean ± standard error. Fifty metaphases were analysed per concentration. Higher concentrations of Ag-np-3 did not yield 
enough metaphases and hence were excluded. Percentage of aberrant cells was expressed as number of cells which showed 








Fragments Breaks Fusions Total 
aberrations 
per cell 
Aberrant cells (%) 
Acentric Centric Ring Dicentric 
0 50 46 ± 0 0 0 0 0 0 0 0 










Fragments Breaks Fusions Total 
aberrations 
per cell 
Aberrant cells (%) 
Acentric Centric Ring Dicentric 
0 50 93 ± 2.25 0 1 0 0 8 0.18 ± 0.062 16% 
25 50 96 ± 2.46 6 3 0 0 7 0.32 ± 0.097 20% 




3.2.7. Calcium fluctuations in silver nanoparticles treated cells 
   Ca2+ plays significant roles in cellular functions by activating many kinases, 
nucleases as well as allowing a smooth cell cycle progression. A typical bell shaped 
curve was obtained with normal cells treated with Ag-np-3 for 48 hrs. On the other 
hand, the kinetic study showed a drop in Ca2+ concentration upon addition of Ag-np-3 
(Figure 3.11A). However, the fluorescence in wells treated with 25 g/mL of Ag-np-
3 increased gradually with time. Data obtained from normal cells, treated with Ag-np-
3 for 4 hrs showed a drop in Ca2+ concentration. A gradual increase in Ca2+ 
concentration occurred after 24 hrs for Ag-np-3 concentrations up to 100 g/mL, 
above which the values fell below the control sample. However, in normal cells the 
Ca2+ concentration stabilised by 48 hrs giving a bell shaped curve (Figure 3.11B). The 
Ca2+ concentration at 400 g/mL of Ag-np-3 was comparable to the controls in 
fibroblasts. In contrast, cancer cells showed a sharp drop in intracellular Ca2+ ion 
concentration except at 24 hrs (Figure 3.11C). Cancer cells at 24 hrs showed elevated 


















































Figure: 3.11: Calcium measurements: Calcium transients in Ag-np-3 treated U251 
and IMR-90 cells: Cells were stained with calcium binding fluorophore and 
subsequently activated with Ag-np-3 (A). Data obtained from experiments where the 
U251 cells were treated with Ag-np-3 for 4 hrs and then stained with the dye (B). 
Graph denotes the calcium concentrations in Ag-np-3 treated IMR-90 cells at 4, 24 
and 48 hrs. (C) Represents data from U251 cells treated with Ag-np-3. * indicates P 
















































3.2.8. Effect of silver nanoparticles on cell cycle 
 Oxidative stress in Ag-np-3 treated cells indicated possibility of DNA damage 
where the early effect would be evidenced in cell cycle progression. Cells with 
damaged DNA accumulate in gap1 (G1), DNA synthesis (S) or in gap2/mitosis (G2/M) 
phase. Cells with irreversible damage undergo apoptosis giving rise to accumulation 
of cells in subG1 phase. Thus toxicity studies were further extended to cell cycle 
analysis, to study apoptosis, cell cycle arrest and evidence of DNA damage. 
 The influence of nanoparticles on the cell cycle was analysed by subjecting the 
nanoparticle treated cells to flow cytometry. Statistical data from raw histograms 
(Figure 3.12) were extracted using WinMDI software and percentage of cells in each 
phase of the cell cycle was compared with that of controls. Both cell types showed a 
concentration dependant G2 arrest (U251 - Figure 3.13A and IMR-90 - Figure 3.13B) 
which was observed as an increase in cell population in the G2/M phase compared to 
control. The lowest concentration of nanoparticles tested (25 g/mL) marked the onset 
of G2/M arrest. As the concentration of Ag-np-3 was increased to 400 g, there was a 
massive increase (approx. 30%) in G2 population. In controls, the major cell 
population was observed in G1 phase, whereas, in Ag-np-3 treated cells, a decrease in 
G1 population accompanied by an increase in G2/M population was detected.  The 
proportion of cells in S phase was less affected as compared to the G2/M population. 
No significant apoptosis was observed as indicated by the absence of cell population 
in sub-G1.  






Figure 3.12: Histograms representing cell cycle analysis of IMR-90 and U251 cells 
exposed to silver nanoparticles. The control showed normal distribution of sub G1, 
G1, S and G2/M (A) The cells treated with 25 g/mL (B), 50 g/mL (C), 100 g/mL 
(D), 200 g/mL (E) and 400 g/mL (F) showed a gradual increase in S/G2 population 
indicating S/G2 arrest for U251 and G2/M arrest for IMR-90. The absence of subG1 
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Figure 3.13: Cell cycle analysis of silver nanoparticle treated cells: Ag-np-3 treated U 
251 cells (A) showed a gradual increase in the S/ G2 population and IMR-90 cells (B) 
showed a concentration dependant G2/M arrest. The statistical data is plotted as 
generated by WinMDI 2.8 software. Markers were set at regions of interest (Sub G0, 
G1, S and G2M) and the % of cells (events) under each area was generated using the 











3.2.9. Recovery and colony formation 
 Normal fibroblasts treated with 0, 25, 100, and 200 g/mL of Ag-np-3 
recovered completely from the proliferation arrest (Figure 3.14A) whereas cells 
treated with 400 g/mL of Ag-np-3 recovered by the end of one month recovery 
period. The cell cycle analysis performed using the recovered cells showed no 
evidence of cell cycle arrest (Figure 3.14B). Untreated cells (Figure 3.14C) and cells 
treated with 25 µg/mL of Ag-np-3 formed colonies (Figure 3.14D) while none of the 
cells treated with higher concentration of Ag-np-3 formed colonies till the end of 
incubation period (Figure 3.14E). An increase in floating cells with time was 
observed at higher concentrations. The morphology of untreated cells appeared normal 
(Figure 3.14F) whereas those treated with Ag-np-3 showed incomplete filopodia 
(Figure 3.14G). The morphology deteriorated more with time (2 weeks) giving rise to 
cells with no protoplasmic extensions, suggesting onset of cell death (Figure 3.14H). 














     
Figure 3.14: Recovery studies: Colony formation studies of Ag-np-3 treated IMR-90 
and U251 cells: The cells after Ag-np-3 exposure was allowed to recover from stress. 
The time (days) taken for the cells to reach confluence is expressed as the recovery 
period (Y-axis) (A). X- axis indicate the concentrations of nanoparticles. Cells treated 
with all concentrations except 400 g/mL recovered. * indicates P value < 0.05. (B) 
Cell cycle analysis of recovered cells showing absence of cell cycle arrest (n=3). (C) 
Untreated cancer cells showing recovery and (D) Ag-np-3 treated (25 µg/mL) cells 
forming colonies (1 week). (E). Cells treated with higher concentration of Ag-np-3 
(200 µg/mL) did not form any colonies. The morphology of the cells under recovery 
deteriorated with time. (F) Control cells showing healthy cells with proper 
protoplasmic extensions. (G) Ag-np-3 treated cancer cells showing unhealthy cells 
with no proper protoplasmic extensions (2 weeks). (H) Morphological deterioration 








3.2.10. Apoptosis and necrosis 
  To assess the extent and mode of cell death, annexin V staining was carried 
out. Statistical data was extracted from the dot plots (Figure 3.15) using WinMDI 
software, based on the percentages of unstained cells (viable cells), those with red 
fluorescent labels (necrotic cells), green label (apoptotic cells) and dual stained cells 
(late apoptosis) were analysed. The data from the annexin V staining experiment 
indicated that only a small percentage of cells were undergoing apoptosis and necrosis 
at higher concentrations of Ag-starch nanoparticles treated U251 (Figure 3.16A) and 
IMR-90 cells (Figure 3.16B).  There was an increase in (5-9% with respect to control) 
in the apoptotic cell population from 25-100 g/mL for fibroblasts which could be 
attributed to the observed ROS production, whilst 16% (±5) of cell death observed 
was due to late apoptosis and necrosis. Induction of apoptosis specifically at low doses 
of nanoparticles accompanied by proliferation arrest at high concentrations suggests 
differential sensitivity of nanoparticle concentrations. It could also be interpreted as a 
situation where cells sustain DNA damage and gain resistance to cell death. A 
concentration dependant increase in DNA damage and G2/M arrest establish that DNA 
damage is increasing with concentration.  Recent reports have identified apoptosis as a 
major mechanism of cell death following exposure to nanomaterials (Hsin et al., 2008; 
Pan et al., 2007). However contradictory results suggest involvement of additional 
parameters in nanoparticle mediated cell death which require detailed study (Khan et al., 
2007; Park et al., 2007). DNA fragmentation analyses were carried out to study DNA 
fragmentation characteristic of late apoptosis. No laddering patterns were observed in 
the gel, which confirmed the absence of late apoptosis where nuclear fragmentation 
occurs (Figure 3.16C). Absence of massive apoptosis and necrosis at higher 




concentrations of Ag-np-3 accompanied by G2/M arrest indicated a retarded cell 



















Figure 3.15: Dot plots from Annexin- FITC staining of U251 and IMR-90 cells. Image (A) is unstained cells (no fluorescence) which 
accumulate at lower left window that represents live cells. Image (B) shows necrosis positive controls (red fluorescence) which accumulate on 
upper left window for red fluorescent cells. Figure (C) shows apoptosis positive controls (Staurosporine treated) accumulating on lower right 
window for green fluorescent cells. Late apoptotic cells will accumulate in upper right window. Values from untreated cells (D) are used to 
calculate % of change in population. Image (E) shows cell population for a concentration 25 µg/mL (F) represents Ag-np-3 concentration of 50 
µg/mL (G) represents Ag-np-3 concentration of 100 µg/mL (H) denotes 200 µg/mL and (I) represents cells treated with 400 µg/mL of Ag-np-3. 
The % of cells under each category (early and late apoptosis, necrosis) is represented in red font, in respective windows.
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Figure 3.16: Apoptosis in silver nanoparticles treated cells: Annexin-V staining of U 
251 (A) and normal fibroblasts (B) to detect the mode of cell death indicated that a 
small percentage of cells are undergoing cell death, and a major population is viable. 
The statistical data is plotted as generated by WinMDI 2.8 software. The % of cells 
stained with PI alone is represented as necrotic cells where as % of cells stained with 
FITC alone represent early apoptosis. Cells at final stages of apoptosis take up both 




stains. (C) DNA laddering experiments in Ag-np-3 treated U251 and IMR-90 showing 
absence of laddering. 
 
3.2.11. Effect of silver nanoparticles on gene expression 
In order to investigate the specific effects of silver nanoparticles on human 
cells, pathway specific gene expression profiles such as genes involved in cell cycle, 
DNA damage and repair, cell adhesion and important signalling cascades were 
evaluated.  To assess the differential expression in a wider perspective, we have 
looked at these effects in both IMR-90 and U251 cells, representatives of normal cells 
and cancer cells respectively. 
It was observed that Ag-np-3 treatment affects the cell cycle process in both 
cells. The list of genes in the cell cycle pathway affected by Ag-np-3 treatment and the 
corresponding expression level changes are presented in Figure 3.17A. Cdc2 was the 
only gene which showed a significant increase in expression in IMR-90 cells, with a 
majority of the investigated genes down regulated (Figure 3.17A). U251 cells showed 
upregulation of CDK5R2, retinoblastoma (Rb) and Bax gene (Figure 3.17A).  Gadd 
45α in U251 cells and Gadd 45 γ in IMR-90 cells were down regulated following 
exposure to Ag-np-3 (Figure 3.17A). We show that there is a decrease in the protein 
expression of p53, p21, PCNA and cyclin B, which are involved in cell cycle control, 
following Ag-np-3 treatment (Figure 3.17B).  Protein levels for PCNA dropped by a 
factor of 0.35 in fibroblasts and 0.31 in cancer cells (Figure 3.17C). Normal cells 
showed a 0.32 fold drop in p53 levels whereas cancer cells exhibited a 0.58 fold 
decrease. There was a 0.12 fold drop in p21 levels in normal cells corresponding to 
0.72 fold in cancer cells. Further, a similar drop in cyclin B levels was observed in 
both the cell types (~ 0.41 in normal cells and 0.42 fold in cancer cells). Low doses of 




Ag-np-3 resulted in a gradual decrease in p53 and PCNA levels (Figure 3.17D). p21 
showed a concentration dependant decrease in densitometry even though the protein 
bands appeared to be of the same intensity in control and in cells treated with 50 or 
200 µg/mL of Ag-np-3 (Figure 3.17E). 
 












Figure 3.17: Differential gene expression profiles in cell cycle pathway. (A) 
Differentially expressed genes in cell cycle pathway, obtained from array analysis. (B) 
Proteins bands in western blot analysis. Downregulation of PCNA, p53, p21, survivin 
and cyclin B1 were observed for a concentration of 400 µg. (C) Normalised values of 
protein levels. Values were obtained by densitometry analysis of X-ray films using 
Kodak molecular imaging software and normalised against actin levels to represent 
accurate values for proteins which deviated from the control. (D) Western blot 
analysis of selected genes for monitoring dose dependant effects. P53 and PCNA 
showed a dose dependant decrease in protein levels. (E) Normalised values for protein 
levels in Ag-np-3 treated cells, quantitated by densitometry. The data showed a dose 
dependant decrease in p21 level. Phospho p53 levels showed a dose dependant 
increase in cancer cells. Slight increase in Caspase 3 and PARP cleavage was 
observed. 
 
Analysis of genes involved in DNA damage and repair pathway showed 
significant mRNA level changes (Figure 3.18A). U251 and IMR-90 cells showed 
differential profiles in this pathway after Ag-np-3 treatment. There was an 
upregulation of GADD45γ in IMR-90 cells while the rest of the observed genes were 
down regulated. U251 cells exhibited an increase in major DNA damage repair 
pathway genes like, ATM, ATR and XPA. The other important genes in this pathway 




like Abl1, Gml, Brca1, Zak, Xrcc5, Trex1, Pms1, Ccnu and Apex2 were also 
upregulated in the cancer cells. Downregulation of genes involved in base excision 
repair (Mbd4, Apex1, OGG1 and Mutyh) and mismatch repair pathways (Mutyh, Abl1, 
Pms1 and MSH2) were observed. DAPI stained images from IMR-90 and U251 cells 
showed numerous H2AX foci in the nucleus. The number of foci was high in cancer 
cells than in IMR-90 cells. Untreated U251 cells showed no/minimal foci (Figure 
3.18B). The green coloured dots increased when concentration of nanoparticles was 
increased from 25 µg (Figure 3.18C) to 50 µg (Figure 3.18D) and further to 100 µg 
(Figure 3.18E). Positive controls also showed increase in number of H2AX (Figure 
3.18F). Similarly, untreated IMR-90 cells exhibited no indication of H2AX while 
foci started appearing with increase in nanoparticle concentration from 25 µg (Figure 
3.18G) through 50 µg (Figure 3.18H) and further to 100 µg (Figure 3.18I). Positive 























Figure 3.18: DNA damage in silver nanoparticle treated cells: (A) Gene expression pattern in DNA damage pathway. H2AX staining of 
untreated U251 cells (B) showing minimal foci, (C) cells exposed to 25 µg/mL of Ag-np-3 (D) 50 µg/mL (E) 100 µg/mL and (F) 10 µM H2O2, 
showing multiple foci. (G) Untreated IMR-90 cells shows no foci whereas, treatment with (H) 25 µg/mL of Ag-np-3 (I) 50 µg/mL (J) 100 
µg/mL and (K) 10 µM H2O2, shows multiple foci. 




Array analyses of cell adhesion and extracellular matrix showed differential gene 
regulation. Genes up regulated and down regulated are listed in Figure 3.19A. Scge 
(sarcoglycan epsilon) was down regulated in both cell lines. ITGA2 and Ctnna1 were 
upregulated in normal cells treated with Ag-np-3. Additionally upregulation of 
integrin was observed in both cells. Transforming growth factor gene (Tgfbi), Spp1 
and ITGA5 were up regulated in cancer cells. Matrix metallo peptidases like MMP3 
and MMP2 were slightly upregulated in normal and cancer cells respectively. RT-PCR 
analysis of IMR-90 and U 251 cells revealed downregulation for filamin, an actin 
binding protein necessary for cell spreading (Figure 3.19B). 
Key molecules regulating signalling cascades showed upregulation following 
Ag-np-3 treatment. Jun, CSF2 and IL-8 showed increased expression in IMR-90 cells, 
whereas, NFκB1, NFκBIA, FN1 (fibronectin 1), GADD45, BIRC2, TMEPAI (prostate 
androgen induced RNA) and CEBPB (CCAAT/enhancer binding protein) were 
upregulated in cancer cells (Figure 3.19C). Gene data corresponding to cell signalling 
are represented in Figure 3.19C. Major pathways involved in Ag-np-3 mediated 
signalling are indicated in Table 3.2.  The induction of the apoptotic pathway is 
supported by the observation of phosphorylation of p53, cleavage of caspase and 
PARP. Ag-np-3 treatment induced phosphorylation of p53 in a dose dependent manner in 
cancer cells but phosphorylation was not detected in normal cells (Figure 3.17E). 
Cleavage of Caspase and PARP was observed in both cell lines (Figure 3.17E). Density 
of Caspase 3 and PARP fragments were measured and presented in Figure 3.17E. Data 
for phospho p53 and proteins involved in apoptosis (caspase and PARP) are displayed 
in Figure 3.17E. Over expression of caspase 3 was observed specifically in cancer 
cells. Normal cells showed upregulation of PARP but no cleavage. In cancer cells an 




increase in caspase and PARP cleavage was observed along with increased levels of 
phospho p53. We have also observed a decrease in the levels of survivin following 












Figure 3.19: Altered gene expression profile in silver nanoparticles treated cells. (A) 
Gene expression changes in cell adhesion and extracellular matrix pathway. (B) 
Shows downregulation of filamin, as evidenced by RT-PCR analysis of the cells. (C) 
Genes differentially expressed in signal transduction pathway. All values are 
normalised against housekeeping genes. Fold change is calculated as treated/control – 1*. 






















Table 3.2: Cell signalling pathways involved in silver nanoparticle toxicity. 
Gene (IMR-90) Pathways Genes (U 251) Pathways 
Jun oncogene 
(JUN) 
a) Mitogenic Pathway: 
b) Wnt Pathway 
c) PI3 Kinase / AKT 
Pathway 
d) Calcium and Protein 
Kinase C Pathway 
Jun oncogene  (JUN) 
a) Mitogenic 
Pathway: 
b) Wnt Pathway 
c) PI3 Kinase / 
AKT Pathway 
d) Calcium and 




protein 2 (BMP2) 
Hedgehog Pathway Fibronectin 1 (FN1) PI3 Kinase / AKT Pathway 
Interleukin 8 
(IL8) NFκB Pathway 
Nuclear factor of kappa 
light polypeptide gene 








a) Calcium and Protein 
Kinase C Pathway 
b) LDL Pathway 
Nuclear factor of kappa 
light polypeptide gene 







Calcium and Protein 
Kinase C Pathway 
Transferrin receptor 
(p90, CD71), (TFRC) 
Calcium and 
Protein Kinase C 
Pathway 
 

















 The results were further validated by RT-PCR, where an upregulation of IL-8 
mRNA levels in fibroblasts as well as downregulation of p53 (Figure 3.20A) was 
observed. MAPK1 mRNA levels were found to be higher in normal cells (Figure 3.20B). 
However, NFκB level in treated IMR-90 cells was significantly less compared to 
untreated controls (Figure 3.20C) while cancer cells showed upregulation of NFκB 
(Figure 3.20D). Real time RT-PCR analysis of oxidative stress response gene HO-1 
(Figure 3.20E) and metal detoxifying Metallothionein-1F genes (Figure 3.20F) 
showed significant upregulation indicating stress conferred by the nanoparticles. 
 
 





Figure 3.20: mRNA profile as measured by RT-PCR. (A) Elevated levels of IL-8 and 
downregulation of p53 in IMR-90 cells. (B) Increased mRNA levels corresponding to 
MAPK1 in normal cells. (C) NfκB mRNA levels in normal cells. A lower level of 
NfκB mRNA was observed in normal cells whereas cancer cells showed increased 
mRNA levels. (D). mRNA profiles showing upregulation of HO-1 (E) and 
Upregulation of Met-1F (F). Statistical significance was determined between 
untreated and treated samples using t test. Values were considered as significant when 
P value was ≤ 0.05. * Sign indicates statistical significance.  
 
3.2.12. Inflammatory response in nanoparticle mediated cells 
Our study to investigate the innate ability of Ag-np-3 to induce cytokine and 
chemokine production revealed that Ag-np-3 triggered production of certain cytokines 
and interleukins (IL) in normal resting human fibroblasts. Of the 17 cytokines tested, 
only a few cytokines exhibited detectable levels in the supernatant of both Ag-np-3 
treated and untreated cells (Figure 3.21A). There was significant increase in the 
production of IL-8, IL-6, ICAM-1, MCP-1, MIP-1β and GRO in those cells treated 
with silver nanoparticles compared to that of control cells (Figure 3.21B). There was 
an increase in the production of GM-CSF and IFNγ in the silver nanoparticles treated 
cells. IL1β, IL-2, IL-7, IL-16, IL-17, TNF, MIP1 and RANTES levels were not 
detected in the culture supernatants of both treated and untreated cells. 






Figure 3.21: Silver nanoparticles induced cytokines and chemokines production in 
normal human lung fibroblasts. The graphs indicate the production of cytokines and 
chemokines in pg/ml (mean ± SD) by normal human fibroblasts after incubating it 
with 400 µg/mL of silver nanoparticles for a period of 48 hrs (A, B). The cytokine 
levels were measured in untreated cells (Control) and in cells treated with silver 
nanoparticles (treated (Ag-np-3)). (*) indicates Student’s t test p value ≤0.05. 
 
3.2.13. Binding of cytosolic proteins with Ag-np-3 
ITC emerged as a potential tool to explore the binding of DNA, proteins and 
amino acids with nanoparticles.  A representative heat change profile for the complex 
formation of cytosolic proteins with starch capped Ag-np-3 and binding of cytosolic 




proteins with starch is depicted in Figure 3.22.  Endothermic nature of the peaks 
indicates the binding between silver nanoparticles/starch with proteins.  Due to the 
lack of exact information on cytosolic proteins such as molecular weight, 
concentration of individual proteins in the mixture, and number of moles of surface 
nanoparticles, binding isotherms were plotted against total volume of protein added.  
It can be seen that a monotonic decrease in the exothermic heat of binding occurs with 
successive injections until saturation is reached. Heat changes observed during 
addition of proteins may be due to binding of nanoparticle or binding of surface starch 
with cytosolic proteins. Control experiments were performed with pure starch in order 
to identify their binding with cytosolic proteins.   
Interestingly, ITC curves representing the titration of cytosolic proteins with 
starch capped Ag-np-3 can only be fitted into a model of two sets of binding site 
(Figure 3.22A) while the ITC titration curve representing heat change for the 
complexation of cytosolic proteins with starch could be fitted into a model of a single 
set binding sites as depicted in Figure 3.22B.   Integral data of the curves in Figure 
18A and 18B are plotted as Figure 3.22C and 3.22D as a function of total volume of 
protein added to Ag-np-3 and starch, respectively. After subtraction of the binding due 
to starch and integration of the corresponding heat changes over time, a typical 
sigmoidal titration curve was generated as shown in Figure 3.22E, which strongly 
supports the binding of the Ag-np-3 surface with cytosolic proteins.  From Figure 
3.22F it is understood that neither starch nor Ag-np-3 were interacting with genomic 
DNA.   Integral data of the curves in Figure 21E and 21F are plotted as a function of 
total volume of protein (Figure 3.22G) and DNA (Figure 3.22H), added to Ag-np-3.   





Figure 3.22: Isothermal titration calorimetry measuring the binding of starch capped 
silver nanoparticles with cytosolic proteins and pure starch with cytosolic proteins.  
(A) binding curves obtained by titration of cytosolic proteins to 1.8 ml of 150 μg 
starch capped silver nanoparticles,  (B) Calorimetric traces obtained by titration of 
cytosolic proteins to 1.8 ml of 150 μg of starch, (C) and (D) integral data of the curves 
in A and B respectively plotted as a function of total volume of protein added. (E) 
Reaction of enthalpy of silver nanoparticles obtained after subtracting the reaction 
enthalpy of cytosolic proteins in 150 μg of starch capped silver nanoparticles with 
cytosolic proteins in 150 μg of starch without silver nanoparticles.  (F) ITC of silver 
nanoparticles isothermal titration calorimetry of starch capped silver nanoparticles 
with genomic DNA. Integral data of curve E and F are shown as G and H 
respectively. 
 





 Cytotoxicity of nanoparticles has been a robust research area in recent years. 
These studies were limited by the fact that in most cases the dependence of time and 
surface functionalisation remained unexplored. In this study, we have employed a time 
and dose dependant approach to evaluate the toxicity of silver nanoparticles (Ag-np-
3). We have used reliable and sensitive parameters such as ATP content to study the 
toxicity. The nanoparticles we have used in our study have been purified extensively 
to get rid of any contaminants that may interfere with the assays.   
3.3.1. Uptake, distribution and bioactivity of nanoparticles 
Studies on the uptake of silver nanoparticles are an unidentified area, which 
could shed light to the mechanisms of toxicity as well as potential therapeutic 
application of nanoparticles. In the present study, we have observed that Ag-np-3 
uptake occurs mainly through endocytosis where the clathrin mediated process and 
macropinocytosis were involved. This observation corroborates with the electron 
micrographs which showed uncoated endosomes of size 150 nm and ~ 1 µm. The 
survival of cells from nanoparticle mediated damage depends on their ability to expel 
nanoparticles. Previous reports have emphasised the role of exocytosis in expelling 
gold nanoparticles from cells, to avoid critical loss of function (Chithrani and Chan, 
2007). Hence exocytosis rates of silver nanoparticles were monitored for a better 
understanding of the cellular retention and expulsion of nanoparticles. Such 
approaches might have implications on long term deposition of nanoparticles in cells 
and chronic toxicity. Exclusion of Ag-np-3 followed a slow and time dependant 
pattern. Though the cells were able to expel nanoparticles efficiently, the nanoparticle 
concentrations in cells were well within detectable limits of Ag concentration even 




after 48 hrs of recovery, which suggests active nanoparticle retention and chances of a 
continuous and prolonged Ag-np-3 mediated stress. 
 A possible reason for nanoparticle toxicity could be the damage to the heavy 
nanoparticle loaded endosomes, resulting in the deposition of the particles in the 
cytoplasm of the cells. Cells with a small number of nanoparticles are believed to 
survive longer. Recent reports have demonstrated a similar mechanism whereby gold 
nanoparticles were taken up by the cells through clathrin and caveoli mediated 
endocytosis (Chithrani and Chan, 2007; Chithrani et al., 2006). The report suggested 
the influence of surface chemistry where different surface functionalisations resulted 
in distinct uptake pathways. Similar properties can be expected for silver 
nanoparticles. However no nuclear deposition was observed in unmodified gold 
nanoparticles The tendency of nanoparticles to accumulate in the nuclei of cells is 
assumed to be associated with their small size which allows them to diffuse freely 
through the nuclear pore complex as reported for gold and silica nanoparticles (Zhao 
and Nalwa, 2007). Another possible reason for mitochondrial and nuclear deposition 
of nanoparticles could be the adsorption of cytosolic proteins, especially those with 
nuclear localisation signals. This type of adsorption is possible as evidenced by ITC. 
The protein nanoparticles corona has a greater chance to get transported to the nucleus 
as cargo complexes, which could also explain the small vesicles carrying 
nanoparticles near the nuclear membrane. 
Experiments have indicated endocytosis of Ag-np-3 into cells and its presence 
in the nucleus. The exact outcome due to nuclear deposition of silver nanopartcles is 
unknown; however, it is expected to have lethal effects on DNA synthesis, DNA 
damage, chromosomal morphology and segregation. Genotoxic studies of titanium 




dioxide (TiO2) nanoparticles revealed dose dependant DNA damage, chromosomal 
aberrations and errors in chromosome segregation (Wang et al., 2007) and formation 
of sister chromatic exchanges (Lu et al., 1998).  Treatment with Ag-np-3 induced the 
production of micronuclei and chromosomal abnormalities further confirming the 
genotoxicity of nanomaterials.  Mroz et al. (Mroz et al., 2008) speculated that 
nanoparticles and reactive oxygen species generated by the nanoparticles induce DNA 
damage, activating p53 and proteins related to DNA repair, mimicking irradiation 
induced carcinogenesis. The observed genotoxic response in our study could be a 
consequence of oxidative damage to DNA.   
3.3.2. Mitochondrial respiratory chain, synthesis of ATP and ROS production 
 The decreased cellular ATP content observed in the experiment could be an 
effect of damage caused to the mitochondrial respiratory chain. The mitochondrial 
damage is also indicated by the reduced dehydrogenase activity as measured by the 
reduction of resazurin to resofurin by CellTitre Blue viability assay. The root of 
mitochondrial dysfunction in toxicology is ROS production and subsequent oxidative 
stress. Oxidative stress is a common mechanism for cell damage induced by nano- and 
ultra fine particles (Xia et al., 2006). Mechanical injury caused by nanoparticle 
depositions in mitochondria may also be the reason for mitochondrial damage. 
Nanoparticles of various sizes and chemical compositions are shown to preferentially 
localise in mitochondria (Derfus et al., 2004), induce major structural damage and 
contribute to oxidative stress (Xia et al., 2006). Treatment of rat liver cell line with 
silver nanoparticles resulted in membrane damage, reduced glutathione levels and 
increase in ROS production indicating influence of nanoparticles on mitochondrial 
respiratory chain (Hussain et al., 2005). Many nanomaterials such as zinc oxide, 




carbon nanotubes and silicon dioxide exerts their toxic effects through oxidative stress 
(Yang et al., 2009a). Titanium dioxide nanoparticles also exhibited a similar mode of 
action (Park et al., 2008). An increase in ROS in the presence of Ag-np-3 could 
explain the metabolic disturbances as well as other toxicological outcomes. In the case 
of many nanoparticles, there is no exponential increase in ROS with nanoparticle 
concentration. This effect may be due to exchange interactions between the unpaired 
electrons of the free radicals and the conduction band electrons of the metal 
nanoparticles. Such an effect has been reported for gold nanoparticles (Zhang et al., 
2003). It is possible that activation of cellular antioxidant network had counter 
balanced the effect of ROS. The role of oxidative stress was further supported by the 
observed upregulation of heme oxygenase 1 gene. 
 Mitochondria are the major sites of ROS production in the cell. During 
oxidative phosphorylation, oxygen is reduced to water by addition of electrons in a 
controlled manner through the respiratory chain. Some of these electrons occasionally 
escape from the chain and are accepted by molecular oxygen to form the extremely 
reactive superoxide anion radical (O2.-), which gets further converted to hydrogen 
peroxide (H2O2) and in turn may be fully reduced to water or partially reduced to 
hydroxyl radical (OH.), one of the strongest oxidants in nature (Boonstra and Post, 
2004). Toxic agents increase the rate of superoxide anion production, either by 
blocking electron transport or by accepting an electron from a respiratory carrier and 
transferring it to molecular oxygen without inhibiting the respiratory chain (Turrens, 
2003). Inhibition of the respiratory chain is expected to cause a decrease in ATP 
synthesis. Deposition of silver nanoparticles in mitochondria can alter normal 
functioning of mitochondria by disrupting electron transport chain ultimately resulting 




in ROS and low ATP yield. ROS are highly reactive and result in oxidative damage to 
proteins and DNA. Hence it is indispensable to investigate genome stability in cells 
with significantly higher ROS production. 
 It is possible that surface oxidation of silver nanoparticles, upon contact with 
cell culture medium or proteins in the cytoplasm liberates Ag+ ions that could amplify 
the toxicity. Also, extreme acidic pH (5 ± 0.2) inside the endosomes (Tycko and 
Maxfield, 1982) could dissolve the metal releasing metal ions. The concentration of 
metal ions released inside the endosome could be quantitated by isolating and 
dialyzing the lysate to separate Ag-np from Ag+ ion. Reactions between H2O2 and 
silver nanoparticles are presumed to be one of the common factors causing Ag+ ions 
release in vivo. Similar activity in cobalt and nickel nanoparticles has been reported. 
They release the corresponding ions that enhance toxicity (Kumar, 2006).  
A possible chemical reaction involves: 
2Ag + H2O2 + 2H+                       2Ag+ + 2H2O  E = 0.97 V    3.1 
 
Half cell reactions are 
 
H2O2 + 2H+ +2e-                        2H2O  E0=1.77 V     3.2 
 
2Ag                      2Ag+ + 2e-   E0= -0.8 V      3.3 
 
H+ ions are present in abundance inside the mitochondria where H+ efflux is the 
main event (proton motive force) in ATP synthesis. 
 Toxicity of silver ions on E.coli and other microbial cells have been studied 
(Yang and Pon, 2003) extensively and the results can be extrapolated to mammalian 




cells due to the similarity in the respiratory chain. Various mechanisms have been 
suggested for the action of Ag+ ion in the respiratory chain. Ag+ ions have been shown 
to inhibit phosphate uptake and exchange in E.coli, which causes efflux of 
accumulated phosphate (Schreurs and Rosenberg, 1982). This effect is reversed by 
thiols, which could be due to the reversal of binding of Ag+ to thiol containing 
proteins in the respiratory chain. Ag+ ions were also shown to cause a leakage of 
protons through the membranes of Vibrio cholerae, thus causing the collapse of proton 
motive force, presumably by binding to membrane proteins (Dibrov et al., 2002). 
NADH: ubiquinone reductase complex (Complex I) in E.coli contains two types of 
NADH dehydrogenases, both containing cysteine residues with high affinity for silver 
(Bragg and Rainnie, 1974; Friedrich, 1998). Both hydrogenases appear as possible 
sites for Ag+ ion recognition (Bragg and Rainnie, 1974). Binding of Ag+ to these low 
potential enzymes of the bacterial respiratory chain will result in an inefficient passage 
of electrons to oxygen at the terminal oxidase, causing production of large quantities 
of ROS and thus explaining the toxicity of ions to E.coli at submicromolar 
concentrations (Holt and Bard, 2005). A consequence of interaction of Ag+ ions with 
enzymes of the respiratory chain is sudden stimulation of respiration followed by cell 
death, due to uncoupling of respiratory control from ATP synthesis. Yet, prokaryotic 
cells and eukaryotic cells have entirely different physiological functions which 
determine sensitivity and survival rate upon exposure to nanoparticles. Eukaryotic 
cells have a prominent nucleus and a complex DNA repair and cell cycle pathway 
which control cell death and survival, which are absent in prokaryotic cells. The 
upregulation of metallothionein gene could be considered as an indication of the 
involvement of Ag metal in the onset of toxicity. 




 Yamanaka et al (Yamanaka et al., 2005) studied the effect of Ag+ ions on 
expression of various proteins in E.coli by proteomic analysis. Silver ions were 
assumed to penetrate through ion channels in the cell without causing damage to the 
membrane. Proteomic analysis of cells treated with Ag+ ions showed a reduction in 
expression of ribosomal subunit S2, succinyl coenzyme (CoA) synthetase and maltose 
transporter (Yamanaka et al., 2005). The reduction in expression of ribosomal subunit 
S2 impairs the synthesis of other proteins, whereas, reduction in synthesis of succinyl 
CoA synthetase and maltose transporter causes suppression of intracellular production 
of ATP resulting in the death of the cell. Hence, we believe that nanoparticle toxicity 
is multifactorial, where size, shape, surface functionalisation and potential to release 
the corresponding metal ions could play pivotal roles.  
 These observations can also be linked to the biodistribution of nanoparticles. 
Nanoparticle deposition was observed inside the mitochondria which could have 
direct or indirect damaging effects through the release of corresponding ions, 
ultimately leading to ROS production.  
3.3.3. ROS, Ca2+ homeostasis and cytoskeleton changes 
Our experiments on Ag-np-3 treated cells demonstrate the occurrence of 
calcium transients. There is substantial evidence linking oxidative stress to Ca2+ 
transients (Chinopoulos and adam-Vizi, 2006), whereby oxidative stress has been 
shown to increase Ca2+ by changing the permeability of mitochondria.  Repeated 
calcium influx and efflux in mitochondria could result in mitochondrial membrane 
damage, resulting in ROS production and inhibition of ATP synthesis (Orrenius et al., 
1992).  Our data link the oxidative stress, Ca2+ and ATP depletion occurring in Ag-np-
3 treated cells. Moreover, Ca2+ overload in mitochondria could release apoptogenic 




factors such as cytochrome C, endonuclease G and other apoptosis inducing factors to 
the cytosol to initiate apoptosis (Belizario et al., 2007).  It was observed that the rise in 
concentration of Ca2+ ions occurred within 48 hrs. Hence, it is possible that the 
mitochondria mediated Ca2+ ions homeostasis occurred during the later stages of 
incubation period resulting in a delayed induction of apoptosis. Ca2+ ions are 
indispensable for cellular functions viz. cellular transport through actin dynamics and 
mitosis.  Although Ca2+ signalling occurs rapidly, a time dependant study was adopted 
based on the fact that nanoparticle diffusion and subsequent binding to specific 
receptors on cellular organelles could result in direct Ca2+ transients or activation 
through other pathways, which will take time to initialise.  Even though the binding of 
silver nanoparticles to plasma membrane receptors is rapid, the rates of diffusion or 
endocytosis and subsequent binding with intracellular targets are relatively slow. The 
possibilities of continuous diffusion of nanoparticles and sustained activation of Ca2+ 
channels are high throughout the incubation period. Moutin et al  (Moutin et al., 1989) 
provided evidence that Ag+ ions act on the same site as Ca2+ ions, regulating the 
release of Ca2+ from sarcoplasmic reticulum. Also, a higher concentration of Ag+ ion 
inhibited Ca2+ release from the intracellular stores similar to higher concentrations of 
Ca2+ ions, resulting in a bell-shaped curve (Moutin et al., 1989). Ag+ ions could trigger 
Ca2+ fluctuations in a similar way. 
Disruption of calcium homeostasis plays a major role in pathological and 
toxicological conditions and is an early sign of cell injury. Calcium ions have the 
potential to activate catabolic enzymes like phospholipase, proteases and 
endonuclease that further augment the toxicity (Orrenius et al., 1992).  It is known that 
an early sign of Ca2+ homeostasis disruption is indicated by blebbing of plasma 




membrane which is a consequence of cytoskeletal injury (Mikhutkina et al., 2004).  
SEM investigations to study the cytoskeletal injury revealed altered spreading patterns 
which may be linked to Ca2+ fluctuations.  
3.3.4. DNA damage and ROS 
 As described earlier, the presence of silver nanoparticles caused the production 
of ROS and reduction in ATP content. ROS are considered to be the major source of 
spontaneous damage to DNA. Oxidative attack on the DNA results in mutagenic 
structures such as 8-hydroxyadenine and 8-hydroxyguanine which induces instability 
of repetitive sequences. The chemical reactions that bring about such mutations are 
based on the formation of highly reactive and short-lived hydroxyl radical (OH.) in 
close proximity to DNA (Cadet et al., 1999). ROS mediated genotoxicity has been 
previously observed for metal oxide nanoparticles (Yang et al., 2009a). 
  Further damage may occur through single and double strand breaks, inter- and 
intra-strand cross-linking etc. On the other hand, silver ions have been shown to 
interact with DNA and RNA under in vitro conditions (Arakawa et al., 2001). Ag+ 
ions form a type I complex by binding to N7 of guanine or adenine and in type II 
complex, it forms interstrand AT and GC adducts without causing much change in the 
conformation of DNA. Hossain and Huq (Hossain and Huq, 2002) proposed 
stabilisation of DNA by Ag+ ions by studying the binding of Ag+ ions to plasmid and 
chromosomal DNA in vitro. Interestingly, they found that in the presence of ascorbate, 
Ag+ ions caused significantly more damage to DNA than the ascorbate alone. It is 
expected that Ag+ ion catalysed the oxidation of ascorbate by molecular oxygen 
releasing free radicals, which could damage DNA.  
 




3.3.5. DNA damage, cellular ATP content and cell cycle arrest 
 In eukaryotic cells, DNA damage causes cell cycle arrest at the G2/M 
boundary, allowing cells extra time to repair prior to segregation of chromosomes. 
The DNA repair machinery must access the nucleosome in order to carry out the 
repair. Two classes of enzymes are involved in regulating the accessibility to 
chromatin, one modifying the core group histone amino acids and the other consisting 
of large multi-subunit complexes known as chromatin remodelers which use the 
energy from ATP hydrolysis to weaken the interactions between histones and the 
surrounding DNA. The reduction in ATP content after Ag-np-3 treatment could affect 
DNA repair, as ATP is required for the cascade of events requiring phosphorylation of 
several proteins taking part in the repair process (Wong et al., 2006).  
 The role of ATP in cell cycle arrest was studied by Sweet et al. (Sweet and 
Singh, 1995) through specifically inhibiting the mitochondrial production of ATP.  It 
was shown that a small reduction in the cellular level of ATP induced a significant 
increase in the G1 cell population while further decrease (up to 35%) elicited a G2/M 
accumulation followed by the onset of cytotoxicity. This suggests that the checkpoints 
regulating passage through cell cycle events are sensitive to altering ATP levels.  
 The extensive damage of DNA, measured by the comet assay and the CBMN 
assay, was reflected in the arrest of IMR-90 and U251 cells in the S and G2/M phase. 
There was a dose dependant increase in cell populations in the G2/M phase following 
treatment with silver nanoparticles. Cell cycle arrest provide enough time for the cells 
to repair the damaged DNA. Carbon-black nanoparticles exhibited similar toxic 
outcomes (Mroz et al., 2007). Cells treated with carbon black nanoparticles suffered 
DNA damage, which resulted in cell cycle arrest. Till date no such studies were 




conducted for silver nanoparticles. This study is the first attempt to unveil the effect of 
Ag-np-3 on cell cycle. DNA damage caused by Ag-np-3 to the U251 cells was more 
extensive than that to the IMR-90 cells, and correlated well with the steeper increase 
in the number of cells in the G2/M phase with concentration of Ag-np-3. The increased 
sensitivity of U251 cells to DNA damage could be due to the impaired repair 
pathways.  
Cytoskeleton injury in most instances blocks chromosome segregation and 
cytokinesis. Similar patterns of cytoskeletal injury were reported in melanoma cells 
lacking filamin, a dimeric actin cross-linking protein (Cunningham et al., 1992).  The 
absence of filamin in cells produces unstable pseudopods (filapodia) around the cells, 
inhibiting their ability to spread (Cunningham et al., 1992). Morphological 
deteriorations in cells exposed to Ag-np-3 are possibly due to the interference with 
structure and function of the actin cytoskeleton, which might be one of the reasons for 
inhibition of cell division. The cytoskeleton damage could result from calcium 
fluctuations and gene dysregulation. The silver nanoparticles and Ag+ ions which get 
released from the nanoparticles are believed to be involved in cell signalling cascades 
with the activation of Ca2+ release that further activates catabolic enzymes and damage 
mitochondrial membranes. The outcome of the signalling cascades inhibits cell 
division. Hence, the next step was to study the effect of these nanoparticles on global gene 
expression. We believe this will provide further insight on their mechanism of action. 
3.3.6. Effect on gene expression profiles 
The functional studies and gene expression data showed that silver 
nanoparticles exposure induced cell cycle arrest at S/G2/M phase of cell cycle. This 
could be due to the changes in the expression levels of genes regulating the cell cycle 




process. We have observed a decrease in the expression of p53, p21, PCNA, cyclin E 
and cyclin B. However the cell cycle arrest seems to be independent of p21 as there 
was no inhibition of cdk through p21 induced G1 arrest. Gadd 45 group of proteins are 
over expressed in cells upon genotoxic stress (O'Reilly et al., 2000) and was also 
found to be significantly elevated in Ag-np-3 treated cells (Gadd 45α in cancer cells 
and Gadd 45γ in fibroblasts). Gadd 45 regulates cell cycle by repressing the 
localisation of Cyclin B1 to the nucleus. This is known to initiate G2/M arrest in target 
cells (Jin et al., 2002). Cdc 2, a binding partner of cyclin B proteins was down 
regulated in both cell types after Ag-np-3 treatment. Increased Cdc 2 levels may be 
due to the accumulation of cells in the G2 phase due to the decreased level of cyclin B 
seen earlier. Rb and E2F form a repressive complex in S phase, which upon 
phosphorylation by cyclin E releases E2F (Zhang et al., 2000).  E2F being the 
transcription factor for S phase genes blocks cell transition through S phase (Zhang et 
al., 2000). We have seen that following Ag-np-3 exposure there was an upregulation 
in the expression of retinoblastoma (Rb) and downregulation of E2F in cancer cells. It 
is evident that the low levels of cyclin E could hypo-phosporylate Rb and fail to 
release E2F rendering them in their repressive forms, resulting in S phase arrest. We 
have also observed an upregulation of Zak proteins which are members of Mitogen 
activated protein kinase pathway (MAPKKK) that triggers cell cycle arrest and check 
point regulation following stress response. Zak has been associated with 
downregulation of cyclin E and S/G2/M arrest (Yang, 2002). Therefore, we suggest 
that events like Zak down-regulating cyclin E which represses E2F and decrease 
cyclin B levels by Gadd45 resulted in the observed cell cycle arrest. Reports have 
already emphasised the role of p53 in regulating PCNA and p21 genes (Fotedar et al., 




2004). Hence, downregulation of p53 is believed to be the reason for lower levels of 
p21 and PCNA which might play a role in determining cellular fate. Along with the 
downregulation of p53 we also observed phosphorylation of residual p53 in treated 
cells and this probably facilitated p53 mediated effects. 
Expression patterns of genes involved in DNA damage response suggest that 
cells treated with Ag-np-3 suffered impaired DNA repair mechanisms in normal cells 
and initiation of DNA repair response in cancer cells. This is evidenced by the 
increase in the DNA double strand break sensors ATM and ATR. This can then activate 
downstream targets for DNA repair (Cuadrado et al., 2006). The activation of 
ATM/ATR is further supported by the H2AX foci observed in immuno fluorescence 
studies. Normal cells showed down-regulation of genes involved in base excision 
repair (Mbd4, Apex1, OGG1 and Mutyh), mismatch repair (Mutyh, Abl1, Pms1 and 
MSH2) and double strand break repair pathways (ATM). These molecular results 
further confirm existing genotoxicity data, where DNA damage and chromosomal 
aberrations were observed to be higher in Ag-np-3 treated U251 cells compared to 
IMR-90 cells. Upregulation of Abl, gml and Brca1 genes specifically in cancer cells in 
contrast to that of the normal cells is a significant observation. Downregulation of 
PCNA following Ag-np-3 treatment could have an effect on the DNA damage 
response.  
Cell adhesion and extracellular matrix genes were not significantly affected by 
nanoparticles treatment. However, an upregulation of alpha integrins was observed in 
both cell lines. Integrins play a vital role in signal transduction and interaction of cells 
with extracellular matrix. Upregulation of integrin operates protective mechanisms 
where cytoskeletal and ECM are challenged by extraneous factors (Mousa, 2008). 




Interestingly, an upregulation of tumour growth factor or Tgfbi was observed in 
treated cancer cells but not in normal cells.  
Signalling pathway analysis identified upregulation of jun in both cell lines 
which can act through JNK pathways regulating cell proliferation or cytokine 
production. Involvement of JNK pathway has been reported in silver nanoparticle 
mediated toxicity studies (Hsin et al., 2008). Our experiments unveiled the 
involvement of JNK pathway via the over expression of the transcription factor Jun. 
NFκB is a major transcription factor regulating immune survival and the anti-apoptotic 
response. NFκB1 and NFκBIA are overexpressed in cancer cells. A significant 
decrease in the expression of NFκB was observed in normal cells following Ag-np-3 
treatment. On the other hand an increase in the expression of MAPK was observed in 
normal cells.  Jun upregulation was accompanied by upregulation of pro-inflammatory 
cytokine IL-8 and granulocyte macrophage colony stimulating factor (GM-CSF) in 
normal cells. Similar observations were reported in carbon nanoparticle toxicity where 
IL-8 production was observed to be mediated by the MAPKinase pathway (Kim et al., 
2005). Another regulator of signalling cascades which was differentially expressed 
was Gadd 45. It is activated by cytokines and signal transduction pathways like 
MAPK (Tong et al., 2001). Once activated, Gadd 45 also triggers signal transduction 
via MAPKinase pathway. 
Upregulation of Bax in cancer cells following Ag-np-3 treatment, suggested 
induction of apoptotic stimuli through the mitochondrial pathway. None of the 
apoptosis related genes were up regulated in normal cells. Downregulation of survivin, 
an apoptosis inhibitor protein (IAP) that blocks caspases renders cells susceptible to 
apoptosis. Survivin is over expressed in cancer which increases resistance to apoptosis 




(Pennati et al., 2008). The differential gene expression profiles observed following 
Ag-np-3 treatment exhibits selective induction of pathways in normal and cancer cells 
which will determine the nature of response to nanoparticle exposure. 
3.3.7. Interaction of silver nanoparticles with cytosolic proteins 
Nanoparticles have a greater tendency to bind with proteins forming a protein 
corona (Lynch and Dawson, 2008) and mimic nutrients which facilitate easy receptor 
mediated uptake. Nanoparticles can also adsorb agonists or antagonists, interfere with 
various pathways and truncate biomolecules (Lynch and Dawson, 2008). All these 
properties significantly influence the predictable toxicity profile of the nanoparticles. 
Here, we show that cytosolic proteins are adsorbed onto the surface of the silver 
nanoparticles, forming a protein-starch coating which could control cellular responses. 
This observation may be useful in the understanding of intracellular behaviour of 
silver nanoparticles. The surface adsorption of proteins limits their availability for 
cellular functions, but stabilises the proteins, thereby inhibiting protein degradation in 
proteosomes (Lynch and Dawson, 2008). This process can alter normal cell cycle 
progression where timely degradation of proteins is necessary for smooth transition in 
to cell cycle stages. Also, binding to the nanoparticle surface can interfere with the 
native conformation of the proteins, thus leading to loss of function. Another outcome 
of nanoparticle binding is increase in activity of proteins as a result of immobilisation 
at surfaces (Lynch and Dawson, 2008). It is conceivable that the affinity and binding 
of silver nanoparticles with proteins varies between cell types that have tissue specific 
proteins. This explains the altered signalling pathways operating in different cell types 
after nanoparticle treatment (MAPK in fibroblasts and NFκB in cancer cells). These 
results set hurdles on cellular response prediction, as the identity of protein adsorbed 




to the nanoparticle remains unclear and the fact that the residency period and choice of 
protein adsorbed on to these nanoparticles varies with cell and tissue types. 
Considering the property of the nanoparticle surface which facilitates surface 
adsorption of proteins, we speculate that nanoparticles label cytosolic proteins which 
require nuclear localisation and are co-transported with them. Absence of direct 
interaction with genomic DNA further supports this notion. This observation has 
implications in nanotechnology to develop tools for nuclear targeting in cancer 
therapy and transfection.  
3.3.8. Release of pro-inflammatory cytokines from silver nanoparticles treated 
fibroblasts 
The current investigation shows the ability of silver nanoparticles to trigger an 
inflammatory response based on induction of various pro-inflammatory cytokines and 
chemokines. A three-fold increase in IL-6 levels was observed subsequent to 
treatment with silver nanoparticles. A similar increase in IL-6 levels following silver 
nanoparticle treatment that was recently reported, corroborates with our observation 
(Castillo et al., 2008). IL-6, produced by a variety of cells including fibroblasts, is a 
pleiotropic cytokine involved in the amplification of inflammatory responses 
(Kamimura et al., 2003).  Rapid increase in IL-6 levels is observed during acute 
inflammatory responses due to injury, infection and stress (Kamimura et al., 2003).  
This induces systemic effects affecting various organs and has been associated with a 
plethora of clinical conditions such as inflammatory lung disorders (Wong et al., 
2001), and rheumatoid arthritis (Hirano et al., 1988). We have observed an 8-fold 
increase in the levels of IL-8, which is produced by a variety of cells, including 
fibroblasts.  Inappropriate increase in the levels of IL-8 has been associated with 




inflammatory disorders as well (Brennan et al., 1990). Intercellular adhesion molecule -1 
(ICAM-1), MIP-1, Monocyte chemoattractant protein – 1 (MCP-1) and GRO-alpha are 
known to be up regulated in inflammatory conditions were also seen upregulated 
following our silver nanoparticle treatment. These modulate chemotaxis, 
degranulation, phagocytosis and signalling mediator synthesis in cells (Brennan et al., 
1990; Staunton et al., 1989). Dysregulation of MIP-1, MCP-1 and GRO-alpha has 
been associated with a variety of inflammatory disorders (Murdoch and Finn, 2000).  
We also observed an increase in the levels of GM-CSF and IFNγ. GM-CSF is 
involved in chemotaxis, phagocytosis and antigen presentation and increased levels 
have been associated with rheumatoid arthritis, chronic obstructive pulmonary disease 
and asthma (Hamilton and Anderson, 2004). IFNγ responds against intracellular 
pathogens and tumour control. Abnormal expression and protein levels of IFNγ have 
been associated with autoimmune and inflammatory conditions (Schoenborn and 
Wilson, 2007). Though our study suggests an inflammatory response following silver 
nanoparticle treatment, we cannot rule out the possibility of modifiers such as cell 
type used and nanoparticle used in the study.  
Looking at the evidence, it is tempting to speculate that silver nanoparticle-
impregnated wound dressings, catheters and other medical devices could induce 
similar detrimental responses in vivo. However, the in vitro data obtained need to be 
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 Platinum complexes are well accepted in modern medicine as 
chemotherapeutic agents. However, like many other medicines they carry undesirable 
side effects such as non-specific toxicity to normal cells. Thus, patients treated with 
the drugs will develop serious organ failures and other symptoms. Following the 
evolution of nanomedicine, researchers started exploring the possibilities of 
developing nanodrugs that can overcome these difficulties. Nanoparticles have 
advantages such as innate bioactivity, a surface that is suitable for conjugation with 
targeting ligands and an amenable synthesis procedure which yield anisotropy for 
various applications. 
 For these applications to become reality, the basic biological properties must 
be known. The innate biological properties of platinum nanoparticles must be known 
to design and target effective nanodrugs. We believe that the present study would 
become one of the pioneer works in this early stage of nanotoxicology/nanomedicine 
where no characteristics of platinum nanoparticles are available. 
 Here we report synthesis, characterisation and investigation of cytotoxicity, 
genotoxicity; oxidative stress, cell cycle and gene expression profile of water soluble 
Pt-np of size 5 - 8 nm in human cells. We have also studied the mechanism of uptake 
of Pt-np into the cells. Changes in the expressions of proteins involved in DNA 
damage and apoptosis were investigated in Pt-np treated cells. We also believe that the 
data obtained could contribute significantly towards understanding the fate of Pt-np 
inside cells, and provide valuable information to develop safety regulations for the use 
of nanomaterials in various applications. 




4.2. Results  
 Transmission electron microscopy (TEM) images revealed that Pt-np has a 
narrow size distribution in the range of size 5 - 8 nm (Figure 4.1A). Energy dispersive 
X-ray spectroscopy (EDX) spectrum further confirmed the presence of Pt metal in the 
area studied (Figure 4.1B). UV-Vis spectroscopy showed a hyperbolic curve for pure 
Pt-np while crude suspension showed a characteristic shoulder at 261 nm (Figure 
4.1C). DLS studies showed nanoparticles of size 6.669 nm (Figure 4.1D).The zeta 
potential of the particles were measured as 0.214 mV. 
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Figure 4.1: Characterisation of Pt-np: (A) TEM image of Pt-np with particles of size 
5-8 nm, (B) EDX spectrum of Pt-np (C) UV-vis spectrum showing shoulder around 
270 nm and (D) size distribution histogram showing hydrodynamic diameter of 
particles in the samples. 
  




 4.2.1. Microscopy of cells treated with Pt-np 
  Microscopic observation of the treated cells did not show many floating or 
dead cells. Untreated U251 cells appeared normal (Figure 4.2A). However, U251 
cells treated with higher concentrations of Pt-np (80 and 160 µg) showed abnormal 
cell morphology characterised by abnormal spreading patterns (Figure 4.2B) such as 
the presence of many cytoplasmic vacuoles (Figure 4.2C). IMR-90 cells without any 
nanoparticle treatment appeared normal (Figure 4.2D) whereas, those treated with Pt-np 
showed abnormal spreading (Figure 4.2E) and formation of vacuoles (Figure 4.2F).  
   
Figure 4.2: Microscopic images of cells exposed to Pt-np: Untreated cancer cells 
showing normal morphology (A) and treated cells showing abnormal morphology and 
spreading (B, magnification × 50). Treated cells showing abnormal morphology 
characterized by many cytoplasmic vacuoles (C, magnification × 200). Normal 
morphology of IMR-90 cells (D). Pt-np treated cells exhibiting abnormal spreading 
(E, magnification × 50). Cells showing abnormal morphology characterized by many 








4.2.2. Uptake and distribution studies 
 ICP-OES analysis of purified Pt-np samples showed a metal composition of 
5.9 wt%. Cells treated with Pt-np under cell culture conditions, that selectively blocks 
energy dependant endocytosis and clathrin pit formation indicated that Pt-np uptake 
occurs mainly through diffusion. Pt-np uptake occurred at 4°C when endocytosis was 
completely blocked (Figure 4.3A) confirming that Pt-np enters the cells mainly 
through diffusion. Inhibition of clathrin in presence of K+ depleted medium did not 
affect nanoparticle uptake to the cells which further confirms only low levels of 
endocytosis. Pt-np uptake at 37°C acted as a control to measure deviation of uptake 
under different conditions (low temperature and K+ depletion) employed. All normal 
methods of uptake are active at 37 °C. 
 Electron micrographs revealed the presence of Pt-np in the cell cytoplasm 
only. As expected, untreated cells did not show any nanoparticles (Figure 4.3B) inside 
the cells. Nanoparticles and aggregated particles were seen inside the vesicles as well 
as in the cytoplasm of both IMR-90 (Figure 4.3C) and in U251 cells (Figure 4.3D). 
Nanoparticles were not observed in the cellular organelles such as mitochondria or 
nucleus. No abnormal blebbing of cells was detected in target cells, but many vacuoles 
were seen inside the cells. Due to the small size and less colour contast of Pt-np, the 
distribution of individual particles was unclear. Dark filed imaging (Cytoviva 
ultrahigh resolution illumination systems for imaging nanoparticles) were employed to 
overcome this challenge which showed no light scattering in the controls (Figure 4.3E) 
while Pt-np treated cells showed numerous bright spots in the cytoplasm, most of them 
near the nucleus (Figure 4.3F). 
 





Figure 4.3: Uptake and distribution of Pt-np: Data from ICP-OES analysis showing 
the Pt-np uptake occurs through diffusion are given. Pt-np uptake was not affected 
when clathrin coated pits were blocked which shows that clathrin is not involved in 
Pt-np uptake. Electron micrographs of Pt-np treated cells showing control (A) and Pt-
np treated IMR-90 cells (B) showing nanoparticles in the cytoplasm and clumps inside 
endosomes. U251 cells (C) showing Pt-np in the cytoplasm and in endosomes. Cells 
were treated with 160 µg/mL of Pt-np. Arrows denotes Pt-np in vesicles and 
arrowheads in cytosol. Dark field image captured using cytoviva high resolution 
systems showing controls (E) and Pt-np exposed cells (F). Nanoparticles are observed 
as bright objects. 





 Cytotoxicity assays showed dose dependant toxicity in both the cell lines. 
IMR-90 and U251 cells showed a dose dependant decrease in ATP content of the cells 
in 24 hrs (Figure 4.4A). Viability in U251 cells reduced to 56% in 48 hrs. However, 
after 72 hrs of incubation, a significant increase in ATP content was observed (66%). 
IMR-90 cells also showed similar pattern in viability (71, 64 and 68% viability after 
24, 48 and 72 hrs, respectively). Similar experiment using the capping agent, 
polyvinyl alcohol (PVA) showed no significant toxicity (Figure 4.4B). Cell–titer blue 
assay showed viability of 59% in U251 at 48 hrs increased to 71% within 72 hrs 
(Figure 4.4C). However, normal cells did not show a significant elevation in viability 
at 72 hrs (73%) when compared to 48 hrs (72%). These results indicated that Pt-np 





Figure 4.4: Cytotoxicity assay of Pt-np treated cells: (A) 
represents results from ATP based viability assay which 
showed a concentration dependant drop in ATP content 
of the cells at different time intervals. (B) Graph shows 
the biocompatibility of PVA in both cell lines. (C) Data 
from fluorescence based assay which measures % of 
metabolically active cells are presented. Both assays 
showed a concentration dependant cytotoxicity which is 
not time dependant. X- axis depicts time in hrs, recorded 
for both cells lines. Y axis shows % of cells. * Represents 
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4.2.4. ROS production 
 Pt-np treated cells exhibited a dose dependant increase in H2O2 and O2- 
production. Exposure to a lower dose (20 and 40 µg) of nanoparticles produced low 
levels of H2O2 in IMR-90 cells than untreated cells (Figure 4.5A). The amount of 
H2O2 increased with concentration of Pt-np, but did not exceed the basal levels in 
controls. On the other hand, cancer cells showed similar trend with increased 
production of H2O2 at 80 and 160 µg/mL of Pt-np (Figure 4.5B). A 7 ± 2% increase in 
florescence (right shift) was observed for Pt-np treated cells (80 and 160 µg).  
 Superoxide production followed a similar pattern where low concentration of 
Pt-np led to the production of no significant O2- when compared to a Pt-np 
concentration of 80 and 160 µg/mL, where an increase in superoxide production in 
both IMR-90 (Figure 4.5C) and U251 cells (Figure 4.5D) was observed. The 
corresponding statistical data generated from the histograms are shown in Figure 4.5E 



























Figure 4.5: ROS production in Pt-np treated cells: (A) Histogram represents DCF-DA 
stained IMR-90 cells showing a concentration dependant increase in H2O2 production. 
(B) U251 cells stained with DCF-DA showing increase in H2O2 levels at 80 and160 
µg of Pt-np. (C) Shows DHE stained IMR-90 cells for O2- production, which shows 
concentration dependant increase. (D) U251 cells stained with DHE shows increase in 
O2- production. Statistical data extracted from the histograms for H2O2 (E) and O2- (F) 
production, using WinMDI software. ROS production in IMR-90 and U251 positive 
controls increased by 62.9% and 74.8% respectively, for hydrogen peroxide and 25% 








4.2.5. Genotoxicity of Pt-np  
 Comet assay done on Pt-np treated cells showed a concentration dependant 
increase in tail moment as compared to control cells, indicating an increase in DNA 
damage (Figure 4.6A). Both cell lines exhibited consistent increase in tail moments as 
concentrations of Pt-np was increased. However, U251 cells sustained increased DNA 
damage as compared to IMR-90 cells.  
 In addition, the CBMN assay results also showed chromosomal breaks in Pt-np 
treated IMR-90 and U251 cells compared to the untreated cells.  Minimal number of 
micronuclei was observed for untreated cells (Figure 4.6B) whereas a significant 
increase was observed in both cell types treated with Pt-np (Figure 4.6C). Pt-np 
treated cancer cells showed a concentration dependant increase in the number of 
chromosomal fragments as compared to normal cells (Figure 4.6D) and untreated 
cancer cells. Therefore, these two genotoxicity assays demonstrate significant 





















































Figure 4.6: Genotoxicity of Pt-np: (A) denotes results from comet assay showing a 
concentration dependant DNA damage. X-axis shows concentration of Pt-np 
employed whereas Y-axis represents tail momentum which is a measure of DNA 
damage. (B) Untreated cancer cells (C) Pt-np treated U251 cells showing micronuclei. 
(D) Denotes data from CBMN assay which shows a concentration dependant increase 



























4.2.6. Effect of Pt-np on cell cycle, apoptosis and necrosis  
  A concentration dependent increase of S-phase cell population was observed 
for IMR-90 cells indicating S-phase arrest. As the dose of Pt-np increased from 20 to 
160 µg/mL, there was a substantial increase in population of cells in sub G1-phase 
from 0.51 ±0.37 (control) to 13 ±3.8% (Figure 4.7A) implying that cells were 
undergoing apoptosis. Similarly, G1 cell population dropped from 71.66 ± 1.95% to 
64.22 ± 1.46% in Pt-np treated (160 µg) cells. This was accompanied by an increase in 
S-phase cell population from 5.2 ± 0.91 to 10.28 ± 0.59% and a decrease in G2/M 
population from 22.46 ± 0.74% to 14.8 ± 0.99%. Even though, only a small 
population of cells showed arrested growth at S-phase, the values obtained were 
statistically significant. 
 Cancer cells (U251) exhibited a concentration dependent S-phase arrest 
(Figure 4.7B). There was also a dose dependent increase of sub G1 phase cell 
population from 4.5 ±1.5%, to 8.8 ±1.01% indicating the presence of apoptosis, but 
the increase was not as high as in fibroblasts (IMR-90). G1-phase cell population 
decreased from 61.48 ±6.01% to 51.69 ±0.89% in Pt-np treated cells. Cell population 
in S-phase was increased from 15.89 ±2.5% to 22.23 ±1.52% in Pt-np treated cancer 
(U251) cells. G2/M-phase population did not show any difference as compared to 
controls. 
 Annexin V staining of IMR-90 cells showed a drop in viable cell population 
from 76.4 to 66.5 % at 160 µg of Pt-np. The percentage of cells undergoing apoptosis 
was increased from 2.1 to 4.21%, while early apoptosis increased from 5.1 to 9.3% 
and late apoptosis increased from 16.1% to 19.5% (Figure 4.7C). This correlates well 




with cell cycle analysis which indicated the presence of apoptosis due to increase in 
cell population in sub G1 phase.  
 In the case of U251 cells (Figure 4.7D), a concentration dependent increase in 
late apoptosis from 19.8 to 38.6 % and an increase in the number of necrotic cells 
from 8% to 11% were observed. Percentage of viable cells dropped from 68.3 to 
48.4%. This percentage is much higher in U251 cells than fibroblasts. It is noteworthy 
that high proportion of late apoptotic cells were observed in Pt-np treated U251 cells 
when compared to fibroblasts. Even though late apoptosis in U251 cells was 
concentration dependant, necrosis was high with Pt-np (40 µg/mL) treated cells. In 
summary, Annexin V-PI staining confirmed induction of cell death in Pt-np treated 



















Figure 4.7: Cell cycle analysis of Pt-np treated cells: IMR-90 cells showed a concentration dependant increase in S phase cell population (A). 
U251 cells showing increase in S phase cells (B). Both cells showed a concentration dependant increase in apoptotic cells (subG1). * denotes P ≤ 
0.05. Annexin V-PI staining of IMR-90 (C) and U251 (D) cells treated with Pt-np showed early apoptosis in fibroblasts and late apoptosis in 
U251 cells. U251 also showed increase in necrotic cell population. X-axis denotes concentration of Pt-np employed and Y-axis represents % of 





























































































SubG1 G1 S G2/M
* * * *
* *
A




4.2.7. Colony formation 
  The evidence of recovery from low levels of damage in Pt-np treated cells was 
measured as their ability to form colonies after treatment. U251 cells showed no statistically 
significant drop in the number of colonies formed in Pt-np treated cells (10, 40, 80, 160 µg), 
indicating absence of permanent damage due to Pt-np treatment (Figure 4.8A). IMR-90 cells 
showed a slight drop in the number of colonies after recovery indicating substantial residual 
damage to the cells which could be due to cell death. Microscopic observations of the 
colonies showed no abnormalities in untreated cancer cells (Figure 4.8B) whereas, Pt-np 
treated cancer cells showed the presence of large cells (Figure 4.8C). Untreated IMR-90 cells 
displayed normal cell morphology (Figure 4.8D) whereas a few large cells were observed 






















               
Figure 4.8: Colony formation studies in Pt-np treated cells: (A) graphs represent colony 
counts from IMR-90 and U251 cells after recovery. IMR-90 showed a drop in the number of 
colonies with increase in Pt-np concentration whereas U251 cells did not show much 
difference. (B) Untreated U251 cells showing normal colony formation (C) Pt-np treated 
(160 µg/mL) U251 cells showing presence of many large cells. (D) Normal untreated 

























4.2.8. Protein levels in Pt-np treated cells 
 Pt-np treated IMR-90 and cancer cells (U251) showed upregulation of p53 and p21 
(Figure 4.9). Cancer cells alone showed increased levels of phosphorylated p53. No 
phospho-p53 expression was detected in normal cells. PCNA was down regulated in both cell 
types following Pt-np treatment. Caspase 3 bands did not show changes in IMR-90 and U251 
cells used in the study, however, small low molecular weight fragments of ~ 37 KD were 
observed. These bands are believed to be the result of sequential cleavage of Procaspase 3. 
The fragments were clearer for U251 cells than in IMR-90. None of the smaller fragments 
(20 or 18 KD) typical of sequential caspase cleavage were detected. PARP was up regulated 
in IMR-90 and a slight increase in cleavage product was also observed in both cells.  Cyclin 









Figure 4.9: Protein expression profiles in Pt-np treated normal cells and cancer cells. Both 
cell lines showed an increase in p53 and p21 expression. Minimal PARP cleavage was 
observed in both cells. PCNA was down regulated in both cells. Phospho p53 was seen in 
cancer cells alone. Caspase 3 showed a high molecular weight fragment however, did not 
show any 20 and 18 kD fragments due to cleavage.  
 
4.3. Discussion 
          Platinum complexes and nanoparticles are interesting due to their anti-proliferative 
properties. We have synthesised 5-8 nm size Pt-np and established that Pt-np enters the cells 




by diffusion and through endocytosis. From our study, it was noted that Pt-np exhibited 
considerable levels of cytotoxicity, genotoxicity and ROS production in cells. Increased 
accumulation of cells in S phase of the cell cycle was observed, followed by a significant 
increase in apoptosis. However, the damage was found to be repairable, as majority of Pt-np 
treated cells still formed colonies. It is possible that Pt-np exerted its effect through p53 and p21 
mediated pathways in inducing growth arrest and apoptosis – toxicity. This is supported by the 
low level expression of PCNA (growth arrest) and induced PARP cleavage (apoptosis). 
         We show that Pt-np of 5 - 8 nm is able to induce considerable cyto- and geno-toxicity, 
probably through increase in ROS production at high concentration. Even though, most of the 
nanomaterials exert toxicity through oxidative stress, Pt-nps have been classified as 
antioxidants (Hikosaka et al., 2008). Pt-np protected with citrate and pectin were found to have 
activity similar to mitochondrial complex I, NADH:ubiquinone oxidoreductase which makes 
them ideal therapeutic targets for oxidative stress associated diseases (Hikosaka et al., 2008). Our 
study demonstrated a dose dependant response in Pt-np treated cells where low doses of Pt-np 
reduced intracellular ROS production supporting the earlier reports. When the concentration was 
increased to 80 and 160 µg, the ROS levels increased slightly beyond controls. This could be 
attributed to the ultra small size of the nanoparticles which tend to aggregate at higher 
concentration forming nano sized clumps. We believe that this instability could contribute to 
increase in ROS production. The Pt-np used in earlier studies had a size of 11 - 35 nm (Elder et 
al., 2007), whereas we employed 5 - 8 nm size particles in our studies. This small size is believed 
to be crucial factor that facilitated increased diffusion in to the cells as compared to large particles 
which are most commonly taken up by the cells through endocytosis. Similar results were 
reported for gold nanoparticles where smaller particles (14 nm) were endocytosed at much slower 
rate than 30 and 50 nm size particles (Chithrani et al., 2006). Electron micrographs revealed 




clumps of Pt-np in endosomes which fits well with the assumption that larger agglomerates were 
endocytosed whereas smaller nanoparticles were diffused into the cells. Hence, we believe that 
the size dependant mechanism plays a vital role in diffusion of Pt-np observed in our 
experiments.  
         Earlier study has reported the absence of membrane damage in Pt-np toxicity by measuring 
the lactate dehydrogenase (LDH) levels in cells (Gao et al., 2007). LDH release occurred in cells 
through cell membrane rupture during necrosis. In the current study, lower ATP levels were 
recorded in Pt-np treated cells which could be explained as metabolic inhibition. It is not 
necessary that metabolic arrest or low metabolic rate represent cell death in all cases. Cell death 
in the form of apoptosis was seen in cells exposed to Pt-np. Caspase 3 fragment was observed in 
U251 cells and PARP cleavage was visible in IMR-90 cells indicating the involvement of 
apoptosis. The absence of low molecular weight Caspase 3 fragments could be due to low 
number of apoptotic cells which is not sufficient to give a clear band in western blot. 
          Similarly, genotoxicity observed in Pt-np treated cells was significant but stayed within 
the minimal levels which can be tolerated by the cells as indicated by the low percentage of 
dying cells. Earlier reports have emphasised intracellular release of Pt2+ ions from Pt-np  
(Gao et al., 2007) which could block cell division by binding to DNAWe speculate the 
involvement of an analogous mechanism in Pt-np toxicity wherein released Pt2+ ions might 
halt DNA synthesis. A possible reaction of Pt2+ ion release involves: 
Pt + H2O2 + 2H+                 Pt2+ + 2H2O  E = 0.592 V     4.1 
Half cell reactions (Bard and Faulkner, 2001; Hamann et al., 2007) are  
 H2O2 + 2H+ +2e-                  2H2O  E0=1.78 V      4.2 
 Pt                   Pt2+ + 2e-   E0= -1.188 V       4.3  




 Based on the evidence, we hypothesise that the binding of Pt2+ ions to DNA led to 
DNA damage leading to the accumulation of cells at different phases of cell cycle. This delay 
gives sufficient time for the cells to repair the damage. ROS production at higher 
concentration of Pt-np may have augmented DNA damage and contributed to the cytotoxicity 
and metabolic stress. 
 Downregulation of proliferating cell nuclear antigen (PCNA), a factor critical for 
DNA replication and repair (Bruning and Shamoo, 2004; Moldovan et al., 2007) following 
Pt-np treatment support the anti-proliferative effects of Pt-np. A negative regulator of PCNA 
functions is p21 (Boulaire et al., 2000), which is also a cyclin dependant kinase 2 (cdk 2) 
inhibitor were up regulated in Pt-np (160 µg) treated cells. In addition, p53 levels were also 
higher in treated cells. Upregulation of both p21 and p53 might have resulted in cell cycle 
arrest and apoptosis.  Involvement of p53 signalling is further supported by observed increase 
in the of phosphorylated p53 levels. Apoptosis mediated by p53 under cellular stress is 
induced by the transcription of many pro-apoptotic genes and involves mitochondrial 
pathway (Chipuk et al., 2003). Hence it is conceivable that the cells with accumulated 
damage undergo apoptotic cell death through p53 pathway (Kaina, 2003). Absence of 
phosphorylated p53 bands in normal fibroblasts could be the result of low protein 
concentration rather than absence of signalling. Activation of p53 signalling pathway can turn 
on downstream targets such as p21 to block cell cycle and induce apoptosis if damage is 
irreparable. Cyclin B is a protein that control S/G2/M transition (Porter and Donoghue, 2003). 
Upregulation of cyclin B was observed in fibroblasts whereas cancer cells showed no 
increase in this protein. The protein, p21 is known to trigger accumulation of inactive cyclin 
B-cdk complexes without significantly changing their expression levels under genotoxic 
stress (Charrier-Savournin et al., 2004). As there was a large population of cells viable 




following Pt-np treatment in the present study, it is conceivable that only those cells which 
could not successfully repair the damaged DNA were undergoing cell death. This could be 
the reason for low density bands for caspase 3 and PARP, which usually give a clear profile 
when large cell population undergoes apoptosis. Though there were no significant changes in 
the colony formation efficiency of treated cells, morphological observation revealed the 
presence of large cells which might represent cells with proliferation arrest. The increase in 
viability with time could be due to the survived cells which continued proliferation after a short 
period of cell cycle arrest and repaired their damage. All in all, it is speculated that Pt-np 
induces genotoxicity but these are reversible and can be repaired efficiently by the cells.  
          In summary, we have demonstrated that Pt-np is able to induce significant cytotoxicity 
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 It is necessary to understand the physiological behavioural change and 
differences in toxicity between in vivo and in vitro models for a better understanding 
of the health effects. Silver nanoparticles are employed in detergents and as 
antimicrobial agents that could end up in environment or inside the organs of animals. 
Moreover, the effluents from research labs and industries carrying heavy nanoparticle 
content also reach environmental resources Here, we have chosen zebrafish embryos 
as the in vivo models for our study, due to the wealth of information available on 
genetics and developmental biology of zebrafish that facilitates screening of toxicity 
(Yang et al., 2009b). It is understood that the embryos are the most vulnerable stage in 
the developmental process and thus clear indicators of chemical toxicity. Zebrafish 
has an extraordinarily fast rate of development and is an interesting vertebrate model 
for toxicology studies because of its great relevance to human genetics (Rubinstein, 
2006). The transparent embryos develop ex-utero, facilitating visual recording of 
organogenesis. The ease of maintenance adds on to its usefulness as an experimental 
model. We have employed gold, silver and platinum nanoparticles. Gold 
nanoparticles were employed as negative controls for embryo toxicity. The 
nanoparticles used for the preliminary screening in vivo, were capped with the same 
capping agent which is PVA. The surface functionalisation of nanoparticles 
determines the toxicity of nanoparticles and thus kept constant among different metal 
nanoparticles in ultra fine size range. When comparing ultrafine size particles the role 
of surface functionalisation in nanotoxicity becomes more important than the size 
(Sur et al., 2010). The nanoparticle which showed high toxicity in screening was 




further explored using different capping agents (BSA and starch) to understand if the 
observed toxicity was contributed by the surface functionalisation. 
5.2. Results 
5.2.1. Comparison of toxicity of different metal nanoparticles 
 UV spectrum of gold nanoparticles capped with PVA (Au-np) exhibited a 
characteristic absorption maximum at 518 nm (Figure 5.1A). Silver nanoparticles 
capped with BSA (Ag-np-2) showed absorption maximum at 420 nm while starch 
capped silver nanoparticles (Ag-np-3) showed maximum absorption at 400 nm (Figure 
5.1B). Transmission electron microscopy (TEM) image showed spherical and oval 
nanoparticles of sizes ranging from 15 - 35 nm (Figure 5.1C). Silver nanoparticles 
capped with PVA (Ag-np-1) showed absorption maximum at 420 nm (Figure 5.1A) 
and spherical shapes with size ranging from 5 nm to 35 nm (Figure 5.1D). Platinum 
nanoparticles capped with PVA (Pt-np) showed a hyperbolic curve (Figure 5.1A) 
with a size range of 3 - 10 nm (Figure 5.1E). A comparison of size distribution of the 
Au-np (Figure 5.1F) and Ag-np-1(Figure 5.1G) indicated a hydrodynamic diameter of 
28.26 and 10.88 nm respectively. The zeta potential of the nanoparticles at pH 6.8 - 7.2 
was -1.72 mV for Ag-np-3; 0.0921 mV for Ag-n-1; - 0.525 mV for Au-np and 0.214 
mV for Pt-np. The weigh percentage of metal in each nanoparticle was compared by 



























Figure 5.1: Characterisation of nanoparticles. (A) UV spectra of Au-np, Pt-np and 
Ag-np-1 in water. Au-np showed an absorbance maximum at 530 nm and Ag-np-2 at 
410 nm. Pt-np showed shoulders hyperbolic curve. (B) UV-Vis spectra of Ag-np-2 
and 3 showing maximum absorption at 400 nm and 420 nm respectively. TEM images 
of (C) Au-np with a diameter of 15 - 35 nm. (D) Ag-np-1 with a size range of 5 - 25 
nm and (E) Pt-np with the size range of 3 - 10 nm. Size distribution of Au-np (F) and 
Ag-np-1 (G) obtained from the DLS studies. 
 




































































































Table 5.1: Weight percentage of metal present in nanoparticles 





5.2.2. Effect of nanoparticles on mortality and hatching rate  
 The control group of embryos developed normally and showed an overall 
mortality of less than 3%. Exposure of embryos to Au-np resulted in no increase in 
mortality compared to the unexposed and PVA exposed control groups. On the other 
hand Pt-np and Ag-np-1 resulted in a concentration dependant increase in mortality 
rate to 20 ±7.1% and 43±7%, respectively (Figure 5.2A).  Control, PVA and Au-np 
treated embryos hatched out normally at all concentrations employed. At a nanoparticles 
concentration of 100 µg/mL, hatching rates were dropped to 50 ± 9.9% and 30±12.8% for 



















































Figure 5.2: Dosage dependant toxicity of nanoparticles in mortality (A) and hatching 
rate (B). X-axis denote concentration of nanoparticles whereas Y-axis frequency in 
percentage. All the values are expressed as mean± standard deviation. Ag-np-1 and 
Pt-np showed a concentration dependant increase in mortality rate, whereas Au-np did 
not show any effect. In panel B, control and Au-np treated embryos showed no 
hatching delays. Pt-np and Ag-np-1 exposure resulted in delayed hatching. Hatching 
rate was calculated as number of embryos hatched out at 72 hpf/ number of live 
embryos at 72 hpf × 100.  
 
5.2.3. Effects of nanoparticles on organogenesis  
 Control (Figure 5.3A) and Au-np treated (24 hpf, Figure 5.3B) embryos 
appeared normal in development of eyes, tail, brain and otoliths. Pt-np treated 
embryos at 24 hpf (Figure 5.3C) exhibited turbid fluid inside the chorion starting at 
50 µg/mL. More severe observations were recorded for Ag-np-1 treated embryos.   




Ag-np-1 treated embryos at 24 hpf showed defects from 25 µg/mL, including absence 
of eyes, growth retardation and undulated notochord (Figure 5.3D). Magnified 
images showing Ag-np-1 treated embryos at 24 hpf are included in Figure 5.4. As the 
incubation period progressed to 48 hpf, control (Figure 5.3E) and Au-np treated 
embryos (Figure 5.3F) remained to appear to be normal in development with normal 
heart rate and pigmentation and no abnormal organogenesis was observed. Pt-np 
exposed embryos showed an increase in turbidity compared to 24 hpf (Figure 5.3G). 
Ag-np-1 exposed embryos showed flakes in the chorion fluid. Ag-np-1 exposed 
embryos showed defective eyes and pericardial edema (Figure 5.3H). At 72 hpf, 
control (Figure 5.3I) and Au-np treated (Figure 5.3J) embryos showed no obvious 
defect in developments. Embryos exposed to Pt-np showed distinct axial curvatures 
when compared to controls (Figure 5.3K). Ag-np-1 exposed embryos showed severe 
phenotypic defects involving pericardial edema; axis defects and defective organs 
(Figure 5.3L). PVA treated controls showed no phenotypic defects at 72 hpf.  














Figure 5.3: Phenotypic observations in nanoparticle treated embryos at different time 
points: Embryos at 24 hpf (A-D): (A) Untreated embryos showing normal 
development. (B) Au-np treated embryos (C) Pt-np treated embryos showing turbid 
fluid. (D) Ag-np treated embryos showing multiple defects.  Diamond arrow denotes 
growth retardation while pointed arrow shows eye defects. All images represent a 
concentration of 100 µg/mL of nanoparticles. Embryos at 48 hpf (E-H). (E) Controls 
at 48 hpf. (F)  Au-np treated embryos. (G) Pt-np treated embryos with slimy fluid. 
Arrow points at the coloured flakes inside the chorion. (H) Twisted tail and edema in 
Ag-np-1 treated embryos. Embryos at 72 hpf (I-L). (I) controls appearing normal. (J) 
Au-np treated larvae. (K) Pt-np exposed embryos showing axial curvatures. Arrow 
points at the control embryos with straight body axis. The red lines denote the length 
of the tail measured. (L) Ag-np-1 treated embryos showing twisted and undulated 
notochord and edema. 
 




 Development and pigmentation of eyes in embryos were recorded at 24, 48 
and 72 hpf. Control and PVA treated embryos developed normally (Figure 5.4A). 
Ag-np-1 treated embryos exhibited developmental delay, significant distortion of 
embryos (Figure 5.4B) and undulated and twisted tail (Figure 5.4C). Ag-np-1 treated 
embryos also appeared to be shorter in length than control (Figure 5.4D). 
Measurement of tail length of 15 embryos revealed a mean length of 2646.4 (±67.6) 
µm, whereas Ag-np-1 treated embryos at 100 µg showed a tail length of 2315.9 
(±92.4) µm. The development of fins in larvae was also noted and Ag-np-1 treatment 
alone induced impaired pectoral fin development in 21.4% of larvae at 100 µg/mL of 
nanoparticle concentration. 
 In addition, Ag-np-1 exposed embryos exhibited eyeless phenotypes (Figure 
5.4E) or had defective eyes (Figure 5.4F). At 72 hpf, 50% embryos showed defective 
eye development at 100 µg/mL of Ag-np-1 concentration. The morphology of the 
heart at 72 hpf was studied. Heart appeared normal in untreated embryos with intact 
atrium and ventricle and normal pumping (Figure 5.4G) whereas, embryos treated 
with nanoparticles showed thin and distorted heart chambers (Figure 5.4H). At higher 
concentrations (75 and 100 µg/mL) atria appeared string like and thin with low 
pumping efficiency and abnormal cardiac rhythm (Figure 5.4I). The percentage of 
embryos exhibiting other types of abnormalities such as defective eyes, growth 






















Figure 5.4: Detailed analyses of phenotypic defects observed in Ag-np-1 treated 
embryos. (A) PVA controls at 24 hpf. (B) Growth retardation observed in Ag-np-1 
treated embryos at 24 hpf. (C) Axis defects observed in Ag-np-1 treated embryos. (D) 
Compares size of the control (arrow) embryos to Ag-np-1 treated embryos at 72 hpf. 
Ag-np-1 treated embryos appeared shorter. (E) Absence of eye in Ag-np-1 treated 
embryos at 72 hpf and (F) defective eyes in Ag-np-1 treated embryos at 72 hpf. All 
images represent embryos treated with 75 µg/mL of Ag-np-1. (G) Heart of control 
embryos showing normal morphology. (H) Ag-np-1 treated embryos showed thin 
cardiac chambers. (I) At higher concentrations (100 µg/mL) heart appeared elongated 
with thin atria and low pumping efficiency. (J) Compares the percentage of phenotypes 
exhibiting the phenotypic defects such as growth retardation, eye defects, edema and axis 
curvatures observed in Au-NP, Pt-NP and Ag-np-1 treated embryos at 72 hpf. 
 
5.2.4. Effect of nanoparticles on cardio vascular system  
 Exposure to silver nanoparticles resulted in a significant drop in heart rate 
starting at 24 hpf (Figure 5.5A) compared to the other nanoparticles used for the 
study. Increase in pericardial edema (Figure 5.4J) was observed with increase in 
concentration. Slow pumping of blood was observed that contributed to a decrease in 
peripheral circulation. Though the blood circulation was slow, it did not stop 
completely at all concentration of silver. Peripheral circulation was critically low in 




Ag-np-1 treated embryos from 50 µg/mL. At higher concentrations, cardiac chambers 
appeared thin and the pumping efficiency was remarkably slow. The drop in heart rate 
continued to plunge after 48 hpf (Figure 5.5B) and 72 hpf (Figure 5.5C) compared to 
untreated embryos and PVA alone controls. No recovery was observed throughout the 
test period. Pt-np also showed a gradual drop in heart rate from 48 hpf onwards, but 
much lower in intensity than Ag-np-1. Au-np did not result in any change in 
cardiovascular system at all time points. Pt-np exposed embryos developed reduced 
heart beat from 48 hpf, which became more noticeable by 72 hpf. No change in blood 
flow was observed for Pt-np and Au-np treated embryos. The severity of effects of  
Pt-np on the cardiovascular system of treated embryos was lower than Ag-np-1, but 
































































Figure 5.5: Comparison of heart rate of embryos: Embryos were treated with PVA, 
Au-np, Pt-np and Ag-np-1. At 24 hpf Ag-np-1 treated embryos exhibited a drop in 
heart rate (A). Platinum nanoparticles also resulted in mild drop in heart rate. Gold 
nanoparticles had no effect on heart rate of the embryos. Heart rate continues to drop 
at 48 hpf in Ag-np-1 and Pt-np, but not in Au-np (B). At 72 hpf, Ag-np-1 showed 
significant drop in heart rate in a concentration dependant manner (C). Pt-np showed 
similar drop. Au-np and PVA controls showed normal heart rate. 




5.2.5. Touch response of the larvae 
 The Ag-np-1 treated embryos were less responsive to touch stimuli at higher 
concentrations (above 50 µg). The touch response of the larvae decreased with 
concentration. At 100 µg/mL of Ag-np-1, none of the larvae exhibited touch response. 
Untreated controls, PVA and Au-np treated larvae did not show significant changes in 
their touch response. Pt-np at higher concentration (100 µg/mL) exhibited a trivial 
drop in touch response. The response of the nanoparticle treated embryos is portrayed 
in Table 5.2. 





Touch  and swim response  
Au-PVA Pt-PVA Ag-PVA Legend 
0 ++++ ++++ ++++ ++++  fast response 
10 ++++ ++++ ++++ +++    medium response 
25 ++++ ++++ +++ ++      slow response 
50 ++++ ++++ ++ +        very slow response 
75 ++++ ++++ + -        no response 
100 ++++ +++ -  




5.2.6. Nanoparticle uptake by the embryos  
 To understand the tendency of nanoparticle accumulation in embryos exposed 
to Ag-np-1, Pt-np and Au-np, embryos showing no significant phenotypic defects 
were assayed for metal content. Embryos treated with 25 and 50 µg/mL of 
nanoparticles had detectable levels of metal accumulation inside the body (Figure 
5.6). Ag-np-1 and Au-np treated embryos showed similar metal content in the body 
whereas Pt-np exposed embryos showed low Pt concentration inside their body. A 
























Figure 5.6: Metal retention of gold, platinum and silver in embryos exposed to 
nanoparticles. X-axis denotes type of nanoparticles and concentrations employed (0, 
25 and 50 µg/mL). Y-axis represents concentration of metals in parts per million 
(ppm) as detected by ICP-OES analyses. The experiment was performed thrice using 
fifty embryos each. 
 
5.2.7. Toxicity of corresponding metal ions 
  Embryos exposed to Ag+, Pt2+ and Au3+ did not shown any increase in 
mortality rate (Figure 5.7A). Pt2+ exposed embryos (100 nM) showed 10% of the 




larvae with pericardial effusion and yolksac edema. No hatching delay was observed 













































Figure 5.7: Toxicity of Ag+, Pt2+ and Au3+ ions in the zebrafish embryos. (A) No 
increase in mortality rate was observed in embryos exposed to ions. (B) Hatching rate 
of Ag+, Pt2+ and Au3+ treated embryos showing only 5% drop in hatching in Pt2+ 
treatment. 
 
5.2.8. Probing the toxicity of Silver nanoparticles 
 The silver nanoparticles, which showed increased toxicity to embryos when 
compared to other nanoparticles, were further screened for their potential toxic 
effects. Silver nanoparticles with BSA and starch capping were synthesised to study if 
the observed effect in the preliminary screening was contributed by the capping agent-
metal combination. 
5.2.9. Mortality, heart rate, edema and malformations 
 The nanoparticle treated embryos showed dose dependant toxicity under 
laboratory conditions. The observations were similar for both Ag-np-3 and Ag-np-2 
particles. The control groups (medium and capping agents) without the added nanoparticles, 
appeared normal (Figure 5.8A) with an overall mortality < 4%. At a concentration of  
5 g/mL, the fluid inside the chorion showed slight turbidity characterised by the 




presence of brownish flakes (Figure 5.8B). The turbidity increased with the 
concentration of nanoparticle and led to a white opaque appearance to the embryos 
(Figure 5.8C). The embryos had a characteristic slimy coating, which resembled 
mucus in texture and appearance (Figure 5.8D). The DAPI staining of the chorionic 
fluid showed no evidence of nuclear staining in controls (Figure 5.8E) whereas, 
nanoparticle treated embryos showed nuclear staining (Figure 5.8F). The DAPI stained 
slimy layer showed similar patterns in both Ag-np-2 and Ag-np-3 treatment. The LC50 for 
the embryos was dependant on the growth stage (64 - 128 cell stage) of the embryos 
exposed to nanoparticle treatment, and was found to vary from 25 - 50 g/mL. The later 
stages of the embryos were found to be more resistant to Ag-np-1 treatment. Above 
50 g/mL, the embryos exhibited severe phenotypic changes characterised by bent 
and twisted notochord, accumulation of blood in the blood vessels near the tail, low 
heart rate, pericardial edema and degeneration of body parts. The pericardial edema 
was observed at 24 hpf and became more pronounced by 72 hpf. The control embryos 
appeared normal throughout the test period (Figure 5.8G). Occurrences of defective 
phenotypes were similar in both Ag-np-2 (Figure 5.8H) and Ag-np-3 (Figure 5.8I). In 
order to study the occurrence of apoptosis, acridine orange staining was performed for 
all embryos above 50 g/mL concentrations at 72 hpf. Surprisingly, only 40-50 % of 
the embryos exhibited bright green spots all over the body while the rest of them had 
a low natural fluorescence. The acridine orange staining to study apoptosis showed no 
significant staining in control embryos (Figure 5.8J) whereas, the Ag-np-2 (Figure 
5.8K) and Ag-np-3 (Figure 5.8L) treated embryos showed green fluorescent spots on 
the body, which could be explained using the decomposition of body parts. The decay 
of the body was more obvious near the head and tail. Above a concentration of 50 




g/mL 60-90% of the survivors showed malformations. The yolk sac of the embryos 
appeared distorted. The pericardial edema was prominent in most of the Ag-np-1 
treated embryos. Also, a bent notochord was common and that none of those embryos 
hatched out by 72 hrs.  
 




Figure 5.8: Microscopic images of silver nanoparticles treated embryos: (A) control 
embryos at 24 hpf, which developed normally: magnification 5×. (B) Ag-np-2 treated 
embryos at 24 hpf (5 g/mL) showing slimy fluid with brown flakes inside the 
chorion and live embryos; (magnification:2.5×) (C) at 24 hpf showing cloudy 
appearance resembling dead embryos (magnification: 2.5×). Inset picture shows the 
distinct appearance of dead and malformed embryos at 48 hpf (magnification: 2.5×). (D) 
Optical images of slimy coating with brown specks, isolated from the embryos (10 
µg/mL, magnification: 40×). (E) DAPI stained chorionic fluid from control embryos 
showing no nuclear staining and slimy coating from Ag-np treated embryos (10 µg/mL, 
magnification: 60×, F) with clear evidence of nuclear staining. Larvae at 72 hpf: (G) 
Normal and healthy control larvae. Figures show deformities in Ag-np-3 treated (H) and 
Ag-np-2 treated (I) larvae (100 µg/mL, magnification: 2.5×). The unhatched embryos 
were decorinated using fine needles. Acridine orange staining (72 hpf): Control 
embryos (J), Ag- np-2 (K, 50 g/mL)) and Ag-np-2 (L, 50 g/mL)) treated embryos 
showing bright green spots on the skin indicating presence of apoptotic cells 
(magnification: 10×).  
 
 The heart rate of the treated embryos decreased with increase in concentration 
and reached an average of 39 heart beats/ min above a concentration of 50 g/mL of 
Ag-np-1s as compared to an average of 150-beats/ min for the control embryos 
(Figure 5.9A). Hatching delay was observed with increase in Ag-np-1 concentrations, 
15% of embryos were hatched at a concentration of 100 g/mL for Ag-np-2 (Figure 
5.9B) and 33% hatched for Ag-np-3 (Figure 5.9B) nanoparticles. The hatching delay 
was calculated from the total number of survivors in each concentration contrary to 
the total number of embryos employed for the study (number of embryos hatched at 
72 hpf/ number of live embryos ×100). Even though, the LC50 (concentration of Ag-
np-1 that killed 50% of the embryos) was between 25 - 50 g/mL, corresponding 
linearity in mortality was not observed at 100 g/mL. At 100 g/mL concentration of 
Ag- np, 15-30 % of the embryos were still alive (Figure 5.9C). No significant 
abnormalities were observed in embryos treated with starch and BSA alone. The heart 
rate and hatching was comparable to control samples suggesting absence of toxicity. 
  




















Figure 5.9: Graphs representing the toxicity of Ag-np-2 and Ag-np-3 in terms of 
heart rate (A), hatching (B) and mortality (C). A concentration dependent increase in 
mortality was observed in Ag-np2 and 3 treated embryos. Hatching delays and drop in 
heart rate was also observed as a consequence of nanoparticle treatment. The values 
are expressed as mean ± standard deviation of 3 experiments. 
  
 As described earlier, Ag+ ion will get released from silver nanoparticles under 


































































evaluated in embryos. Ag+ ions treated embryos showed no significant abnormalities 
when compared to Ag-np-1. The highest concentrations of Ag+ ions tested (20 nM) 
showed 10% mortality rate whereas rest of the concentrations showed ≤ 5% death 
(Figure 5.10A). Also, 4% embryos exhibited hatching delays compared to control. 
No other abnormalities were observed. Heart rates of treated embryos were 
comparable to control (Figure 5.10B). The development was unaffected by Ag+ ion 
treatment. The toxicity profiles of Ag-np-1, Ag-np-2 and Ag-np-3 followed similar 












Figure 5.10: Graphs represent effect of Ag+ on embryos. (A) Mortality and hatching 
rate of embryos at 72 hpf. No significant hatching delay was observed in Ag+ treated 
embryso. At 20 nM of Ag+ ions, 10% mortality was observed. (B) Heart rate of 














































5.2.10. Biodistribution of silver nanoparticles in zebrafish embryos 
 The biodistribution of nanoparticles using TEM analysis showed that the silver 
nanoparticles have an affinity for the nucleus. Most of the nanoparticles were 
deposited inside the nucleus of the cells (Figure 5.11A), whereas the cytoplasm had 
only a few nanoparticles (Figure 5.11B). The magnified view of the nucleus showed 
small clumps of nanoparticles (Figure 5.11C) along with depositions of nanoparticles 
on skin (Figure 5.11D), heart (Figure 5.11E,F), and brain (Figure 5.11G). However, 
no clumping of Ag-np-1 was observed inside the brain. The nanoparticles deposited 
inside the brain appeared to be well dispersed. Uniform distribution of nanoparticles 
was observed throughout the embryos. The energy dispersive X-ray analysis (EDX) 
of the zebrafish tissue sections showed a significantly high concentration of silver 
(Figure 5.11H). 
5.2.11. Cell cycle Analysis of single cells isolated from zebrafish embryos 
 Cell cycle analysis of cells prepared from untreated embryos showed normal 
distribution of cells in sub G1, G1, S and G2M (Figure 5.12A). Cells from embryos 
exposed to 25 (Figure 5.12B) and 50 g/mL (Figure 5.12C) also showed no 
abnormality. The cell population in the subG1 region was comparable to that in 
uncreated cells, indicating no inhibition in cell cycle progression. The comparison of 
percentage of cells showed an average 4 % increase of cells in S phase. However the 


















0 5 10 15 









Figure 5.11: TEM images of ultrathin sections of the embryos treated with 25 µg/mL 
of silver nanoparticles. Deposition of the nanoparticles in the cytoplasm (A) and 
nucleus (B) of the cells near the trunk and tail respectively. Images were captured 
using JEOL JSM 3010F. Nucleus is indicated by “n” and cytoplasm by “c”. 
Magnified images of the nucleus (C) showing nanoparticles deposition. Clumps of 
nanoparticles were seen near the epithelium (D). Low magnification images of the 
heart (E), showing dark spots containing nanoparticles. (F) Magnified images from 
heart confirming the presence of nanoparticles. The lattice plane identifies 
nanoparticles. (G) Sections of brain showing presence of nanoparticles. (H) EDS of 































G2/M S G1 subG1D
Figure 5.12: Cell cycle analysis of embryos exposed to silver nanoparticles: (A) 
histograms representing normal distribution of untreated cells in subg1, G1, S and 
G2/M. (B) shows cell cycle histograms from embryos treated with 25 g/mL of 
Ag-np-3. (C) Is embryos exposed to 50 treated embryos g/mL of Ag-np-3. (D) 
Percentage of cells distributed in subG1,G1,S and G2/M in controls and 
nanoparticle treated embryos. 




5.2.12. Gene expression in silver nanoparticles treated embryos 
 Based on the in vitro data, genes involved in double strand breaks, cell cycle 
and oxidative stress was explored. The analyses demonstrated an upregulation of 
double strand DNA break repair genes such as BRCA1, ATR, MDM2 Ku70 and Ku80 
(Figure 5.13A). ATM and RAD 51 were down regulated (Figure 5.13B). RAD 50 
levels were unchanged. Other genes such as p53 was upregulated in both 
concentrations while p21showed no significant changes. PCNA downregulation was 
also observed. The genes involved in cell cycle pathways revealed downregulation of 
cyclin E and upregulation of cyclin B, however were statistically not significant. 
Significant upregulation of cdc 2 and cyclin D1 was observed. Interestingly a 
significant upregulation of BAX, a promoter of apoptosis was observed along with the 
up regulated Bcl2. SOD2 which is an indicator of oxidative stress was observed to be 
upregulated (Figure 5.13A). Up regulation of SOD in the zebrafish embryos indicate 
that oxidative stress could be a potential source of toxicity as observed in in vitro 
models. 
 The eye defects were further screened at the molecular level by looking at the 
genes involved in the eye development. Pax6a, pax6b and BMP4 were investigated 
which showed downregulation of pax6a and b and upregulation of BMP4. 
5.2.13. Protein expression in silver nanoparticles treated embryos 
 Due to the disparity in results from in vitro systems on p53, the protein levels 
were examined for p53, p21, cyclin B and PCNA (Figure 5.13C). Western blots did 
not show any striking change in protein levels. However densitometry analysis 
showed a downregulation of p53, Gadd 45 and p21corresponding to 25 and 50 of   




Ag-np-3 concentration. P53 levels were higher in 25 µg, however down regulated in 















Figure 5.13: mRNA and Protein levels in zebrafish embryos after nanoparticle exposure. Graphs show up regulation (A) and down regulation 
(B) of genes involved in double strand DNA damage pathway and cell cycle pathway. (C) Shows Protein expression in embryos following silver 



























































































 Toxicity assays are necessary to monitor the cytotoxicity as well as ecotoxicity 
of the nanoparticles in the event of an environmental release. These bioassays help to 
assess the health risk associated with the in vivo use of nanoparticles. Experimental 
studies indicate that small size, large surface area and the ability to produce reactive 
oxygen species play a role in the toxicity of the nanoparticles (Xia et al., 2009). Our 
current studies were designed to validate the in vitro data and to study the teratogenic 
effects of the nanoparticles. These results could be extended to nanoparticles of 
similar metal type. 
 Earlier reports on metal oxide nanoparticles have emphasised the deleterious 
effects of nanoparticles in vivo and in vitro (Zhu et al., 2008). It has been observed 
that the toxicity of nanoparticles in vitro differ significantly from in vivo models. 
Silver nanoparticles are well known for its cytotoxic response; however, in rats 
inhalation of silver nanoparticles did not induce any toxicity (Kim et al., 2008). 
Similarly, gold nanoparticle is considered as non-toxic in vitro (Bakri et al., 2008), 
whereas injection of gold nanoparticle in mice has shown tissue damage and apoptosis in 
liver (Cho et al., 2009). Platinum nanoparticle has not been investigated in in vivo models 
whereas, in in vitro systems, it caused significant cytotoxicity (Gao et al., 2007). 
It is also known that toxicity of nanoparticles vary with capping agent (Chung 
et al., 2008). In this study, same capping agent was employed for all nanoparticles; to 
compare the effect between different metals. Different capping agents were employed 
for silver nanoparticles to study whether toxicity was altered by the changes in surface 
functionalisation. Toxicity studies of the capping agent alone did not show any 




phenotypic defects throughout the incubation period, strongly suggesting that the 
observed effects are the result of nanoparticles.  
 The TEM images showed that the silver nanoparticles have a tendency to get 
accumulated in the nucleus that may lead to genomic damage and instability. It was 
shown in in vitro systems that the nanoparticles could enter the cells through 
endocytosis. Electron micrographs suggest that silver nanoparticles can enter the 
embryos through their skin. This is observed as clumps of nanoparticles throughout 
the epidermis of the larvae. The formation of slimy coating around the embryos may 
be the consequence of local injury, caused by the nanoparticles while entering the 
fragile skin of the embryos. Experimental evidences suggest potential skin penetration 
of many nanomaterials including silver nanoparticles and QDs (Vlachou et al., 2007; 
Zhang and Monteiro-Riviere, 2008). The uniform distribution of silver nanoparticles 
could be a result of translocation of nanoparticles entering through the outer layer of 
the embryo and subsequent traslocation. The clearance mechanisms are less effective 
in immature embryos, since the immune cells develop at a later stage (Trede et al., 
2004). The silver nanoparticles could be translocated to various cellular organelles 
from the site of entry.  
 Earlier reports have shown that nanoparticles can translocate to brain thus 
affecting the nervous system (Oberdorster et al., 2004). Our results are in line with 
earlier reports where silver nanoparticles were observed in the brain. Nonetheless, 
presence of nanoparticles in the brain of embryos does not establish that nanoparticles 
are crossing blood brain barrier. It is also possible that the nanoparticle entry during 
early embryonic stages resulted in a uniform distribution throughout the organ 
systems as blastomeres are the precursors for various cell lineages that make up organ 




systems, viz. nervous system and circulatory system in mature larvae. However, 
nuclear deposition of the nanoparticles is believed to initiate a chain of toxic events in 
the form of oxidative stress, DNA damage or proliferation delay. 
 The silver nanoparticles treated embryos showed a normal cardiac 
morphology, with atria and ventricle differentiated normally with proper orientation 
with time. The cardiac cycle was irregular with increase in silver nanoparticles 
concentration showing a little or no pumping of blood. Accumulation of blood in 
aorta near the tail and below the cardiac cavity was common, which indicated 
obstruction of normal blood flow. Such observations suggest that the pumping of 
heart was not strong enough to restore normal blood flow and silver nanoparticles 
were interfering with the normal activity of cardiac muscles either directly or by 
blocking the energy sources that influence smooth functioning of the system. Blood 
flow cut off must have forced the cells to starve out of essential nutrients and gases 
that ultimately lead to decomposition of the body. A proper blood flow to the brain 
and spinal chord is a critical event in the survival of the larvae. Nanoparticles are 
known to interact with vascular endothelium or have direct effects on atherosclerotic 
plaque (Lam et al., 2006) or act as a site for thrombus formation (Chen et al., 2009) 
thus leading to myocardial infarctions. The observed insensitivity of the larvae to 
touch leads to a suspicion of the neurological disorder amplified by the absence of 
blood flow. The fluid imbalance is believed to be a contributing factor in bent body 
axis, so is the deposition of nanoparticles in the brain. The nanoparticle deposition in 
the brain could interfere with functioning of nervous system and signal transduction 
processes. The nanoparticle could act as a foreign body, restricting the normal activity 
of the cell or organ, where it is deposited. It is conceivable that under such 




circumstances, the larvae are not expected to survive. The observed hatching delays 
and abnormal body axis restricts the chances of survival. The non-toxicity of BSA and 
starch controls showed that the observed effects are specifically mediated by silver 
nanoparticles. Ag+ ions have been reported to have toxicity in aquatic species. Ag+ 
ions treatment induced ion regulatory impairment and increased mortality in rainbow 
trout eggs (Guadagnolo et al., 2000). Silver nanoparticles used in this study were 
washed many times in ultra pure water to ensure complete removal of residual 
capping agents and Ag ions. It is believed that Ag+ ions get released by the surface 
oxidation of Ag-np-1 under the complex physiological conditions in vivo that can 
contribute to silver nanoparticle properties like antimicrobial activity (Lok et al., 
2007). We have used Ag+ ions in our studies for comparing occurrence of phenotypic 
defects in both cases. None of the phenotypic defects observed in silver nanoparticles 
treatment was present in Ag+ ions treated embryos. This suggests that silver 
nanoparticles mediated toxicity is different from what is exhibited by its structural 
components (Ag and starch). 
It has been reported previously that chemical-induced toxicity impair cardiac 
functions thereby causing edema and various forms of axis curvatures due to impaired 
or slow pumping of blood and fluid accumulation in the body (Incardona et al., 2004). 
The edema and axis curvatures observed in platinum and silver nanoparticles exposed 
embryos are assumed to share the same mechanisms. However, the undulated 
notochord in silver nanoparticle treated embryos was observed in zebrafish even 
before the onset of circulation and involved somites thus could be due to direct 
interference with the development of notochord. Similar undulations in notochords of 
zebrafish embryos were previously observed upon treatment with cadmium, where 




cadmium skewed somite formation thus leading to kinks and undulations (Chow and 
Cheng, 2003). Zebrafish embryos exposed to quantum dots exhibited similar 
observations as well (King-Heiden et al., 2009). 
Disorders involving touch response were previously recorded for zebrafish 
embryos exposed to different chemicals. Caffeine treatment not only impaired 
neuromuscular junction and axons, but also interfered with muscle fibre alignment, 
thereby impairing the touch response and movement (Chen et al., 2008). Cadmium 
toxicity could also abolish muscle cell differentiation and axon growth skewing touch 
response and swimming of larvae (Chow and Cheng, 2003). It is possible that silver 
nanoparticles could act in similar pathways to exert the toxicity. Exposure to 
nanoparticles is known to injure the fragile skin of the embryos causing tissue 
damages as observed for metal oxide nanoparticles (Zhu et al., 2008). Such skin 
irritations can cause secretion of mucus to the chorion fluid which could explain the 
flakes and slimy nature of the fluid. It is well known that silver nanoparticles can penetrate 
easily through such damaged skin (Larese et al., 2009). These nanoparticles could 
translocate to CNS and cause significant damage, thus causing  impaired touch response 
(Wang et al., 2008). 
 As evident from the acridine orange staining, there was only low to moderate 
levels of apoptosis occurring in the embryos. This was supported by increased Bax 
levels. Bax initiates apoptosis by forming pores on mitochondrial membrane releasing 
cytochrome c. On the other hand Bcl2 blocks apoptosis by preventing Bax 
localisation. Upregulation of Bcl2 suggests a balance between the proteins, thus 
minimal apoptosis. This is confirmed by cell cycle profiles, where no significant 
increase in sub-G1 peak was observed.  




Various forms of eye defects such as microphthalmia (small eyes) and 
anophthalmia (absence of eyes) are known to occur in in vivo models as a 
consequence of physical disruption of genes responsible for eye developments 
(Mihelec et al., 2008). Disorders of eyes occur when genes such as PAX6, PITX2, 
FOXC1, MAF, TMEM114, SOX2, OTX2 and BMP4 are disrupted (Mihelec et al., 
2008). Similar defects were reported previously in zebrafish as a consequence of 
mutations affecting chokh genes (chk mutants) which result in downregulation of 
essential genes for eye development (Loosli et al., 2003). Pax6 plays vital role in the 
development of eyes and mutations in the gene will show the phenotypes even before 
24 hpf (Kennedy et al., 2004; Loosli et al., 2003). Downregulation of the Pax gene 
support the fact that the damage occurred at the genetic level. Silver nanoparticles 
have DNA damaging effects, which might have damaged specific coding sequences.  
Based on the existing results, it is assumed that eyeless phenotypes could be 
consequence of DNA damaging effects of silver nanoparticles. Silver nanoparticle 
induced DNA damage is also evidenced by the upregulation of double strand DNA 
damage sensors such as ATR, BRCA1, ku70 and ku80. Molecular data from in vivo 
systems corroborates the in vitro data where double strand DNA damage was 
observed.  
The phenotypic defects observed in the embryos could be a consequence of 
damage (DNA damage/mutations) occurred to the embryonic precursor cells. Critical 
loss of function of precursor cells could lead to developmental defects specific for the 
organs which develop from the damaged precursor cells. The evidence of genotoxic 
stress is also provided by the upregulation of p53. Upregulation of SOD-1 supports 
the hypothesis that oxidative stress plays a significant role in the observed damage in 




the embryo. Cyclin levels were not changed significantly suggesting that the cell cycle 
was not hindered in the survived embryos. It is possible that minor disturbances in cell 
cycle in actively dividing cells of the embryo can result in fatality. Thus, the survived 
embryos even though deformed are expected to show a normal cell cycle profile. 
To determine whether metal accumulation occurs in healthy embryos that have 
no visible phenotypic defects, metal concentration was assayed and accumulation of 
nanoparticles in embryos was confirmed. This observation implies that nanoparticles, 
despite of their immediate lethal effects, could also cause detrimental effects on long 
term deposition inside the embryo body, such as organ failure. Embryos that do not 
exhibit phenotypic defects cannot be considered as healthy, as they are accumulating 
metals in their body. Similar cases were reported for many metals such as cadmium 
where accumulation of the metal was observed in fish organs (de Conto et al., 1997). 
These results indicate chances of an indirect human exposure due to consumption of 
contaminated fish.  
 The three nanoparticles employed in the preliminary study (PVA capped 
nanoparticles), were capped with the same capping agent to minimise variation in 
biological properties. Silver and platinum complexes are known to be harmful for 
cells and tissues (Mayr et al., 2009; Yamashita et al., 1993) whereas, metallic gold is 
less toxic and has more medicinal values (Bhattacharya and Mukherjee, 2008). On the 
other hand, gold in colloidal form is highly reactive, capable of exerting toxic effects 
(Brown et al., 2008). The gold nanoparticles used in this study did not result in any 
toxicity probably due to the ligand, while silver nanoparticles exhibited toxicity 












 This study employed both in vitro and in vivo models to study the toxicity of 
silver and platinum nanoparticles.  The in vitro systems were employed for 
identifying the toxicological end points which was further confirmed using in vivo 
models. Silver and platinum nanoparticles were found to be causing entirely different 
damages in in vitro and in vivo systems. 
 Silver nanoparticles were taken up by the cells through clathrin dependent 
endocytosis and macropinocytosis. Exocytosis occured in a time dependant manner in 
cancer cells which still retained significantly high concentration of silver 
nanoparticles. A uniform intracellular distribution of silver nanoparticles was 
observed in the cells. Nanoparticle deposition was observed inside mitochondria and 
nucleus. Both cell types showed nanoparticle deposition in the cytoplasm and 
organelles. Calorimetric titrations revealed the binding of silver nanoparticles with 
cytosolic proteins, which could transport nanoparticles to the nucleus through cargo 
complexes. 
 Cytotoxicity studies demonstrated mitochondrial dysfunction and induction of 
ROS by silver nanoparticles which in turn set off DNA damage and chromosomal 
aberrations. Acentric and centric chromosomal fragments were observed following 
nanoparticle treatment. DNA damage and chromosomal aberrations are believed to be 
the prime factors that resulted in the observed G2/M arrest. The fate of the cells 
arrested at G2/M interphase was analysed by Annexin V-PI staining which showed no 
massive cell death, suggesting involvement of an active DNA repair pathway. The 
cells which successfully repair the damage could re-enter the cell cycle and those with 
massive damage will not be able to repair the DNA effectively and thus will execute 




apoptosis at a later stage. Colony formation and cell recovery were studied to 
understand the inhibition in proliferation and recovery of the damaged cells which 
revealed absence of colony formation and recovery. Cytoskeletal deformities further 
suggested silver nanoparticle induced damage. Ca2+ fluctuations added on to the 
lethality of silver nanoparticles. 
 Gene/protein expression pattern revealed involvement of genotoxic stress and 
subsequent downregulation of DNA repair pathways. Improper DNA repair could be 
a reason for accumulating cells at S/G2/M phases of the cell cycle. Silver 
nanoparticles are able to down regulate many proteins involved in cell cycle 
progression and DNA repair by preventing their degradation possibly by surface 
adsorption. Silver nanoparticles can activate a variety of pathways including MAPK 
and NFκB pathways resulting in transcription of many genes involved in proliferation 
and inflammatory response. Our findings also suggest that only a small population of 
cells are undergoing apoptosis while majority are alive and are undergoing 
proliferation arrest. Our data reveal that silver nanoparticle toxicity could trigger a 
detrimental inflammatory response. A more in-depth and multi parametric studies are 
recommended to elucidate the diverse role and effects of nanoparticles on different 
types of human cells including cancer cells. Such studies will further facilitate 
accurate toxicological profiling of nanoparticles and their potential therapeutic use in 
the management of different pathological conditions in humans. 
                Platinum nanoparticles are able to induce dose dependant cytotoxicity and 
genotoxicity in normal and cancer cells. We believe that this process is initiated 
through the combined effects of platinum nanoparticles and Pt2+ released from the 
nanoparticles which causes ROS production and DNA damage. The platinum 




nanoparticles were deposited inside the cytoplasm. DNA damage is the driving force 
that activates p53 which could up regulate p21 signalling cascades leading to 
downregulation of PCNA and accumulation of cells at S phase. Cells with irreparable 
damage showed apoptosis. When allowed to recover, the treated cells including those 
accumulated in S phase formed colonies which could be a result of successful DNA 
repair and subsequent recovery from nanoparticle induced stress. Owing to the large 
area of the nanoparticle surface, it is amenable to modifications with anticancer drugs 
or anti-bodies which could augment their bioactivity through surface functionalization 
and selective targeting to cancer cells. From the toxicological point of view, exposure 
to platinum nanoparticles should be minimized to overcome undesirable side effects. 
 In vivo studies showed that, among the different metal nanoparticles tested, 
silver nanoparticles were found to be the most toxic. Our studies with the gold 
nanoparticles showed that they are non toxic at the employed concentrations and do 
not cause obvious abnormalities in developing zebrafish embryos. One of the 
significant observations from our studies includes high mortality, hatching delay, 
axial curvatures and malformed eyes among zebrafish hatched in presence of silver 
nanoparticles. Silver nanoparticles treated embryos appeared shorter compared to 
controls. Platinum nanoparticles were more toxic than gold nanoparticles, inducing 
reduced heart rate, hatching delay and axis curvatures. Metal accumulation was 
observed in embryos that appeared healthy, following exposure to low doses of 
nanoparticles. These results points out the risk associated with in vivo application of 
silver and platinum nanoparticles which could result in similar toxicity outcomes. An 
indirect human exposure is possible through consumption of fresh water fish exposed 




to nanowastes. Hence it is necessary that extreme care must be taken for nanowaste 
disposal and in vivo applications of nanoparticles.  
 The detailed study of silver nanoparticles showed that the toxicity was not 
significantly affected by the change in surface functionalisation. However the 
concentration at which the damage ocuur might be different for different ultra fine 
silver particles due to the change in silver concentration in each type of nanoparticles. 
The entire silver nanoparticle treated embryos exhibited phenotypic defects, altered 
physiological functions viz. bradycardia, axial curvatures and degeneration of body 
parts. Clumps of nanoparticles were seen throughout the epidermis of the larvae 
confirming the aberrations of skin caused by the silver nanoparticles. The presence of 
slimy coating is believed to be a result of nanoparticle entry through the abraded skin 
of the embryos. The TEM images showed the presence of nanoparticles in the brain of 
the embryos. Nanoparticle deposition in central nervous system could have 
deleterious effects, by negatively controlling the cardiac rhythm, respiration and body 
movements. The pathological events following long-term deposition of nanoparticles 
in the nervous systems and other organs remain unclear. It is proposed that the 
deposition of nanoparticles inside the nucleus of the cells led to the observed toxicity 
through various mechanisms such as DNA damage and chromosomal aberrations. 
Furthermore, the exposure of silver nanoparticles resulted in accumulation of blood in 
different parts of the body, thereby causing edema and necrosis. Gene expression 
patterns confirmed the observation from in vitro systems where double strand DNA 
damage was evidenced. Silver nanoparticle treated embryos showed no cell cycle 
arrest, but evidenced oxidative stress and DNA damage. The proposed mechanism of 
nanoparticle toxicity is depicted in Figure 6.1. 




 The phenotypic defects in platinum nanoparticle treated embryos were much 
less compared to the silver nanoparticle treated embryos. The only phenotypic defect 
was mild axis curvature. This study points out that the applications involving 
nanoparticles should be given special attention and promoted only after detailed 
studies are done. The release of untreated nanoparticle waste to the environment 
should be restricted for the well being of human and aquatic species.  Hence it is 
necessary that the biological applications employing silver nanoparticles should be 
given special attention besides embracing the antimicrobial potential. Further studies 
must be conducted in this field to achieve the deeper understanding of silver 
nanoparticles toxicity. We strongly believe that the data gathered from our 
experiments will help future research studies to unravel the detailed mechanisms of 
the nanoparticle toxicity. 
6.2. Future prospects 
 The work can be further extended to understand the kinetics of nanoparticle 
protein binding and affinities of silver nanoparticles for different proteins. Though we 
have shown that nanoparticles are able to bind to cytosolic proteins, the affinity and 
specificity for different proteins are unknown. Future studies can be directed towards 
understanding the dependence of size, charge, and amino acid composition of 
different proteins in nanoparticle-protein complex formation. As we have observed, 
nanoparticles do not bind to genomic DNA, however, the chances of them binding to 
single stranded DNA or RNA cannot be eliminated.  This could be another area for 
research. The data can be used to create a database that could be made available to 
researchers for designing nanodrugs. The mechanisms of nanoparticle toxicity could 




be explored to determine the pathways which are specifically affected by nanoparticle 















                       Figure 6.1: Proposed mechanism of action of silver and platinum nanoparticles
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